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Abstract
A novel 3-D dosimeter system comprising a leuco-dye doped plastic 3-D dosimeter 
(PRESAGE™) and an in-house CCD-based optical computed tomography (CT) scanner has 
recently been introduced. PRESAGE™ is based on a clear polyurethane matrix doped with 
radiochromic components, leuco dyes, which generate a colour change, and hence optical 
density change, on exposure to ionizing radiation.
A prototype CCD-based scanning system that has been constructed (with a similar 
configuration of a “first generation” X-ray CT scanner) provides optical attenuation profiles 
of the irradiated dosimeter following the Beer-Lambert law. A complete plane of data is 
acquired at each step, obtaining a 2D projection planar image of an object in a relatively short 
time depending on the hardware and averaging options selected. This source-detector 
combination measures parallel beam projection geometry, then the sample is rotated, and the 
acquisition is repeated until the desired number of 2-D projections has been obtained, and 
thus, data for a complete 3-D region are acquired.
This thesis focuses on dosimetry measurements of a 60 MeV proton beam and 
investigates possible LET dependence and proton energy in PRESAGE™. Experimentally, 
we observed that in the plateau region the dose-response is independent of linear energy 
transfer (LET) until we get the expected lower response of the dosimeter to the dose deposited 
at the Bragg maxima caused by the high-LET at this point. We used the track structure theory 
(TST) to give possible explanations for the LET dependence of PRESAGE™. From these 
calculations, we found that PRESAGE™, in general, is not LET independent which makes it 
unsuitable for proton dosimetry. Then we investigated the behaviour of both an optically 
absorbing and an optically scattering dosimeter using our optical-CT apparatus with the aim 
of eliminating optical artefacts due to the optical-CT scanner from that radiation induced 
effects in our measurements.
A calibration protocol/ jig system in which a standard distribution is irradiated in the 
same dosimeter thus establishing a dose conversion for each batch with specific dose 
sensitivity was carried out, yielding three-dimensional dose maps that are of sufficient 
accuracy, resolution and precision to allow verification of complex treatment deliveries.
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1 Introduction
1.1 Hadron therapy
The aim of radiotherapy is to deliver a localised, precise and conformal dose to the target, to 
achieve tumour control, while minimizing complications by limiting the dose to normal 
tissue. Hadron therapy is a highly localised form of radiation therapy that employs subatomic 
particles called hadrons. Strictly speaking, the term “hadrons” can also refer to neutrons, but it 
has become common to restrict the name hadron therapy to treatments that employ positively 
charged particles, such as protons, helium ions, carbon ions, neon ions and oxygen ions. 
Hadron therapy was proposed for the first time by the nuclear physicist Robert Wilson in 
1946 [1].
Hadrons have a well-defined range of penetration in tissues which can be adjusted by 
varying their energy; they exhibit an inverse depth dose profile and deposit most of their 
energy at the end of their path in the so-called Bragg peak. Conversely, clinical photons are 
characterised by an exponential dose fall-off with depth, and clinical electrons have a limited 
range of penetration (< 10 cm) in tissue and at high electron energies, the depth-dose fall-off 
is analogous to that of photon beams. These physical characteristics allow the delivery of high 
doses to the target while sparing surrounding healthy tissues better than with the most 
sophisticated photon techniques. In addition, hadrons produce a more spaced (sparse) 
ionization in the first part of their path that gets denser at the end (Bragg peak) with an 
increased relative biological efficacy (RBE ~ 1.1 for protons, RBE < 3 for carbon ions). This 
high RBE (due to high density of ionisation) results in clustered damage to the DNA with 
multiple double-strand breaks that is beyond the capability of repair mechanisms. Carbon ions 
are also effective against tumours traditionally considered to be radio-resistant.
One of the most relevant experiences employing proton beams began in 1973 where 
patients with ocular tumours were treated at Harvard Cyclotron Laboratories (HCL) in a 
collaborative effort that included the Massachusetts General Hospital (MGH) and the 
Massachusetts Eye and Ear Infirmary. Constable and Koehler recognized that proton beams 
are well suited for treating intraocular neoplasms, and a dedicated proton beamline was 
installed for ocular treatments at the Harvard Cyclotron Laboratory in 1975. The patient 
outcomes with heavy particle beam therapy appear efficient as an optimal alternative therapy
2to 125I or 106Ru plaque radiation therapy [2]. The outcome prompted the construction in 1992 
of the first hospital-based proton therapy facility in Loma Linda, California. Treatments with 
other species of ions (e.g. helium, neon, etc.) were initially performed at the Bevalac 
Laboratories of the University of California at Berkeley in California but were not 
subsequently pursued in the USA. The Heavy Ion Medical Accelerator in Chiba (HIMAC) , 
was the first hospital-based facility to employ ions, and it began operation in 1994 in Japan 
where carbon ions were chosen as the most promising particles. Carbon ions have also been 
employed in Hyogo Ion Beam Medical Centre, Hyogo and in a physics research centre in 
Germany (Gesellschaft fur Schwerionenforschnung (GSI), Darmstaadt). For so many years, 
hadron therapy was available only in a few centres throughout the world, but nowadays there 
is much interest in this treatment modality in the oncology community, mostly protons and 
carbon ions. For example, Compact Particle Acceleration Corp. through a collaboration with 
scientists at California’s Lawrence Livermore National Laboratory (LLNL) are currently 
marketing a revolutionary proton therapy system that is compact, cost-effective, and that 
could be installed in existing radiation therapy facilities [3].
More than 50,000 patients have been treated with protons worldwide, and over 3,000 
patients have been treated with carbon ions up to now [4].
1.2 Dynamic radiation therapy
Conventional external photon radiation therapy has progressed considerably over the years 
with the development of three-dimensional conformal radiation therapy techniques such as 
achieved by Intensity Modulated Radiation Therapy (IMRT), and is becoming standard of 
practice. In turn, it is now possible to use inverse dose optimization algorithms similar to 
those created for intensity-modulated radiotherapy and therefore to perform the so-called 
intensity-modulated particle therapy (IMPT), which can fully exploit the favourable physical 
features of hadrons, especially with the availability of “active” dose-delivery systems e.g. 
raster or spot scanning where the narrow beam extracted from the accelerator is scanned over 
the target volume, which is therefore irradiated one sub-volume at a time (Figure 1-1 (a)). 
Figure 1-1 (b) shows the difference in dose distribution achievable with protons using 
“passive” and “active” and dose-delivery techniques [4]. In a “passive” scattering technique, 
the width of the monochromatic Bragg peak, approximately a few millimetres, is increased to 
some centimetres to match the thickness of the target with ridge filters or with rotating 
modulator wheels; these obtained fields are then shaped with collimators and finally, the 
distal edge of each field is conformed to the target with a patient-specific bolus. In “active”
3delivery systems, individual pencil beams are sequentially delivered directly to the patient 
under computer control. High conformity is achieved by changing the dosage and the position 
of each pencil beam individually and in the lateral direction the beam is usually scanned 
through magnetic deflection of the beam ahead of the patient. The modulation in depth is 
achieved by changing dynamically the energy of the protons, and the range is adjusted as a 
function of the beam position in both transverse directions (variable range modulation).
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Figure 1-1: (a) Dose delivery with a 3-D active scanning technique (Siemens Medical), (b) Comparison of active 
and passive dose delivery techniques with the target outlined in yellow and organs at risk (OARs) in red [4],
1.3 Three-dimensional dosimetry
The conformal dose delivery achieved in modem IMPT delivery techniques results in 
complex dose distributions with high dose gradients, requiring high spatial precision. This 
necessitates accurate identification of the target and a precise and reproducible patient set-up. 
Furthermore, the doses are delivered dynamically, so that some points in the irradiated 
volume do not receive their dose until the end of radiation treatment. The dose measurement 
required for the verification of IMPT dose delivery is very labour intensive and often 
impractical with the available traditional dosimetry (e.g., using ion chamber, TLD, or film 
techniques). There is, therefore, great interest in developing new three-dimensional 
verification techniques that provide improved dosimetry techniques.
Dosimeters can be categorized as point (0-D), linear (1-D), planar (2-D) and 
volumetric (3-D) dosimeters. Three-dimensional measurements are often approximated by
4scanning with lower dimensional detectors e.g. 3-D dose distributions are measured by 
scanning a single (0-D) ion chamber in a water phantom along 3 orthogonal directions, a 
linear array of ion chambers (1-D) in two directions or a planar array of detectors (2-D) in one 
direction. An alternate 3-D approach is to fill a volume with 0-D, 1-D or 2-D detectors. These 
limitations in conventional dosimeters spurred the development of gel dosimetry. Gel 
dosimeters mimic the target and surrounding volume sufficiently well that contouring and 
imaging are possible and the complete planning and delivery validated.
Day and Stein were the first group to experiment with and look at the chemical 
effects of ionising radiation in gels containing dyes (methylene blue), which are reduced with 
a change of colour on irradiation, in the search for a suitable system which would enable 
three-dimensional distributions of absorbed energy to be demonstrated [5]. Gel dosimetry 
however, is founded mainly on the work of Gore et al (1984) who demonstrated that changes 
due to ionising radiation in Fricke dosimetry solutions could be measured using nuclear 
magnetic resonance (NMR) [6]. Gore et al. [7] and Maryanski et al. [8] demonstrated the 
potential of optical-CT as an alternative and low-cost imaging technique to MRI for 
polyacrylamide gel (PAG)-type polymer dosimeters. They designed the first scanner in the 
OCTOPUS™ series, now commercially available from MGS Research Ltd. Optical imaging 
is important, since access to MRI, the “gold standard” imaging modality, is often very limited 
for radiotherapy departments given the long waiting lists for patients requiring diagnostic 
scans. Since the introduction of optical-CT many other scanner designs have been evaluated 
and built; these fall into two categories: a laser scanning system coupled to a photodiode 
detector [7, 9] and an incoherent light source coupled to a CCD detector [10-12].
1.4 Prior work at the University of Surrey
A prototype CCD-based scanning system was first constructed at the University of 
Surrey in 1999 [13] which provides optical attenuation profiles of irradiated dosimeters. A 
complete plane of data is acquired at each step, obtaining a 2-D projection in a relatively short 
time typically between 50 ms and 5s, depending on the hardware and averaging options 
selected. This source-detector combination measures parallel beam projection geometry, then 
the sample is rotated, and the acquisition is repeated until the desired number of 2-D 
projections has been obtained, and thus, data for a complete 3-D region are acquired. A 
schematic diagram that illustrates the operation of the improved prototype optical computed 
tomography (CT) device is shown in Figure 1-2.
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Figure 1-2: Parallel beam geometry optical-CT at University of Surrey [10].
In the continually evolving area of 3-D dosimetry, a new class of polymer dosimeter 
PRESAGE™ (Heuris Pharma, Skillman, NJ) was proposed in 2003 based on clear 
polyurethane combined with a leuco-dye. The components of the dosimeter include an alkyl 
diisocyanate prepolymer, a hydroxyl reactive polyol along with a catalyst, which polymerises 
into optically clear polyurethane. Although not suitable for MRI evaluation, this tissue- 
equivalent dosimeter contains a leuco dye which in its oxidised form has a maximum 
absorbance at a wavelength of 633 nm and is therefore suitable for evaluation with 
commercially available optical scanning systems. PRESAGE™ has many favourable 
characteristics for optical-CT dose readout, including non-requirement of an external 
container, linear radiochromic response based on light absorption not light scattering, 
robustness in a lab environment and post-irradiation spatial stability of the radiochromic 
response, making PRESAGE™ a clinically convenient and viable integrating 3-D dosimeter 
tool. Previous work at the University of Surrey has investigated the use of PRESAGE™ 
combined with optical-CT in photon [14] and electron [15] teletherapy and brachytherapy 
[16].
1.5 Project aims and thesis layout
Previous successful work suggested that 3-D dosimetry applied to proton therapy 
should be an attractive option. The overall aim of this PhD project was thus to investigate the 
potential of this new technique. Initial experimental results (Ch.3) showed that the 3-D 
imaging part of the project was highly successful, but revealed a significant under-response of
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6the dosimeter in regions of high-LET. In order to explain this, the physical mechanisms of 
dose deposition in PRESAGE™ were investigated (Ch.4).
A further important aspect of proton dosimetry is the wide dynamic range of dose 
deposited (factor of 4.5 difference between entrance dose and Bragg peak). A second strand 
of the thesis project thus addressed the question of how well the optical-CT system was able 
to measure dose in very attenuating samples (Ch.5). Finally, it is clear that calibration in 
radiotherapy dosimetry is vital and thus the last part of the thesis was concerned with this 
topic.
The layout of the remainder of this thesis is thus as follows: In Chapter 2, the 
theoretical aspects of the interactions of hadron beams with matter are described and an in- 
depth study is made of the radiobiological effectiveness and clinical uses of hadron beams. 
The available particle accelerators are described, along with the fundamental quantities and 
units for ionizing radiation which play a key role in radiation dosimetry.
Chapter 3 presents preliminary experiments in which PRESAGE™ samples were 
irradiated with a 62 MeV proton beam at the Clatterbridge Centre for Oncology (CCO) and in 
which the optical-CT dosimetry results were compared with the current “gold standard” of 
ionisation chamber measurements. The key interest whether a similar under-response of the 
dosimeter would be observed, compared to that seen in other studies with polymer gels [17- 
20] to the dose deposited at the Bragg maxima caused by the high-LET at this point compared 
to x- or gamma irradiation.
To explore and understand the physical processes that cause the under-response in 
our dosimeter, we devote Chapter 4 to the interpretation and analysis of the results of 
Chapter 3 using a radiological model known as the track structure theory (TST), first 
introduced by Katz in the late 1960s. This model is mainly based on statistical (cumulative 
Poisson distribution) single/multiple hit interaction of the dose deposition mechanism where 
sensitive sites or targets susceptible to single-hits lead to linear behaviour whereas multiple 
hits lead to a supra-linear dose-response. The model has successfully described and predicted 
the response of heavy charge particles (HCPs) for many different dosimeters and biological 
systems by folding the x- or gamma response of the dosimeter with a dose distribution around 
the track of the HCP.
Chapter 5 investigates the behaviour of both an optically absorbing radiochromic 
dosimeter and an optically scattering gel dosimeter using our optical-CT apparatus with the
7aim of discovering optical artefacts resulting from our optical-CT apparatus rather than from 
genuine effects resulting from radiation-induced dose-dependent optical density increases. I 
investigate the causes of these image artefacts and whether they can be corrected or 
eliminated.
Chapter 6 investigates a calibration protocol proposed by De Jean et al [21] in which 
PRESAGE™ dosimeters are irradiated with standard x-ray distribution establishing a dose 
conversion i.e. 3-D dose map for a particular batch with specific dose sensitivity with 
sufficient accuracy, resolution and precision to allow verification of complex radiosurgery 
deliveries.
Finally, Chapter 7 collects and summarizes the experimental and theoretical results 
from each chapter, and discusses their significance, providing pointers for future work.
82 Theoretical aspects
2.1 Introduction
Shortly after Roentgen’s discovery of x-rays in 1895, their therapeutic as well as diagnostic 
benefits were recognised [22]. Low-voltage x-rays were first used for skin tumour irradiation 
in 1896 and thus began the concept of employing ionising radiation for the treatment of 
various diseases, mainly oncological ones. However, dose delivery was limited by the 
physical parameters of the depth dose distribution and the lateral scattering of the beam 
associated with the penetration of a thick target like that of the human body. For low energy 
x-rays the depth dose profile is far from optimal as at energies of even hundreds of keV, the 
dose maximum is at the skin, and the dose then decreases exponentially with depth [23]. This 
will result in deep-seated tumours receiving a rather low dose compared to the dose delivered 
to the skin and tissues in the x-ray path. This disadvantage was later rectified with the 
introduction of new and better external beam therapy units. First, came the widely used 
artificial radioactive source therapy units such as the Co-60 therapy unit with a mean gamma 
energy of 1.25 MeV [24]; these provided a build up effect with a noticeable shift of the 
maximum dose below the skin. Then high-energy electron accelerators emerged. These units 
are capable of producing bremsstrahlung beams with energies in the supervoltage range [25], 
that is, above 2 MeV. There, at 2 MeV, the maximum dose is located 3 cm below the skin, 
followed by a slowly decreasing exponential curve, allowing a higher dose to deep-seated 
tumours, and most radiosensitive skin tissues can thus be spared.
Ideally, the objective of radiation therapy is to deliver a sufficiently high dose to kill 
the tumour cells without exceeding the radiation tolerance dose of adjacent normal tissues that 
are not considered to be at risk of containing tumour cells.
The recent availability of highly sophisticated three-dimensional treatment planning 
systems [26], with complete access to integrated multimodality imaging [27, 28], beam’s eye 
view, three-dimensional dose distribution and dose-volume histograms, can now provide a 
complete representation of the irradiated target volume. In addition, on-line imaging systems 
[29] and digitally reconstructed radiographs (DRRs) allow verification of patient positioning
9during each treatment session and comparison with previous sessions. Also, the recent 
development of three-dimensional conformal radiotherapy has allowed the radiation beam to 
conform to the treatment volume by means of multileaf collimators containing multiple pairs 
of thin leaves that can be moved independently to obtain any desired field shape [30]. 
Modulation of the beam intensity profile, either through beam scanning, dynamic beam 
shaping or elaborate beam modulators, has further improved control of dose distribution [31]. 
Finally, computerised control of the whole radiotherapy process allows complex and accurate 
treatments that were not possible with conventional radiotherapy units [32].
Despite all this, experience with conformal radiotherapy has shown that local tumour 
control cannot be achieved with some tumours, called radio-resistant tumours and that 
sometimes even with radio-sensitive tumours one cannot achieve the desired conformity 
because of the unavoidable associated dose to nearby critical body structures like the spinal 
cord. This disadvantage is evident even with intensity modulated radiation therapy [33] where 
multiple fields (up to 10) are targeted on the tumour volume from different directions.
The transition from electromagnetic radiation to hadron therapy, which uses neutrons, 
protons, and heavier ions like carbon, could be regarded as the next logical step to improving 
the efficiency of external radiotherapy. The radiotherapeutic benefit of heavy charged 
particles is that they offer both improved dose distributions because of a relatively rapid fall- 
off of dose with depth beyond the target volume and an improved biological efficiency of cell 
killing in the target volume relative to that achieved in the entrance region. Note that the 
superior physical properties of charged hadron beams could not be fully exploited without the 
improved target definition, meticulous treatment planning and highly accurate delivery 
recently developed for conventional photon therapy.
Much of the initial research in hadron beam therapy took place in physics 
laboratories, as therapy was feasible only with the help of the nuclear physics community, 
which had developed the high-energy accelerators for basic physics research. Current 
advances in photon therapy technology helped lay the foundation for the development of 
hospital-based accelerators dedicated to particle therapy.
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2.2 Physical interactions of hadron beams
The term hadron describes compound subatomic particles made of quarks and antiquarks, 
bound together by the strong nuclear force. It includes all ions [34].
The hadrons employed today in radiation therapy are neutrons, protons, pions and 
light ions such as helium, carbon, oxygen and neon (Figure 2-1).
p(66) /  Be neutrons100
200 MeV protons, 
8 MV X-Rays jf
80-
Co
40-
20 - t-^ 20  MeV electrons
Depth in water (cm)
Figure 2-1: Depth-dose-distribution of Co-60,20 MeV electron, 200 MeV proton, and neutron (produced by 66 
MeV protons imparting on beryllium (Be) target) beam [35].
The therapeutic advantages of hadron beams when compared to electron and photon 
beams are: (i) the ability to deliver the dose to the tumour with greatly improved control of 
the macroscopic spatial distribution, thus sparing the normal tissues surrounding the irradiated 
tumour that are traversed by the beam, and (ii) the ability to vary the radiobiological effects of 
the radiation by influencing the pattern of the energy deposition at the microscopic scale.
This distribution is influenced by the energy and atomic number of the impinging 
hadrons. One often speaks of hadrons as densely ionising radiation as opposed to sparsely 
ionising radiations such as x- and gamma rays.
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2.2.1 Interaction of Photon Radiation with matter
For x- or gamma rays, the energy is partially or completely transferred from the 
electromagnetic radiation via Compton scattering, photoelectric absorption, and pair 
production into more or less energetic electrons [36]. The processes that are of interest here 
are the primary ionisation effects of these electrons and their subsequent electron cascades. 
When striking the penetrating material, the primary intensity of the beam (i.e. the intensity 
incident on the absorber) decreases exponentially with the penetration depth and the beam 
does not have a finite range. In addition, the lateral scattering of the secondary electrons is 
large. The absorption process is described as [36]:
I  =  I oe - (M»-p. 2 1
where I is the remaining intensity after penetration of a material’s layer of thickness t and 
density p. The proportional factor p/p in units of cm2/g is called the mass absorption 
coefficient. This coefficient is a function of incident energy and the atomic composition of the 
absorption material (otherwise known as the cross-section).
When a photon interacts with the electrons in the absorbing material, part or all its 
energy is converted into kinetic energy of electrons. In the former case, the photon will be 
scattered with reduced energy, and will interact again with a partial or complete transfer of its 
energy to the electrons. The fraction of photon energy transferred into kinetic energy of 
charged particles per unit thickness of the absorber is given by the energy transfer coefficient
(Ptr).
The electrons that are set in motion will mainly lose their energy by inelastic 
collisions (ionisation and excitation) with the atomic electrons of the absorbing material but 
will also lose energy via bremsstrahlung interactions (refer to section 2.2.4) with the nuclei. 
The bremsstrahlung energy is radiated out of the local volume in the form of x-rays and is not 
included in the calculation of the locally absorbed dose. The energy absorption coefficient 
(Pen) is the product of the energy transfer coefficient and (1-g) where g is the fraction of 
energy of the secondary charged particles that is lost due to bremsstrahlung.
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The attenuation coefficient varies with the photon energy and the atomic number of 
the absorber, and the resultant total mass attenuation coefficient will be the sum of all the 
individual coefficients for the different types of photon interactions:
where acoh, x, c c, and 7t are the attenuation coefficients for coherent scattering (<10 keV), 
photoelectric effect, Compton effect, and pair production, respectively ([37], p.63).
As the scope of this work does not include interaction of photons with matter, the 
reader is to refer to other literature for a detailed description.
2.2.2 Interaction of Heavy Charged Particles with matter
2.2.2.1 Electronic energy loss
Heavy charged particles interact with matter primarily through Coulomb forces between the 
positive charges of the nuclei and the negative charge of the orbital electrons within the 
absorber atoms [36]. In regard to the latter, depending on the proximity of the encounter the 
electrons are either raised to a higher-lying shell within the absorber atom (excitation) or 
removed completely from the atom (ionisation). The energy that is transferred to the electron 
has an immediate effect on the charged particle: its speed is decreased and its trajectory 
changed as the result of the encounter. The maximum energy that can be transferred from a 
charged particle of mass M with kinetic energy Ek to an electron of mass m in a single 
collision is about 1/500 of the particle energy per nucleon. Since this is only a small fraction 
of the total energy, the primary particle must undergo many such interactions to lose all its 
energy. So the net effect is to decrease its speed quasi-continuously until the particle is 
stopped.
The maximum energy that a charged particle can lose in a collision with an atomic 
electron is calculated via the expression Qmax = 4mMEk/(M  + m)2 where Ek =M V2/2 is 
the initial kinetic energy of the incident particle, M is the mass of the charged particle, m is 
the electron mass at rest ([3 8], p. 109).
2-2
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Calculation of Qmax enables one to understand part of the physical basis for the 
different kinds of trajectories seen for electrons and for heavy charged particles in matter [38]. 
Further details about charged-particle penetration can be deduced from the spectra of single­
collision energy losses to atomic electrons, which reflect the effects of the binding energy of 
the electrons in atoms.
The products of these collisions in the absorber are either excited atoms or ion pairs 
[36], Each ion pair is made up of free electron and the corresponding positive ion of an 
absorber atom. At the end of the slowing down process (track), the ion pairs have a natural 
tendency to recombine to form neutral atoms.
In close encounters, electrons ejected from a parent atom, may themselves have 
sufficient kinetic energy to create further ions. These energetic electrons are sometimes called 
delta rays (8-rays) and represent an indirect means by which the charged particle energy is 
transferred to the absorbing material.
In fact, the majority of the energy loss of the primary charged particle occurs via 
these 8-rays. The range of these electrons is relatively small compared with that of the 
incident energetic particle, so the ionisation is still formed close to the primary track. On a 
microscopic scale, one effect of this process is that the ion pairs have a tendency to form 
many ‘clusters’ of multiple ion pairs distributed along the track of the particle (Figure 2-2).
Incident Partic le
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'Delta Ray
Figure 2-2: Representation of the track of an ionising particle in matter [39].
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2.2.2.1.1 Stopping power
The average rate at which a particle loses energy per unit path length is defined as the 
stopping power (S) of the absorber medium. The stopping power is a function of the mass, 
charge, velocity of the ion, the atomic number and density of the medium. This energy loss is 
a statistical process because the amount of transferred energy in each collision varies. The 
stopping power for the energy range of projectiles relevant in radiation therapy is described in 
the following Bethe-Bloch formula [40]:
s = - ®
dx ]
2( 4jiZpNA
L4jce„ J , Am e0)2 ( E « w >
2-3
where z is the projectile effective charge, Z, A and p are, respectively the atomic mass 
number, atomic number, and density of the stopping material, NA is Avogadro’s number, nig is 
the electron mass, <EB(e)> is the averaged ionisation energy of the stopping material, and D (= 
(3c) is the relativistic ion velocity. The relativistic expression for the maximum energy transfer
is Qmax = 27mV2/ l  + 2ym/M + m2/M 2 wherey = l/- \/l- P2 , M is the heavy particle rest 
mass, V = n, and m = me.
The overall energy dependence can be written as a function of the ion energy using an 
exponent k if all constants are combined.
( const.'!
2-4dx Ek
The dominating term in the above expression varies as 1/u2: a smaller contribution 
comes from the logarithmic term. Equation 2-4 is an empirical approach which has been 
proven reliable if k  ~ 0.8 for practical calculations.
By a simple numerical integration of Equation 2-4, the range of particles in matter 
can be calculated:
r = M ( M “ e1+‘
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The range of a particle is defined as the distance it travels before coming to rest. The 
inverse of the stopping power gives the distance travelled per unit energy loss. Thus, the 
range R of a particle of kinetic energy Ek is the integral of this quantity down to zero energy. 
It is evident that as the energy decreases, the stopping power increases. Therefore, the number 
of ions produced in the medium per unit path length (ionisation density) increases, until the 
end of range is reached. This is illustrated in the Bragg curve (Figure 2-3).
6
!C- ions (270 MeV/
Photons (21 MeV)
4
Protons (148 MeV/ u)
2
0
0 50 100 150
Depth in water (mm)
Figure 2-3: The Bragg peak (depth of maximum ionisation density) for protons of 148 MeV/u and 12C-ions of 270 
MeV/u compared to that of photons (Dmax) in water [40].
To determine the dependence of the stopping power from the ion velocity, Equation 
2-4 can be re-written as:
—  ocZ2f(0)) 
dx 2-6
Here, the dependence on the actual charge z of the projectile is emphasized. This 
leads to the range of the particles to be expressed as a function of the ion velocity f (d):
n [° dE me 
” (dE/dx) 06 z2 2-7
This equation is very useful for estimating the range of a charged particle in matter.
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Equation 2-3 also shows the dependence on the density of the stopping medium, 
which is given for a fixed charge by:
\
2
The mass stopping power, -  dE/pdx with units of MeV cm2 g'1 is a useful quantity as 
it expresses the rate of energy loss of the charged particle per g cm'2 of the medium traversed.
To summarise [34], the energy lost from the primary ions is mostly transferred to the 
electrons. Depending on the initial energy, 65% to 75% of the energy losses are transformed 
into kinetic energy of the electrons; 15% to 25% is needed to overcome the binding energy 
and only 5% to 15% are consumed for electronic excitation. According to this distribution, 
most of the electrons are liberated from their atomic binding. These electrons then dissipate 
their energy in some distance from the primary collision forming a track of ionisation around 
the projectile trajectory.
In radiobiology, it should be possible to predict the biological damage by a 
comparison of this track structure with the geometry of the biological relevant molecule 
DNA.
The stopping power is also referred to as the linear energy transfer (LET) of the 
particle, usually expressed in keV/pm ([41], p.114). The stopping power and LET are closely 
associated with the dose delivered by charged particles, charged recoil particles produced by 
incident photons, or neutrons, and with the biological effectiveness of different kinds of 
radiation. For a fuller discussion, see section 2.3.2.
Stopping power is calculated from energy-loss spectra where for a given type of 
charged particle at a given energy, the stopping power is given by the product of (1) the 
probability p per unit distance of travel that an electronic collision occurs and (2) the average 
energy loss per collision, Q ^ .  The former is called the macroscopic cross-section, and has 
the dimensions of inverse length. The latter is defined as [38]:
1 dE Z , 2me0) oc—in —Y-r
P dx A \ ( e b{c)
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Qavg =  f ""  Q W (Q )dQ*Vmin
2-9
where is the minimum (threshold) energy transferred (Qmin > 0) for excitation or 
ionisation of an atom, and W(Q)dQ is the probability that a given collision will result in an 
energy loss between Q and Q + dQ, with Q expressed in eV.
As a result, the stopping power is given in MeVcm'1 by:
Hence, the stopping power depends upon the type of particle, its energy, and the 
medium traversed.
2.2.2.1.2 Restricted Stopping Power
The stopping power gives the energy lost by a charged particle in a medium ([38], p. 157). 
However, this is not always equal to the energy absorbed in the target, especially if the target 
is small compared with the ranges of the secondary electrons {delta rays) produced. On a 
biological scale, living cells have diameters of the orders of microns (lO^cm), and subcellular 
structures are many times smaller (DNA double helix- 20A). Delta rays and other secondary 
electrons effectively transport energy out of the original site in which it is lost by a primary 
particle.
The concept of restricted stopping power was introduced to associate energy loss in a 
target more closely with the energy that is actually absorbed there. The restricted stopping 
power,-(dE/dx)A, is defined as the linear rate of energy loss due only to collisions in which the 
energy transfer does not exceed a specified value A. To calculate this quantity, one integrates 
the weighted energy-loss spectrum only to A, instead of to Q ^ .  Thus, the restricted stopping 
power is defined as [38]:
dE
dx
pQavg =p  f maxQW(Q)dQ 2-10
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where different values of A can be selected depending on the application (e.g. -(dE/dx)iooev), 
and Qmax or oo is used to designate the usual stopping power [38]:
2.2.2.1.3 Specific Ionisation
The specific ionisation is the average number of ion pairs that a particle produces per unit 
distance travelled [38]. This quantity is useful when studying the response of materials to 
radiation and in interpreting some biological effects. The specific ionisation of a particle at a 
given energy is given by the quotient of the stopping power by the average energy required to 
produce an ion pair at that particle energy. For example, the stopping power of air for a 5- 
MeV alpha particle is 1.23 MeV/cm, and an average of about 36 eV is needed to produce an 
ion pair. Hence, the specific ionisation of a 5-MeV alpha particle in air is equal to (1.23 x 106 
eV cm 1)/(36 eV) = 34,200 cm'1. The stopping power of water or soft tissue for a 5-MeV alpha 
particle is 950 MeV/cm, and an average of about 22 eV is needed to produce an ion pair. 
Hence, the specific ionisation = 4.32 x 107 cm'1.
2.2.2.1.4 Energy and Range straggling
When a charged particle penetrates matter, statistical fluctuations occur in the number of 
collisions along its path and in the amount of energy lost in each collision ([38], p. 161). 
Consequently, a number of identical particles starting out under identical collisions will show 
(a) a distribution of energies as they pass a given depth and (b) a distribution of pathlengths 
traversed before they stop. These phenomena of unequal energy losses under identical 
conditions, and the existence of different pathlengths are called energy and range straggling 
respectively. The effects of these phenomena will be discussed further in section 2.3.4.
2-12
19
2.2.2.1.5 Multiple Coulomb Scattering
Another phenomenon that is considered in particle penetration is the elastic scattering from 
atomic nuclei via the Coulomb force ([38], p. 166). The path of a charged particle in matter 
deviates from a straight line because it undergoes frequent small-angle nuclear scattering 
events. Another effect of multiple Coulomb scattering is that it causes a spread of a pencil 
beam of charged particles into a diverging beam as it penetrates a target. The magnitude of 
the spread increases with the atomic number of the material. This is an essential factor in 
charged-particle beams radiation therapy as it significantly diminishes the dose that can be 
concentrated in a tumour, particularly when it is located at some depth in the body.
2.2.3 Nuclear Energy loss
The most important energy loss mechanism for charged particles is the interaction of the 
effective charge with the target electrons but at very small energies (E < lOkeV/u) the nuclear 
energy loss is more dominant [34]. Nuclear energy loss is caused by the scattering of the 
projectile at the screened nuclear potential of the target atom as in Rutherford scattering or 
alpha-particle-induced reaction. The recoil energy transferred to the target atom is higher than 
the binding energy; as these atoms are released from their chemical environments, this can 
trigger a chain reaction if the kinetic energy is big enough. Nuclear energy loss is biologically 
very efficient when the biological target molecules like DNA are hit directly. However, the 
dominance of nuclear collision process is restricted to very low energies and to very small 
volumes. Therefore, for the radiobiological and therapeutical benefits nuclear stopping is not 
considered and the observed effects are caused mainly by the interactions with the electrons 
(Figure 2-4).
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Figure 2-4: Schematic representation of energy loss of heavy charged particles [34].
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2.2.3.1 Fragmentation
As mentioned earlier, heavy charged particles interact with matter primarily through Coulomb 
forces between their positive charge and the negative charge of the orbital electrons within the 
absorber atoms whereas nuclear interactions are less dominant. However, nuclear interactions 
play a significant role in heavy ion beams, in which the primary beam, may fragment into 
lower atomic number particles [42, 43]. Here, the mean free path for nuclear interactions is 
about 20 g/cm2, whereas the range required for radiotherapy is approximately 25 g/cm2 [41]. 
This implies that a substantial fraction of the particles will fragment. Fragmentation is 
dependent on the atomic mass and increases as a function of the atomic mass to the 2/3 
power. The presence of fragments from the primary beam has two major effects. First, the 
production of fragments diminishes the depth dose advantages of very heavy ions relative to 
photon radiations as the nuclear fragments are peaked in the forward direction and have 
residual ranges several centimeters greater than the primary beam. This results in the 
irradiation of tissues distal to the target volume. Second, the LET of the nuclear fragments is 
lower than the primary beam quality and dilutes the high LET within the spread peak. 
Therefore, the choice of ion for radiotherapy may depend upon evaluation of this most 
important parameter, whether or not dose localization or enhanced biological effect through 
high-LET is more important for tumour control.
2.2.4 Electrons and positrons
All charged particles suffer collisional energy loss -  (dE/dx)coi when passing through matter, 
including fast electrons and positrons (Equation 2-3). However, compared to heavy charged 
particles, fast electrons tend to follow a much more tortuous path through absorbing materials 
[36]. This is due to its mass being equal to that of the orbital electrons with which they are 
interacting. This leads to large deviations in the electron path, and a much larger fraction of 
the energy is lost in a single encounter. In addition, due to their small mass an additional 
energy loss mechanism comes into play: the emission of electromagnetic radiation (dE/dx)rad, 
also known as bremsstrahlung, arises from the acceleration of the electron (or positron) by 
electrical attraction (or repulsion) in the field of the nucleus. The total stopping power for 
electrons is the sum of the collisional and radiative losses [36]:
2-13
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At energies below 10 MeV the contribution of the radiative energy loss to the total 
energy loss is relatively small. Note that at very low energies (~ 50 keV) these light particles 
approach almost the velocity of light, and equation 2-3 has to be modified as their energy loss 
as well as their range has to be calculated on the basis of the theory of special relativity. Here, 
the collisional interaction is efficient only for a short time. The quantity (dE/dx)coi is much 
smaller but the particles undergo many collisions. Thus the range is generally very different 
from the calculated path length in equation 2-5; it is much larger. Electrons lose a much 
higher fraction of their energy in collisions with other electrons and therefore the range is 
much less well defined than that of heavy particles.
Positrons behave, as long as they are fast, very similarly to electrons. However, at the 
end of their range they go into an annihilation process where they form a hydrogen-like atom 
called positronium, which annihilates into gamma quanta. The sum of energies corresponds to 
twice the electron mass 2mec2 = 1.022 MeV.
2.2.5 Neutrons
Like photons, neutrons are uncharged, and are attenuated exponentially in matter ([38], 
p.212). The interaction of neutrons with electrons, although electromagnetic in nature, is 
considered negligible. Thus, neutrons interact with matter via nuclear reactions, which depend 
strongly on their energy and the nuclei with which the neutrons collide, which can scatter via 
elastic and inelastic collisions. The scattering is called elastic when the energy lost by the
neutron is equal to the kinetic energy of the recoil nucleus ( Qmax = 4mMEn/(M + m)2). 
Inelastic scattering is when the nucleus absorbs some energy internally and is left in an 
excited state. The neutron can also be captured, or absorbed, by the nucleus, leading to 
reaction, such as (n,p), (n,2n), (n,a), or (n,y) which subsequently changes the atomic mass 
number and/or atomic number of the struck nucleus.
In general, a fast neutron will lose energy in matter by a series of (mostly) elastic 
scattering events. This slowing down process referred to as neutron moderation. As the 
neutron energy decreases, scattering continues; nevertheless, the probability of capture by the 
nucleus increases. Should a neutron reach thermal energies, it will move about randomly by 
elastic scattering until it is absorbed by a nucleus.
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The interaction with hydrogen is the most important because of the almost equal 
masses of both particles. Since the human body is 70% water, the hydrogen bound in water 
dominates the biological tissues. If a neutron collides with a proton, that proton can be 
released from its molecular structure (elastic scattering and neutron capture) and can penetrate 
as a charged particle through matter for which the Coulomb interaction then causes energy 
loss according to the Bethe-Bloch formula. Fast neutrons have been tested for external beam 
therapy and found to be effective in treating special types of cancer.
2.3 Radiobiology effectiveness of Hadron beams
2.3.1 Mechanism of cell damage by radiation
The biological effects of radiation result principally from damage to the DNA in the nucleus 
which is the most critical target within the cell; however, there are also other sites in the cell 
which, when damaged, may lead to cell death such as the induction of mutations [43, 44]. 
When directly ionising radiation is absorbed in biological material, the damage to the cell 
may be inflicted via two different pathways [44]. The first of these is called direct action, and 
refers to the direct interaction of the radiation with the critical target in the cell. The atoms of 
the target (DNA) may be ionised or excited through Coulomb interactions leading to the chain 
of physical and chemical events that eventually produce the biological damage. Direct action 
is dominant in the interaction of high-LET particles with biological materials. The second 
method is called indirect action, and refers to interaction of the radiation with other 
molecules and atoms, mainly water, within the cell to produce free radicals that can, through 
diffusion in the cell, damage the critical target. In this interaction short-lived and extremely 
reactive free radicals such as H20 + (water ion) and OH* (hydroxyl radical) with an unpaired 
valence electron are produced. These free radicals break the chemical bonds and produce 
chemical changes that lead to biological damage. A more detailed discussion of radiation 
damage to DNA can be found in the next section.
The effects of radiation on tissue as a function of dose are measured with assays. The 
results are given in the form of cell survival curves or dose response curves. Three methods of 
tissue assays are in use [44]:
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■ Clonogenic assays: measure the reproductive integrity of the clonogenic stem cells in 
tissue and result in cell survival curves.
■ Functional assays: measures tissue function such that radiation effects for various tissues 
are documented resulting in dose response curves. The response is measured on a graded 
reaction scale or expressed as a proportion of cases where reactions are greater than a 
specified level.
■ Lethality assays: quantify the number of animal deaths after irradiation of a specific organ 
with a given dose, where deduced values of the parameter defined as the (lethal) dose to a 
specific organ that kills 50% of the animals is the result.
2.3.1.1 Cell cycle
Mammalian cells in vivo can be classified into three distinct types of population [42, 44]: (1) 
continuously dividing cells (mitosis M); (2) non-dividing cells i.e. the period of DNA 
synthesis S; and (3) resting cells (G0) that can be stimulated to divide (Figure 2-5 (a)).
The S and M portions of the cell cycle are separated by two time periods (gaps) Gi 
and G2 when DNA is not yet synthesized but other metabolic processes take place. The time 
between the midpoints of two successive divisions (mitoses) is the cell cycle time. The S 
phase is usually in the range of 6-8 hours, M less than an hour, G2 in the range of 2-4 hours, 
and Gi from 1-8 hours, making the total cell cycle in the order of 10-20 hours.
There is a variation in radio-sensitivity during the cell cycle, which can be measured 
quantitatively using clonogenic assays that plot the cell survival curves when cells are 
irradiated at different stages of the cell cycle (Figure 2-5 (b)) [42].
There seems to be a general tendency for cells in the M and G2 phases to be the most 
radio-sensitive and for cells in the late S phase to be the most resistant. The sensitivity in G2 
is mainly a result of a short repair time before cell division takes place. In general, the cell 
cycle time of malignant cells is shorter than that of some normal tissue cells; however, during 
regeneration after injury normal cells can proliferate faster.
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Figure 2-5: (a) Mammalian Cell cycle [45]; (b) Variation of radio-sensitivity of HeLa cells after x-irradiation. 
Redrawn from [42].
2 .3 .1 .2  O x y g en  e ffect
Cell response to ionising radiation is strongly dependent on the presence or absence of 
molecular oxygen within a cell. The larger the cell oxygenation above anoxia, the larger is the 
biological effect until saturation occurs. Oxygen is considered a powerful sensitizing agent as 
it acts on the free radicals and contributes to the fixation of radio-lesions which would be 
reparable otherwise ([43], p.30]). As shown in Figure 2-6, the effect is quite dramatic for low- 
LET (sparsely ionising) radiations, while for high-LET (densely ionising) radiations it is 
much less pronounced. Enhancement of radiation sensitivity in the presence of oxygen is 
expressed in terms of the ‘oxygen enhancement ratio’ ,OER, defined as the ratio of radiation 
dose required to produce an effect under hypoxic conditions to the dose required to produce a 
similar effect under oxygenated conditions:
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Figure 2-6: Typical cell surviving fractions for x-rays, neutrons and particles for well oxygenated cells (dashed 
curves) and for hypoxic cells (solid curves) [44],
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For x-rays, this value ranges between 2.5 to 3.0. Therefore, hypoxic tumours are more 
radio-resistant.
2.3.1.3 Dose-rate and fractionation
For the same radiation dose, radiation delivered at a low dose rate may produce less cell 
killing than the same overall dose of radiation delivered at a higher dose rate. This is because 
sub-lethal damage repair occurs during the prolonged exposure. As the dose-rate is reduced, 
the slope of the survival curve becomes shallower and the shoulder tends to disappear.
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Figure 2-7: Fractionation survival curves. Less sub-lethal damage recovery is seen in a system with higher oc/p 
values and vice versa. Low a/p represents repair whereas high ot/p represents no repair; the smaller the size of 
fraction, the more sparing of normal tissues with low a/p [45].
This is closely related to the concept of fractionation, in which the therapeutic ratio is 
improved by dividing the dose given in the treatment into multiple fractions, delivered over a 
period of weeks. Although the total dose in such a course of radiotherapy is larger than could 
be used in a single treatment, the cancer control is better and normal tissue is spared (Figure 
2-7). The ot/p value of a tumour response or of a normal tissue damage endpoint, is a useful 
descriptor of the effect of fractionation (see section 2.3.2.1.2 & 2.3.2.2 for a detailed 
explanation). The basis for this is rooted in five primary biological factors also known as the 
five Rs of radiotherapy ([46], p.274): (1) radio-sensitivity, (2) repair of mammalian cells from 
radiation damage, (3) repopulation of the tumour and normal tissues between fractions, (4)
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redistribution of normal and tumour cells in the cell cycle, and (5) re-oxygenation of the 
tumour during the course of treatment.
As noted earlier, mammalian cells have different radio-sensitivities throughout the 
cell cycle although there is no consistent difference between normal tissues and tumours. 
Indeed, there is a close similarity between the mean lethal dose of tumours and normal tissues 
(under aerated conditions) from which they arise but, when it comes to the other biological 
factors, there are some differences that influence their response to fractionated therapy, and 
hence the iso-effect curves.
2.3.1.3.1 Repair
Reduction of the dose rate leads to an increase in cell survival owing to repair of sub-lethal 
damage taking place during irradiation. This is a complex process that involves repair by a 
variety of enzymes and pathways. Many tumours are known to be hypoxic and it has been 
reported that mammalian cells that are deficient in oxygen have diminished capacity to repair 
sub-lethal damage. The accumulated damage of fractionated therapy is then greater in 
tumours than the surrounding normal tissues that are well oxygenated. Furthermore, some 
tumour cells have little or no capacity to repair sub-lethal damage.
2.3.1.3.2 Repopulation
During fractionated radiotherapy both repair and repopulation will tend to reduce the 
effectiveness of the total radiation dose. This is due to the irradiation being extended over a 
long enough time in comparison with the renewal time of the tissue, and hence cell mortality 
is partly compensated by proliferation and the iso-effect dose increases with the period of 
irradiation. However, though both the normal and tumour cells show similar reduction in both 
cell populations, the normal cells will begin to proliferate, and do so at a faster rate than the 
tumour cells. The time interval between treatments will then allow the normal population to 
be fully restored whereas the tumour cell population will progressively decrease, and the 
number of clonogenic tumour cells might then be reduced to the level required for cure.
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2.3.1.3.3 Redistribution
Redistribution in proliferating cell population throughout the cell cycle increases cell 
inactivation from fractionated treatment relative to single session treatment. This is due to the 
fact that cells that survive a first dose of radiation will tend to be in a resistant phase of the 
cell cycle and within a few hours they may progress into a more sensitive phase.
2.3.1.3.4 Re-oxygenation
Re-oxygenation of hypoxic cells occurs after irradiation during a fractionated course of 
treatment, making them more radio-sensitive to subsequent doses of radiation. The 
mechanisms of tumour re-oxygenation are not fully understood. During fractionated course of 
treatment, the mechanisms that led to the appearance of hypoxic cells are somewhat reversed. 
The resultant tumour regression leads to improved blood perfusion of the residual tumour, 
once the killed cells and cellular debris have been eliminated. This reduction of tumour 
volume also relieves tissue compression and so improves blood flow. One possible 
explanation is the migration of the hypoxic cells towards the well-oxygenated zones. Another 
possibility is that cells surrounding the capillaries consume less oxygen after irradiation, thus 
increasing the quantity of oxygen available and thereby improving the transport of oxygen to 
the zone of hypoxic cells.
The inhomogeneous distribution of radio-sensitivity and the cell cycle block have led 
to the introduction of fractionated radiation treatment in order to redistribute radio-resistant 
cells in their proliferation status to become more radio-sensitive. The high resistivity of 
hypoxic tumour cells that become re-oxygenated during the treatment usually over a course of 
30 fractions in 6 weeks is another reason. All these factors play an important role in tumour 
cell inactivation with x-irradiation. Fractionated dose delivery enables sparing of normal 
tissues, as the survival level after each fraction is far greater than that of the target volume. 
This is achievable either by lowering the dose to the surrounding normal tissues or by having 
a larger repair capacity, i.e. a larger shoulder, for the normal tissues to that of the tumour 
cells. Then fractionated treatment can potentiate these differences and yield a greater tumour 
cell inactivation combined with sparing of normal tissue.
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With high-LET radiation these modifying factors of cell sensitivity are strongly 
suppressed. Even the repair of sub-lethal lesions plays a minor role with increased RBE 
(section 2.3.3) of high-LET radiation. The main contribution of fractionated radiation 
treatment in particle therapy is in the low RBE region as the case with protons (RBE ~ 1.1). 
Consequently for proton therapy fractionation can be regarded in the classical way as for 
sparsely ionising radiation where the treatment course of 30 fractions in 6 weeks is applicable.
The situation is far complex for heavy particles. Repair is dominant in the entrance 
path and dose fractionation improves normal tissue recovery in the low-LET region. 
However, once in the target volume channel, RBE is much higher and the arguments for 
fractionation are no longer valid. In summary, tumour inactivation efficiency becomes widely 
independent of fractionation and a hyper-fractionated regime is strongly preferable.
2.3.1.4 Therapeutic ratio
The local or regional failure to deliver tumour control doses without unacceptable effects on 
normal tissues within the treatment volume is a major concern in conventional radiotherapy 
[34j. This is illustrated in the figure below (Figure 2-8), where it is seen that the dose 
required to achieve 100% probability tumour control corresponds to a high probability 
incidence of normal tissue complications.
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Figure 2-8: Dose-effect curves for neo-plastic and normal tissues, with the therapeutic window indicated (green) 
[47],
On the basis of these observations, normal tissue complications can be reduced by 
minimising the volume of normal tissues encompassed in the radiation field; this, in turn, 
makes it possible to increase the dose to the tumour without exceeding normal tissue
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tolerance. For a typical radiotherapy treatment, the tumour control probability (prC) is ideally 
> 0.5 and the normal tissue complications probability (Pntc) ^ 0.05.
The farther the Pntc curve is to the right of the pTc, the easier it is to achieve the 
radio-therapeutic goal, the larger is the so-called therapeutic ratio, and the less likely will be 
that the treatment causes complications. The therapeutic ratio generally refers to the ratio of 
Ptc and Pntc at a specified dose level. However, it is preferably defined as the ratio of doses at 
a specified level of response (usually 0.05) for normal tissue as a result of the tumour 
response varying between one tumour and another. Thus, the tolerance of normal tissues 
represents the essential reference level.
In principle, the p-rc curve in certain tumours never reaches a value of 1.0, because 
there is usually microscopic or metastatic spread of the disease beyond the primary tumour 
site. Therefore, it is imperative that the average doses to normal tissues be kept lower than the 
doses to tumours in order to minimize treatment complications and optimise treatment 
outcomes. The therapeutic ratio varies with many factors, such as the dose-rate and LET of 
the irradiation, the presence of radio-sensitizers or radio-protectors.
2.3.2 Linear Energy Transfer
In radiobiology and radiation protection, a physical quantity that is useful for defining the 
quality of an ionising radiation beam is the linear energy transfer (LET). Whilst the stopping 
power focuses attention on the energy loss by an energetic charged particle moving through a 
medium, the LET focuses attention on the linear rate of energy absorption by the medium as 
the charged particle traverses it.
The absorbed dose, i.e., the energy deposited per unit mass is a basic quantity in 
which to measure and compare radiation effects. For a unit mass irradiated with particles, the 
dose can be calculated as the energy deposited by each particle multiplied by the number of 
particles, also defined as the particle fluence. The energy loss by a single particle has been 
already discussed in 2.2.2 (Bethe-Bloch formula).
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The term linear energy transfer (LET) has been introduced as the energy imparted to 
the biological tissue. According to the International Commission on Radiological Units and 
Measurements (ICRU), LET is defined as follows: "LET of charged particles in a medium is 
the quotient dE/dl, where dE is the average energy locally imparted to the medium by a 
charged particle of specified energy in traversing a distance of dl" [39]. However, the term 
“locally imparted” was not precisely specified, and LET was not always used with exactly the 
same meaning. That is where the Restricted Stopping Power (dE/dx)A comes in. This is 
defined as the restricted stopping power for energy losses not exceeding A ([38], p. 161).
LEToo is equivalent to the total energy loss with no restrictions in regards to the 
spectrum of the emitted electrons. The infinity sign here indicates that all electron energies 
are contributing to the energy deposition. Although LET is often found in literature with no 
subscript or other clarification, it is generally assumed that the unrestricted value is implied 
[38]. The dose imparted by particle radiation [48] can then be written as
D(Gy) = <D dE
pdx
= (1.602x 10"16)-LET •<&•- 2-16
P
LET is generally quoted with units of keV/jim and the proportionality factor is the 
energy conversion of kilo-electron volts to joules, p is the density of the stopping material 
and, as water is considered as tissue equivalent, a value of p = lkg/cm3 is used. <E> is the 
particle fluence in units of cm-2 and 1 pm= 10‘4cm.
Particles with LET values < 1 0  keV/pm are termed sparsely ionising radiation. 
Particles with LET values > 1 0  keV/jim are considered as densely ionising radiation. In 
general, high-LET radiation has a greater biological effectiveness than low-LET radiation 
(Figure 2-9).
Among the hadrons that are used, neutrons and light ions are considered to be high- 
LET particles. Protons show almost the same LET as conventional photon and electron beams 
at the entrance channel, but have an increasing LET at the end of their path in tissues.
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Figure 2-9: Absorbed energy and ionisation distribution on a macroscopic scale. This diagram illustrates the 
distribution of ionisations in a mass of 10'10g (of cell nucleus magnitude) receiving a dose of lGy to 20 000 
ionisations in 10'10g. The distribution depends on the nature and energy of the particles. A total of 20 000 
ionisations can be created by 700 electrons of 1 MeV which lose 200 eV pm'1 (in water) across the volume and 
produce 6 ionisations each per pm; the same total number of ionisations can be created by 140 electrons of 30 keV 
or 14 protons of 4 MeV whose stopping powers are, respectively, 5 and 50 times greater than that of 1 MeV 
electrons. Though, the mean density of ionisations per unit mass (2xl04ions g'1) and the dose (lGy) are the same in 
all three cases, die distribution of ionisations, spread respectively along 700,140 and 14 tracks, is different [43].
The major part of the LET is transferred to the liberated electrons as kinetic energy. 
These electrons then move away from their origin and form a track of ionisation around the 
trajectory of the primary heavy particle. Note that, the biological effectiveness depends on the 
local ionisation density, that is, on the distribution of the ionising events over the complete 
cross-section of the track. In effect, identical LET values could yield different biological 
responses, if the electrons have a different energy distribution and the track diameters are 
different. This occurs with particles of different atomic number that have the same LET but 
different specific energies (see section 2.7.4 for definition).
The track radius depends mainly on the range of the electrons with the highest 
energies, given by the following formula [40]:
E =4- m,
m.
Ep • cos 0 2-17
where Ee is the electron energy, nie is the electron mass, mp is the projectile mass, Ep is the 
projectile energy, and 0 is the scattering angle for the outgoing electrons.
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In the forward direction (0 = 0), the electron energy is at its maximum. These high- 
energy electrons are emitted initially in the forward direction, and are subsequently followed 
by scattering that homogenises the angular distribution.
The dose distribution inside this track ranges from several hundred thousands of 
grays in the central part to a fraction of a gray at the outer diameter. In the outer part of the 
track, the dose is made up of only a few electrons sparsely distributed, thus acting similarly to 
sparsely ionising radiations like x-rays. In the centre of the track (a region of a few nm in 
diameter) the ionisation density is much higher as more energy is locally deposited than 
necessary to produce the biological effect. This is defined as the ‘overkill’ effect in terms of 
cell inactivation.
2.3.2.1 Relation of LET to cell survival
An understanding of the nature of radiation damage on the cellular and sub-cellular levels 
provides insight into the potency of the radiation treatment. This information may be used to 
construct radiobiological models capable of predicting radiation effectiveness and, 
subsequently, cell survival or clinical outcome.
2.3.2.1.1 Cell death
When irradiated with a high dose, all cellular functions cease and the cell undergoes cytolysis 
i.e. immediate cell death or death in interphase. When lower doses are delivered to dividing 
cells or cells that are still able to divide, a proportion of the cells lose their capacity for 
division or proliferation. Therefore, a non-viable damaged cell that appears morphologically 
intact may still be able to synthesise proteins or DNA and may even be able to pass through 
one or a small number of mitoses. Nevertheless, this cell is eventually killed in the sense 
defined above if it has lost its capacity to divide indefinitely and if its descendants are 
doomed to die. Contrary, a viable cell is one that has retained its proliferative capacity and is 
therefore able to give rise to a colony or clone. These cells are referred to as clonogenic ([43],
p.86).
This definition is relevant in radiotherapy because a tumour is locally controlled only 
when all its cells have lost their power of indefinite proliferation whereas for normal tissues 
most of the acute or late effects of radiation are caused by loss of cellular viability.
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2.3.2.1.2 Cell survival curves
A cell survival curve describes the relationship between the fraction of irradiated cells that 
maintain their reproductive integrity i.e. surviving fraction of cells and the absorbed dose. It is 
usually plotted on semi-logarithmic co-ordinates (log S as a function of D). This type of plot 
emphasises the small values of S at high doses but is difficult to appreciate at low doses. To 
compare the curves it is more convenient to represent them by mathematical models ([43], 
p.97).
For mammalian cells, the relationship between the surviving fraction S and the 
absorbed dose D is complex but almost exponential in certain cases and is given by the 
equation:
- o d  2-18S = e
Thus, a survival curve could be characterised by an initial convex part called the 
shoulder that turns into a straight line with the slope -a.
This exponential curve is a result of the simple target theory. An ionising particle 
traversing a cell may produce a lethal event. The production of lethal events is a random 
process and the total number of lethal events is directly proportional to the dose. 
Consequently, the surviving fraction of cells is an exponential function of dose.
The lethal events produced are distributed at random among the cells, various 
proportions of which suffer 0 .. n lethal events. A mean number of lethal events per cell (A) is 
defined which is equal to the total number of lethal events produced in cells divided by the 
total number of cells.
The statistical law of Poisson states that the proportion of cells where there is no 
lethal event is equals to e'A i.e. the surviving fraction of cells. By equating the expressions S = 
e'A and S = e‘aD one sees that a  is equal to A/D. For a dose D equal to 1/a, the mean number 
of lethal events per cell is equal to 1.
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From a biological point of view, this model signifies that the death of the cell is an all 
or nothing phenomenon. The surviving cell is therefore intact, its radio-sensitivity 
unmodified, and single-hit (damage) to the target is sufficient to kill.
However, the proportion killed by a given increment of dose increases with the dose 
given; hence the shoulder part of the curve. This could mean that (i) cell death is a result of an 
accumulation of events which individually are incapable of killing the cell but became lethal 
when added together (target models) or (ii) lesions that are individually reparable become 
irreparable and cause cell death if the efficiency of the enzymatic repair mechanisms 
diminishes with the number of lesions and therefore with the dose (models based on repair).
2.3.2.2 Target theory models
The term “target” does not imply the cellular structure, damage to which leads to cell death, a 
concept that is the base of classical target theory. The widely used linear quadratic (LQ) 
model (Barendsen, 1982) states that the probability of a given cell experiencing a lethal event 
may be represented as:
P(n,A) = (xD + pD2 2-19
which leads to a surviving fraction S = e-A. The value A is dependent on the cell type, 
conditions of the exposure, and D is the absorbed dose. The type of radiation involved 
influences the shape of the cell survival curves. Factors that make cells radio-resistant are: 
removal of oxygen to hypoxic state, the addition of chemical radical-scavengers, the use of 
low dose-rates or multi-fractionated irradiation, and cells synchronized in the late-S phase of 
the cell cycle.
According to this model a cell is killed in two ways, either by a single lethal event or 
by an accumulation of sub-lethal events. If these modes of cell death are considered 
independently, the probability of survival (S) is the product of the probabilities of each type 
of lethal event:
S = S1Sn 2-20
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where S2 = e 00 is the surviving fraction due to single-hit lethal events and Sn is the surviving 
fraction following the accumulation of sub-lethal events:
Therefore,
s  _ e(-aD+pD2) 2-22
The coefficients a  and p relate, respectively, to the two modes of death and oc/(3 is the 
index of their relative importance where a/p is large when the survival curve is exponential 
and small when the shoulder is wide. The dose is expressed in Gy, a  in Gy'1, P in Gy'2, and 
a/p in Gy.
The ratio a/p is the dose of which cell death is due to irreparable lesions (linear 
component) and to the accumulation of sub-lethal lesions (quadratic component). Thus aD = 
PD2 and D = a/p where the value of this ratio is dependent on the type of cell and can be used 
to characterise the cells from a radiobiological point of view. Note that, the surviving fraction 
S depends on the total dose D but cell death by the accumulation of sub-lethal events depends 
on fractionation and dose rate owing to the phenomenon of cellular repair.
The LQ model may be analysed making the following assumptions. In some cases, 
particularly for high-LET radiation but to a small extent low-LET radiation, the energy 
deposited along a single particle track is sufficient to cause lethal damage to the cell. The 
probability of this occurrence increases linearly with the absorbed dose, leading to the linear 
term of the LQ model. The probability of two particle tracks causing ionisation damage to a 
single cell is proportional to D2, leading to the quadratic term in the model. We assume that 
the probability of three or more hits by different particles is remote, so higher order terms are 
not used. The LQ model has proven itself as an accurate descriptor for many experimentally 
determined cell survival curves.
Let us analyse the model for the important example of radiation damage to the 
double-helical DNA molecule. A single ionisation event from low-LET radiation generally 
damages only one strand. This is known as sub-lethal damage (i.e. there is the possibility for
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repair). Lethal damage requires the breaking of both strands and so requires two ionisation 
events or “hits”. If the probability for breaking one strand is given by P = bD, then the 
probability for breaking both strands is P2= (bD)2. Therefore, cell survival is given by:
S = e -b2° 2 2-23
Assume that a single hit on a single target is required to inactivate a cell. This model 
is analogous to the exponential attenuation of indirectly ionising radiation. The cell survival S 
is given by equation 2-18 where a  represents the probability per unit dose of killing a cell and 
D is the absorbed dose. With high-LET radiations survival curves are usually found to be 
exponential and can be represented by the expression S = e'aD. High-LET radiation typically 
damages both strands and so only a single hit is necessary; therefore, we can use the simple 
target theory above (A = ocD). Cell death is essentially due to directly lethal lesions, 
independent of fractionation and dose rate.
We often speak about the ‘shoulder’ of a cell survival curve. The shoulder represents 
repair. High-LET (a) damage is not repairable and therefore the curve for a-particle is simply 
a straight line on the log plot. Low-LET ((3) damage is repairable. At high doses, the |3 
damage increases more rapidly because sub-lethal damage that was repaired at lower doses 
become lethal with the induction of more DNA strand breaks.
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Figure 2-10: Survival curves for human cells exposed to x-rays, neutrons or a-particles. As the LET increases, the 
P term becomes smaller, resulting in a pure exponential curve [46].
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In summary, densely ionising radiations (high-LET) exhibit a cell survival curve that 
is almost an exponential function of dose, shown by almost a straight line on the log-linear 
plot whereas for sparsely ionising radiation (low-LET), the curves show an initial slope 
followed by a shoulder region and then become nearly straight at higher doses. This 
behaviour is typical for any radiation response, not just cell inactivation. In Chapter 4, the 
statistical (cumulative Poisson distribution) single/ multiple hit interaction of the dose 
deposition mechanism is used to predict the relative effectiveness of high-LET radiation for 
our 3-D dosimeter.
2.3.3 Relative Biological Effectiveness (RBE)
We have previously discussed the importance of absorbed dose and identified it as the 
physical parameter most widely used for relating the amount of radiation delivered to its 
effect on a system. However, absorbed dose is not entirely sufficient for this purpose and a 
further quantity, the relative biological effectiveness (RBE) has been introduced to quantify 
the elevated effectiveness of high-LET radiation. RBE is defined as the ratio between the 
absorbed dose Dx of a reference radiation (250 kVp x-rays) and that of the test radiation Dp 
that produces the same biological effect (Figure 2-11):
RBE = ^  2-24Dp
The definition of RBE is quite general; since the only constraint is that both doses produce the 
same endpoint (level of effect). The RBE of a given radiation may therefore have several 
different values if different endpoints are considered.
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Figure 2-11: The relative biological effectiveness (RBE) illustrated for cell survival curves [49].
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This relationship is illustrated in Figure 2-10 where cell survival is plotted in a semi- 
logarithmic scale as a function of dose for different radiation qualities.
A quick analysis of both curves, that is, that of x- and particle radiation, show that 
for cell survival at high doses both curves parallel each other and RBE—>1.0 whereas for high 
survival at low dose the RBE becomes larger because of the large shoulder of the x-ray curve. 
The ratio of the a  terms as the initial slope defines the maximum RBE value.
2.3.3.1 RBE Dependence on LET and Atomic Number
The RBE increases with LET until it reaches a maximum value at about 100 keV/pm. That 
corresponds to an optimal ionisation density where the proportionality of inducing a lethal 
lesion is close to one in a single particle hit. Beyond this value of optimal ionisation density 
more dose is deposited in a single particle track and the local ionisation density increases 
further but greater probabilities to induce more than one lethal lesion do not play a role in the 
efficiency of cell killing. This is attributable to an ‘overkill’ effect, based on the fact that once 
a cell has received a lethal number of ionisation events; any more will have no further effect. 
In this ‘overkill’ region, the RBE drops to values below 1.0 i.e. below sparse ionisation 
radiation.
For particles of different atomic numbers a similar RBE-LET dependence is 
observed, but this maximum RBE value is shifted to higher LET values for greater atomic 
numbers with a slight decrease in the height. The reason for this is that the same LET values 
are realised at different energies for different atomic numbers. At higher velocities the track 
diameter is larger and therefore, the ionisation density is lower. Therefore, an increase in the 
biological effectiveness requires similar ionisation densities and consequently different LET 
values.
2.3.3.2 RBE Dependence on repair
The main target of the radiation attack is the DNA as the largest molecular structure and 
carrier of all genetic information.
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The number of single strand and double strand breaks is related to the ionisation 
densities, where with increasing ionisation density, local clusters of lesions are produced with 
high probability. While the cell can repair SSB and DSB with high reliability, a complete 
repair becomes less probable for clustered lesions and the chance of cell inactivation increases 
drastically. This is true for sparsely ionising, low-LET radiation with increasing dose; 
however, for particles the high local doses are found inside the track of one individual 
particle, thus causing cell inactivation. Although the absorbed dose in a microscopic volume 
is low, this low dose can then be multiplied by a large RBE value to account for the greater 
efficiency.
2.3.4 Other High-LET Reactions important for Radiotherapy
The main reason for introducing high-LET radiation to therapy was its reduced dependence 
on the presence of oxygen.
Experiments with heavy particles show that at the maximum RBE, the difference 
made by oxygen is small and can disappear completely in the high-LET region. Figure 2-12 
shows us the variation of RBE and OER as a function of LET,*,, and confirms the increase in 
radio-sensitivity for hypoxic tumours when using high-LET radiation.
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Figure 2-12: OER and RBE versus LET [46].
Other factors that influence the radiation response to x-rays also become less 
important for particles of higher LET. Examples of these effects are cell cycle dependence of 
the radio-sensitivity and retardation in cell progression.
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2.4 Requirements for a Hadron Beam Therapy Facility
A hospital accelerator intended for proton therapy should deliver a beam of accelerated 
protons with a maximum energy of 250 MeV for a penetration depth of approximately 37 cm 
in water for deep-seated tumours [34]. This energy should also be easily controlled over a 
wide range of values (60-250 MeV) because of the need to have the depth distribution 
modified in order to accommodate the full range of typical tumour depths. To produce a dose 
rate of several Gy min'1 in a volume of 1000 cm3, the beam intensity required is around 1010 
particles per second. For heavy ion therapy including the use of helium, carbon, oxygen and 
neon ions, the beam intensities are comparable to those needed for proton therapy which leads 
to a beam current of 10-20 nA, but the energies are higher ranging from 50 to 430 MeV/amu 
[50, 51]. Modem accelerator technology that exists nowadays meets all the clinical 
requirements within a reasonable budget for hospital-based hadron therapy facilities (Figure 
2-13).
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Figure 2-13: Schematic diagram of the NPTC facility with the cyclotron and one gantry [52].
2.4.1 Hospital based accelerators
The three principal hospital-based accelerators in operation are the cyclotron, the synchrotron 
and the linear accelerator [34].
The cyclotron is a fixed-energy accelerator capable of producing a high-intensity 
continuous beam. With respect to standard linear accelerators of the same energy it has 
greater energy homogeneity, and it is more compact. Despite the fact that the conventional 
cyclotron is considered to be the most reliable in a medical facility, one of the main
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disadvantages of this conventional design is the weight of the magnet system. Depending on 
the design, this ranges from 80 to 190 tons.
The synchrotron is generally more flexible as it is able to produce proton beams of 
variable energy, and it also has a lower weight and power consumption. However, a far more 
complex ion injector system is required. The main disadvantage is the beam output, which is 
limited by the design of the injector and the pulse repetition rate. Even with a high extraction 
efficiency the maximum beam intensity that can be obtained is quite near the lower limit 
required for radiotherapy.
The linear accelerator has an adequate beam output but requires a large space 
allocation. In theory a linear accelerator can deliver beams of variable energy; however, this 
requires extraction of the beam after different stages of acceleration. A linear accelerator 
produces a pulsed proton beam.
2.4.2 General Principles of Operation
Particle accelerators are built with the aim of accelerating charged particles to kinetic energies 
sufficiently high that they can be used to produce nuclear reactions [53]. Usually the 
accelerated particles are electrons, light positive ions (H+, D+, He++), or heavy ions (for 
example, C+). The kinetic energies one can obtain depend on the design of the machine and in 
some existing accelerators energies of tens of billions of electron volts are reached. The 
energy is limited primarily by the enormous cost of these machines.
The only method for accelerating charged particles is to use an electric field in the
proper direction (Fc = qE). The different types of accelerators differ essentially in the way 
this field is produced and how it acts on the particles that are to be accelerated.
The operation of an accelerator consists of the following phases. The particles are 
injected into the machine from a “source.” Then the particles, collimated into a beam, follow 
a certain trajectory (in a vacuum of the order of 10'5 to 10~6 mm Hg to avoid being slowed 
down and deflected by collisions with gas molecules) under the action of an accelerating 
electric field (which can be continuous or pulsed) until they have reached the required energy. 
The beam is made to hit a “target,” where the desired nuclear reactions occur. The secondary
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particles produced in the reaction can then be selected, collimated, and used to study further 
reactions. In most cases, the target is placed inside the machine; but in some cases it is 
possible to extract the beam of accelerated particles from the machine and make them hit an 
external target.
The following points should be considered when evaluating the performance of a 
particle accelerator:
■ Maximum energy of the particles.
■ Beam intensity, that is, the number of particles accelerated per unit time.
■ Energy stability.
■ Energy homogeneity.
■ Collimation of the beam.
■ Type of particles.
■ Pulsed or continuous operation.
■ Cost.
Accelerators can be divided into two main groups. The first group consists of 
electrostatic accelerators, in which the particles are accelerated by applying a voltage 
difference, constant in time, whose value fixes the value of the final energy of the particles. 
The Van de Graaff and the Cockcroft-Walton accelerators belong to this group. The energy 
that can be reached is limited by the discharges that occur between the high-voltage (HV) 
terminal and the walls of the accelerator chamber when the voltage drop is greater than a 
certain critical value (of the order of 106 eV). Thus the particles can be accelerated up to only 
a few MeV (Ek = qV).
To overcome this limit one must avoid the use of electrostatic fields as they are 
conservative and their circulation is zero. The kinetic energy gained by the particles depends 
only on the point of departure and on the point of arrival and hence cannot be larger than the 
potential energy corresponding to the maximum voltage drop existing in the machine. If, 
instead, a variable non-conservative electric field is used (necessarily associated with a 
variable magnetic field by the equation curl E= -3B/3t, it is possible to find some closed paths 
along which the circulation of E, and hence the kinetic energy gained by a particle, differs 
from zero. However, if the particles are made to follow such a path many times, one obtains a 
process of gradual acceleration that is not limited by the maximum voltage drop.
43
The machines that use this principle constitute the second group of particle 
accelerators and are called cyclic accelerators. Here, the accelerating voltage corresponds to a 
small fraction of the value of the final energy attained by the particles and this is obtained by 
applying the accelerating voltage to the same particle a large number of times. The 
trajectories of the particles can either be straight or curved. In the first case we have the linear 
accelerators; in the second case we have various types of accelerators, differing only in the 
details of the acceleration process, such as the betatron, the cyclotron, the synchrocyclotron, 
and the synchrotron.
2.4.2.1 Linear accelerator
The linear accelerator, often called a “linac”, accelerates charged particles along 
approximately straight trajectories by means of alternating electric fields. The earliest linear 
accelerator was of the “drift tube” design [53] and was developed by D.H. Sloan and E.O. 
Lawrence (1938). This type of accelerator is used for heavy particles (protons and heavier 
ions).
The machine consists essentially of a series of cylindrical tubes, which are connected 
to a high-frequency oscillator. The connection between the electrodes and the supply line are 
arranged in such a way the successive electrodes have alternating polarity (Figure 2-14). The 
beam of particles is injected along the axis of this structure (inside a vacuum chamber). The 
machine is designed in a way that inside the cylinders the electric field is always zero and in 
the gaps between two consecutive cylinders the electric field alternates with the frequency of 
the generator. The length of the cylinders is chosen so that a particle, which encounters the 
required accelerating field in the first gap, crosses each tube in a time equal to the half-period 
of the generator. Therefore, this particle always encounters the field in each gap with the same 
phase as in the first, and so it is accelerated at each transit, where it receives an energy qV, if 
V is the voltage drop across the gap at the instant of the transit.
«
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Figure 2-14: Schematic diagram of the drift tube of linear accelerator with the arrows showing the direction of the 
electric field at a given time [54].
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The length 1 of each cylinder must be equal to vT/2, where T is the period of the 
oscillator and v the velocity of the particles in the cylinder. Since v increases from each 
cylinder to the next one, the cylinders are of increasing length; however, as the particles reach 
velocities near the speed of light i.e. as v approaches c (strongly relativistic particles), the 
velocity jumps become smaller and smaller and so the length 1 tends to be a constant value, 
equal to cT/2.
The main disadvantage of this type of linear accelerator is that if the velocity of the 
particles is to be large, either the total length of the machine must be great, or the frequency 
used must be high. In order to avoid enormous machine lengths, very high frequencies are 
used, but then the transmission of energy becomes difficult in practice because of the large 
energy losses in the conductors. The development of radar during WWD led to the availability 
of high power high frequency microwave transmitters. Thus, the technical problems of this 
type of accelerator can be solved by the use of what is called resonant cavities.
Typical linear accelerators produce beams of energies below 200 MeV and are often 
used as auxiliary machines (injectors) for large accelerators (synchrotrons).
2.4.2.2 Cyclotron
The cyclotron was first conceived by E.O. Lawrence in 1930, and tested experimentally for 
the first time by E.O. Lawrence and M.S. Livingston in 1931, at the University of California, 
at Berkeley (Lawrence and Edlefsen, 1930; Lawrence and Livingston, 1931a, b, 1932) [53, 
55]. The particles are accelerated by an RF electric field of a frequency of 10 to 30 Mc/sec but 
instead of moving along a straight line as in linear accelerators they follow a spiral trajectory, 
guided by a constant and almost uniform magnetic field.
In this machine, the particles move inside a vacuum chamber of the form of a flat 
cylinder. This comprises of two hollow electrodes whose shape can be thought of as obtained 
by cutting a very flat, hollow cylinder along a meridian plane. Because of its shape, such an 
electrode is called a “dee.” An RF voltage is applied between the electrodes, so that there is 
an alternating electric field in the gap, but no field inside the dees. The vacuum chamber is 
placed between the pole pieces of a large magnet as shown in Figure 2-15 (a), which produces 
a constant and practically uniform magnetic field perpendicular to the plane of the dees. The 
ion source is placed at the centre of the vacuum chamber so that the ions are accelerated in the
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gap and enter one of the dees. Here the magnetic field makes them follow a semicircle orbit, 
with constant speed, until they cross the gap again. In the meantime, the electric field has 
reversed its direction, and the particles are again accelerated; then in the other dee they follow 
a semicircle of larger radius than the former one, and so on. The resulting orbit has the shape 
shown in Figure 2-15 (b). The operation of the machine is possible if the time required for the 
particles to describe each semicircle is kept constant and if the angular frequency co 
(= qB/m ) of the RF generator is chosen so that the transit time inside one of the dees is 
equal to the half-period of the field oscillation. Thus, the particles always encounter the 
electric field in the gap with the same phase and gain the same amount of energy at each 
transit.
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Figure 2-15: (a) Vertical cross-section through a cyclotron, showing the magnet yoke, excitation coils, vacuum 
chamber and ‘dees’, (b) Planar view of ‘dees’ showing the particle orbit as a series of successive semicircles of 
increasing radius [55].
However, the cyclotron suffers another serious disadvantage, which was first 
recognized by Bethe. The synchronism between the RF and the particle orbit applies only so 
long as the velocity of the particle is low compared with the speed of light. As relativistic 
velocities are approached, part of the energy given to the particles serves to increase their 
effective mass, and so does the transit time. Until now, the angular velocity (© = v /R ) of the 
ions being accelerated has been supposed to be independent on the orbit radius or velocity or 
energy when working out the dynamics of the orbits for an ion of mass m and charge q 
moving with velocity v normal to magnetic induction B. The Lorentz force qvB perpendicular 
to both v and B produces a circular motion with a radius curvature R determined by the 
momentum ( qBR = mRoo) and R cancels out making the resonance component independent
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of the radius and from that the kinetic energy (E k =m v2/2 = mco2R 2/2 ) can be calculated. 
However, as the ion mass increases with its velocity (or energy or radius), the angular 
velocity of the ion decreases with its orbit radius. As a result, the orbital frequency falls, and 
the particles drop out of synchronism with the RF field i.e. the particle delays with respect to 
the electric field until eventually they encounter a negative field and are decelerated. For this 
reason, classical cyclotrons are useful for energies up to about 25 MeV for protons, and to 
correspondingly higher energies for heavier ions. A possible solution could be to increase the 
magnetic induction as a function of the radius; however, this is not possible for a classic 
cyclotron, because of orbit stability which is related to the magnetic induction as a function of
the radius described (at least for small variations) by th& field index n where B(R) = l /R n .To 
obtain both axial and radial orbit stability, a field index between zero and unity is required 
which is not fulfilled in a classic cyclotron as the condition for isochronism, i.e. the magnetic 
induction increasing with the radius to compensate the relativistic mass increase is for n < 0. 
For an isochronous cyclotron this limitation will be overcome, as will be explained below.
In an isochronous cyclotron, a negative field index is applied to compensate for the 
relativistic mass increase, and the axial orbit instability, such a magnetic field causes, is 
overcompensated by strong axially focusing forces [56]. The idea of maintaining both 
isochronism and axial focusing to high energies by introducing an azimuthal variation in the 
magnetic field was proposed in 1938 by Llewellyn Thomas whereby the orbital stability can 
be retained by particular shaping of the magnetic poles [57]. By removing radial sectors (at 
least 3) from the magnet poles, 'hills' and 'valleys' are created. Ions experience a strong 
magnetic field in the hills as a result of the N and S pole being closer than for the valleys, and 
a weak magnetic field in the valleys. In the azimuthal direction, i.e. perpendicular to the 
radius, along the equilibrium orbit, ions experience an azimuthally-varying field, hence the 
name ‘AVF cyclotron’. In such a field ions do not resemble a circular equilibrium orbit any 
more (Figure 2-16 (a)). Their radius of curvature R is smaller in the stronger field (hill) and 
respectively larger in the weaker field (valley), so the orbit weaves back and forth about a 
circle. Consequently, the ion velocity vector v has, besides the azimuthal component Ve, a 
radial component vr, directed outward when moving from a weaker field (valley) to a stronger 
field (hill). The radial component is directed inward when moving from a hill to a valley 
(Figure 2-16 (b)).
Another phenomenon to be put into consideration is Synchrotron radiation. A charged 
particle whose motion is not rectilinear and uniform radiates energy in the form of 
electromagnetic waves. This also occurs for particles in accelerators especially for electrons
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in circular accelerators. A fraction of the energy supplied by the machine to the particles is 
not used to increase their kinetic energy but is lost in radiation. This phenomenon is of 
considerable practical importance to electron linear accelerators [55].
Figure 2-16: (a) Magnet pole of an isochronous cyclotron or AVF (azimuthally varying field) cyclotron plane, (b) 
Mid-plane view of equilibrium orbit in an isochronous cyclotron [56].
2.4.2.3 Synchrocyclotron
Alternatively, a variant of the cyclotron called the synchrocyclotron or frequency-modulated 
cyclotron, also overcomes the energy limit of the latter.
On the whole, the design of the synchrocyclotron is similar to that of the cyclotron. 
The main difference is that the frequency of the RF generator is modulated, that is made to 
change periodically, and the machine is used during the times when the frequency is 
decreasing i.e. the effect of the relativistic increase of mass can be compensated for by 
varying the frequency of the accelerating voltage synchronously with the increase in mass. 
This could only apply to the particles, which are injected at the right moment to take 
advantage of this frequency modulation. Thus, while the output beam from a cyclotron is 
virtually continuous, that from a synchrocyclotron is broken up into bursts of particles, a burst 
occurring each time the radio-frequency is modulated through the appropriate cycle. This 
leads to a reduction of the mean intensity of the output beam with respect to the cyclotron
hill
<g)B
valley
equilibrium orbit in a classic cyclotron isochronous cyclotron
([53], p. 14).
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Although the maximum particle energy theoretically attainable for synchrocyclotrons 
may range from 200 MeV to 1 GeV, those attained in practice are mostly limited for 
economic reasons. This is because the maximum energy achieved in the synchrocyclotron is 
proportional to the square of the electromagnetic radius and the large dimensions of the 
electromagnet are quite costly.
2.4.2.4 Synchrotron
As the radius of the magnet is related to the final energy of the particle, the size and the cost 
of the magnet become prohibitive for energies above a hundred MeVs. Consequently, with 
the cost of a cyclotron-type magnet going up (- cube of the pole diameter), another idea was 
needed before higher energies could be achieved economically. Oliphint, Veksler and 
McMillan independently proposed that if the magnetic field was low at the time of injection 
of the particles, and was increased appropriately as the particles gained energy, then only an 
annulus of the magnet pole would be required [55]. Accordingly, for higher energies, 
synchrotrons are built, in which the particles are accelerated by an rf electric field, but are 
made to follow a circular orbit (of radius R) rather than a spiral ([53], p. 15). As a result, the 
magnetic field is required only in the region of the orbit and not in the space enclosed by it. 
The cost of such a ring-shaped magnet is roughly proportional to the radius. The particles 
follow a fixed orbit, and the vacuum chamber is given the shape of a torus (“doughnut”). The 
RF electric field for particle acceleration is localized at a certain point in the vacuum 
chamber, and is obtained by replacing the huge dees with exciting stationary electro-magnetic 
waves in a metal box (resonant cavity) through which the particles pass.
The angular frequency,©, of the radio-frequency is such that the corresponding period 
is equal to (or a submultiple of) the time required for a particle to complete one turn. As this 
time decreases with increasing energy, the frequency is modulated (CO increasing), but will 
tend to the limiting value c/R as v approaches c.
To keep the particles on a fixed orbit of radius R as the energy increases, the 
magnetic field that is used to steer the particles must also change with each turn because the 
particle energy increases.
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To avoid too wide a range of modulation of the radio-frequency, the particles are 
usually injected into the machine after being accelerated to energy of a few MeVs by means 
of a linear accelerator.
The magnet coils are fed with a low-frequency A.C. or with a saw-tooth current, and 
the particles are accelerated only when the magnetic field is increasing. This synchronization 
of field strength and energy allows the production of protons and heavy ions with variable 
energies unlike the cyclotron, which has fixed extraction energy. That is why in the case of 
the cyclotron, the energy degradation by a material in the beam path leads to an increase in 
energy spread and beam emittance, and, thus, reducing the system’s efficiency [58].
However, the success of such an approach depended on two things, phase stability 
and focusing [55]. McMillan and Veksler independently recognized that, in a system where a 
beam passes periodically through an RF field, and for which the time taken for each particle 
to orbit depends on its energy, particles will tend to bunch at a particular phase of the RF [55]. 
Therefore, a particle with excess energy will orbit more rapidly and, arriving at an earlier 
phase, will see a lower field. Similarly, a particle with less than the correct energy will take 
longer to orbit, arrive at a later phase and thus receive a greater acceleration. So, particles 
injected in a range of phases with respect to the RF will oscillate about the correct energy. 
This produces what is referred to as “phase stability”, and is shown in Figure 2-17. All 
particles lying within the enclosed area are stable and those outside are considered unstable.
Figure 2-17: A diagram of phase stability, (a) A particle passing through the acceleration system at a phase cp5 
gains the correct energy increment each turn and those passing through in the phase range <pi to 7t-<p5 will oscillate 
about cp5. (b) The ‘fish’ diagram shows the variations of momentum and phase during these oscillations where 
particles inside the fish are captured and those outside are lost [55].
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The other requirement, focusing, applies to all accelerators, but it becomes 
particularly important for an accelerator using a magnetic field extending over a narrow 
annulus, as particles injected into an accelerator will have some spread of position and 
transverse velocity from the central line of the beam, and space-charge effects will increase 
the divergence of a beam of charged particles. This requires some mechanism to prevent the 
beam from expanding as it circulates round the accelerator.
Accelerators for clinical use are evolving into more compact designs with improved 
operational reliability and performance which may allow the accelerator to fit in the treatment 
room, as in the case of conventional electron/photon linear accelerators.
One known system is the fixed-field alternating gradient (FFAG) accelerator. The 
application of altemating-gradient (AG) focusing since its discovery in 1952 was proposed to 
fixed-field accelerators independently by Haworth and Snyder and by Symon in the USA, by 
Ohkawa in Japan, and by Kolomenskyin the USSR [57]. The most intensive studies were 
carried out by Symon, Kerst, Ohkawa and others at MURA (the Midwestern Universities 
Research Association) in Wisconsin, who gave FFAG its name, but their proposal for proton 
FFAGs were not realised due to lack of funding. FFAGs operate in the same mode as 
synchrocyclotrons i.e. fixed magnetic fields, modulated radiofrequency, and pulsed beams, 
and like them allow higher pulse rates and larger acceptances (and therefore higher 
intensities) than synchrotrons. What was new was to break the magnet into sectors with strong 
radial field gradients, thus providing edge and strong focusing but free of the requirement for 
isochronism. Another distinction from synchrocyclotrons was removing the central region, 
creating a ring- rather than disc-shaped machine. This technique requires injection of a pre­
accelerated beam, but drastically reduces the width and cost of the vacuum chamber and 
magnets which can be further restricted by choosing a design with high momentum 
compaction, creating an orbit with a very tight spiral. These features made it possible to 
design machines with high pulse repetition rates for much higher energies than was 
practically possible for synchrocyclotrons. The advantage of a fixed field machine is that it 
keeps the guide field separate from the acceleration process.
Mori and his group at KEK in 2000 were the first to commission the 1 MeV PoP 
(Proof of Principle) proton FFAG, and went on to build three more radial and one spiral- 
sector machine, ranging in energy from 2.5 to 150 MeV. Their work stimulated renewed 
interest in FFAGs for applications requiring high intensities and very high repetition rate (> 
50 Hz). In 1997, Mills and Johnstone pointed out that FFAG designs need not be restricted to
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the ‘scaling’ approach if resonance crossing is not an issue. Currently, about a dozen scaling 
and a dozen non-scaling designs are under study for the acceleration of protons, heavy ions, 
electrons and muons, with top energies ranging from 1 MeV to 20 GeV, and diameters from 5 
cm to 400 m [57].
Proton acceleration by ultrashort, high-intensity (I > 1020 W/cm2) laser pulses 
interacting with thin foils ( a process known as laser-plasma acceleration) has attracted a great 
deal of attention during recent years and has been widely examined both experimentally and 
theoretically to determine whether laser acceleration of protons to the therapeutic energy 
range of 200-250 MeV can be achieved for cancer therapy [59]. The emitted protons reach 
large particle numbers of up to 1013 per pulse with energies in the MeV range. In comparison 
to conventionally accelerated proton beams, these beams have low transverse emittance and 
high brightness as well as short pulse duration. In this scheme, relativistic electrons generated 
by the laser-plasma interaction penetrate through the target foil, escape on the rear side, and 
form an electron sheath resulting in an electric field of the order of TV/m on the rear surface. 
This rear-side accelerating mechanism is called target normal sheath acceleration (TNSA) 
[60]. Atoms at the rear surface, mostly protons present in impurities on the target surface, are 
ionized by the field and are accelerated normal to the surface into vacuum along the electric 
field lines. After the acceleration period (order of 1 ps) the proton beam is space charge 
neutral due to comoving electrons [61]. Recently, scalability studies for the TNSA have 
shown that, owing to their compact size and reasonable cost, such table-top laser systems with 
high repetition rates could contribute to the development of new generations of particle 
injectors that may be suitable for medical proton therapy as well as the production of quasi- 
monoenergetic proton and heavier ion beams depending on the target design (Figure 2-18)
[62].
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Figure 2-18: Laser acceleration of protons from the back side of a micro-structured target [62],
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2.4.2.4.1 Energy Selection System
The Energy Selection System (ESS) consists mainly of a variable thickness degrader, followed 
by slits to limit beam emittance, and a momentum analysing, selection and recombination 
system. Together, these produce a near monoenergetic but variable energy beam of suitable 
quality for radiotherapy from a fixed energy source. This is useful in the case of the fixed 
energy cyclotron where one wishes to produce the sharpest possible distal beam fall-off.
2.4.2.4.2 Beam Transport
The beam transport system plays a role in transporting the extracted beam from the 
accelerator to the treatment room; it is mainly a series of dipole and quadrupole magnets. This 
arrangement of magnets, vacuum chambers, and diagnostic instrumentation is called a beam 
line.
A stable and efficient transport of the beam is most important, as the major 
requirement of therapy is a reproducible beam and thus reliable patient treatment. The 
stability of the centroid of the beam position should be better than 1.0 mm. This places 
constraints on the rigidity of the bending and focusing magnets needed to control the beam 
position and profile. The term beam tuning is used here and refers to adjusting the beam 
optics through the beam line to transport the given beam to the desired location with the 
desired parameters at that location.
2.4.2.4.3 Gantry
Conformal radiotherapy requires the use of multiple beam entrance ports as means to 
distribute the dose evenly around the tumour volume while keeping the dose delivered to the 
surrounding healthy tissue within the tolerance levels [34, 58]. In order to irradiate a patient 
from any desired angle the treatment head has to be able to rotate as opposed to a fixed 
horizontal beam line where patients can be treated only in a seated or near-seated position. 
This helps in positioning the patient in a reproducible manner and similar to the way the 
patient was positioned during imaging prior to planning and treatment. Most patients are 
treated lying down on the treatment table, implying the need for a device providing variable 
incidence angle i.e. a rotating gantry between the horizontal plane and the beam. Here, the 
beam that is coming along the axis, is guided by magnetic fields away from the centre and
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bent back towards the axis to cross it orthogonally. If the beam line ends at the axis, the 
gantry is considered to be isocentric. This rotating gantry can be either introduced to be a part 
of the beam transport system or the beam delivery system.
These rotating gantries are usually large structures because, firstly protons with 
therapeutic energies can only be bent with large radii, and secondly beam monitoring and 
beam shaping devices have to be positioned inside the treatment head affecting the size of the 
nozzle [58]; for example, the nozzle at NPTC-IBA has a length of about 2.5 m, which results 
in a distance between isocentre and beam entering the gantry of about 3 m. Figure 2-19 shows 
the innovative PSI project “compact spot-scanning gantry” also known as an eccentric gantry
[63], which is a very good optimisation of the size (diameter of 4 m) mainly because of the 
option chosen to move the patient during the treatment (eccentric conception). To guarantee 
precise dose delivery the mechanics of the gantry has to be able to keep the isocenter of 
rotation always within 1 mm under all rotation angles. This requires careful design of the 
mechanical structure, as the overall weight can be several tens of tons. The end result is that 
the equipment rotates about the original beam direction as axis.
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Figure 2-19: The eccentric PSI Gantry [58].
The treatment nozzles consist of various components for beam shaping and beam 
monitoring (Figure 2-20). The beam-monitoring component consists of ionisation chambers 
to detect deviations in beam position, measure the total beam current and check the beam size 
and uniformity. Ionisation chambers usually consist of parallel electrode planes divided in 
horizontal and vertical strips that allow the quantification of the lateral uniformity of the 
radiation field. Note that, the strips are integrated separately to collect the current in each 
strip. The ionisation chamber is located the at nozzle entrance, i.e. where the proton beam 
exits the beam-line, to monitor the size of the initial beam spot and the angular distribution of 
the beam. Beam shaping devices in the nozzle are scatterers, absorbers, and other patient 
specific hardware, which will be discussed in the next section. This nozzle also has a snout
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that permits the mounting and positioning of the field-specific aperture and compensator 
along the beam axis. The snout is telescopic and is used to adjust the air gap between the final 
collimator or compensator and the patient.
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Figure 2-20: Schematic drawing of the nozzle at the NPTC [64]. The beam monitoring devices consist of 
ionisation chambers (IC) and a range verifier (multi-layer Faraday cup). The beam shaping devices consist of 
scattering systems, range modulators, and wobbling magnets. Variable collimators and the snout determine the 
field size.
2.4.2.4.4 Beam Delivery systems
A proton beam delivered by an accelerator is a narrow beam that is mono-energetic with a 
localised Bragg peak over a small region. In contrast, the tumour volume to be irradiated 
comes in different shapes and sizes. Even the normal tissues that the proton beam passes 
through to reach the tumour volume are not uniform. This requires the use of beam modifiers 
in order to expand the beam in the transverse plane for total tumour irradiation, adjust the 
proton energy according to the depth of the tumour, increase the energy spread for uniform 
tumour irradiation, and make corrections to take into account the shape of the tumour shape 
and any non-uniformity of normal tissues as the proton beam passes through. The beam 
delivery system is usually located in the treatment room at the end of the beam line. This 
system is responsible for modifying and monitoring the beam to achieve the prescribed 
radiation dose distribution inside the target volume (Figure 2-21).
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Figure 2-21: Schematic diagram of beam delivery system with double scatterer [65]
A typical beam delivery system for a compact synchrotron (70-250MeV) with a 
circular irradiation field of 20 cm in diameter consists of the following [34, 65]:
■ A scattering system is incorporated into the nozzle on the gantry to make beam spread in 
the transverse plane. A dual-ring double scattering method is applied in order to achieve 
sufficient beam spreading in the distance from the scatterer to the target position. A point 
in the target is called an “isocentre”, which is the centre of rotation of the irradiation axis. 
The thickness of the first scatterer and the type of the second scatterer can be set 
automatically for different respective energies. The flatness of the irradiation field is 
sensitive to deviation of the beam position on the second scatterer. Therefore, the flatness 
is monitored in order to obtain a homogeneous dose at the target.
■ A fine degrader is installed in the beam preparation system to adjust the proton energy 
according to the tumour depth. This causes range shifts of 0 to 127 mm water equivalent 
length with a step size of 1 mm. It consists of two thick acrylic edges that are facing each 
other. It can change the proton energy continuously by changing the overlapping acrylic 
thickness; thus making it possible to produce a Bragg peak in a tumour of any depth.
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■ A ridge filter to expand the energy spread to an extent corresponding to the thickness of 
the tumour. This is an array of metallic bars with stepwise thickness. This causes the 
protons to pass through different thickness of metal, producing Bragg peaks at different 
depths. This creates the necessary spread of Bragg peaks (SOBP) for each tumour. A 
rotating changer can introduce a ridge filter into the beam, which is designed to produce 
the required spread-out peak of between 0 mm and 120 mm.
■ A bolus (or range compensator) is machined from an artificial chemical wooden material. 
This is positioned above the final collimator and corrects for the maximum proton energy 
in the lateral plane, following the configuration of the tumour.
This type of beam delivery system is generally referred to as a passive method of 
Bragg peak modulation. Although the target volume can be shaped according to the tumour 
volume in such a way that the tumour is completely covered by the high dose area, a perfect 
congruence between irradiated volume and tumour cannot be reached with passive beam 
shaping systems and frequently a large fraction of normal tissue is contained in the high-dose 
region causing lateral side effects.
The shortcomings of such a system can be overcome by employing magnetic control 
of the beam in the x-y plane in conjunction with an independent system of depth modulation 
control [58, 66]. Using this technique, a target volume of any shape can be irradiated within a 
precision of a few millimeters. In practice, one usually starts with the deepest layer (highest 
energy) and does one x-y scan. The energy is then reduced, and the next layer is painted, and 
so forth until all layers have been delivered. As the density does tend to vary in a patient, the 
Bragg peaks of one layer are not generally in a plane. It is also useful to keep in mind that the 
distal layers deliver various amounts of dose (depending on the curvature of the distal target 
surface) to the more proximal regions, such that each layer needs to be intensity modulated in 
order to generate a uniform target dose. Each layer is delivered multiple times to reduce 
delivery errors and uncertainties.
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Three different modes of proton and heavy ion beams scanning techniques have been 
devised [58]:
■ Discrete spot scanning: This is a step-and-shoot method in which the predetermined dose 
is delivered to a given spot at a static position (constant magnet settings). The beam is 
then switched off and the magnet settings are changed to target the next spot, where dose 
is delivered to the next spot, and so forth. The magnetic scan is performed in one 
direction only, and the position in the orthogonal direction is changed through a change of 
the table position. Because the table motion is kind of slow, it is the least favoured 
method. First the magnetic scan is performed to create one line of dose (along discrete 
steps), then the depth is varied by changing the energy, and another line of dose is 
"drawn" at a more shallow depth. This process is repeated until dose is delivered at all 
relevant depths. Finally the table is moved to the next position, and the whole process is 
repeated.
■ Raster scanning: This method, which was devised for heavy ions at the GSI in Darmstadt, 
Germany [67], is very similar to discrete spot scanning, but the beam is not switched off 
while moving to the next position. The dose distributions are almost similar for the two 
methods as long as the scan time from spot to spot is small compared to the treatment 
time per spot. Typically, this is not fulfilled if the scan is done with the treatment table.
■ Dynamic snot scanning: The beam is scanned fully continuously across the target volume. 
Intensity modulation can be achieved through a modulation of the output of the source, or 
the speed of the scan, or both. Although, the combination of the two reduces the required 
dynamic range of the source output, it puts higher demands on the control system.
2.5 Clinical indications for proton therapy
The main clinical indications for proton or ion beam therapy are the proximity of some target 
volumes to critical structures and low tumour radio-sensitivity [34]. Proton therapy is superior 
to photon beam therapy for treating certain tumours such as uveal melanomas and 
chondrosarcomas, and chordomas of the base of the skull and spinal region. Non-malignant
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lesions such as cerebral anterior-venous malformations and pituitary adenomas are also 
successfully treated with protons. Figure 2-22 shows the improved control rates after ion 
beam therapy compared to conventional therapy.
Other malignancies including tumours of the brain, head and neck, oesophagus, 
prostate, rectum, female reproductive systems, as well as soft tissue sarcomas, where 
improved local control is likely to result in higher cure rates, have indicated the advantage of 
hadron therapy over conventional photon radiotherapy (Table 2-1). However, as these studies 
were done with comparatively small groups of patients, often with a very short follow-up 
period, the results need further verification with larger studies.
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Figure 2-22: Local control rate of ion beam and conventional radiation therapy as function of delivered dose [66].
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liv e r  tu m ors 5 y  S 2 3  % lOO % (H IM A C )
c er v ix  uteri (s ta g e  IIEB) L C R 6 6  % 7 3  % (n eu tron  b o o st)
urinary b lad d er  c a rc in o m a D S 3 0  % 5 0  % (n eu tro n  b oost)
prostate  (C , D 1 ) L C R 31 -  6 8  % 8 9  % n eu tron s
sa liv a r y  g la n d s L C R 2 4  -  28  % 61 %
so ft tissu e  ca rc in o m a 5 y -S 31 7 5  % 5 2  83 %
Table 2-1: Hadron therapy results from multi-centre studies represented by: LCR = local control rate, DS= down 
staging, 5y-S = 5-year survival time rate, PFSR = progression free survival rate, and AST = average survival time 
[68].
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2.5.1 Skull-Base Tumours
Chordomas and chondrosarcomas of the skull base and cervical spine are considered rare 
tumours [34, 69]. For skull-base tumours such as chordoma, chondrosarcoma, meningioma, 
craniopharyngioma, and pituitary adenoma, the ability to deliver an adequate dose using 
conventional photon radiotherapy is often limited by the proximity of these tumours to critical 
structures such as the brain stem, temporal lobes, optic chiasm, and optic nerves. Most 
patients treated with conventional radiotherapy after surgery die of locally progressive 
disease. New conformal photon therapy techniques that rely on modulating the beam intensity 
dynamically may eventually be useful in treating these tumours, but the advantages of these 
technologies compared to particle therapy have not been fully tested clinically. Therefore, 
skull-base tumours are good candidates for charged-particle irradiation. With conventional 
photon therapy, one generally can deliver only ~ 50 Gy to such tumours, whereas with 
protons, doses as high as 70 Gye are routinely used. The term Gye stands for Gray-equivalent 
or effective dose, which is obtained by multiplying the physical dose delivered by the RBE 
for the particle in question (De [Gye] = D [Gy] x RBE). Using conventional radiotherapy, the 
3-year local-control rate for chordoma and chondrosarcoma is -  40%, whereas for proton 
therapy, the reported overall 5-year actuarial local-control rate for these tumours is 82%.
A trial to evaluate local control after treatment of benign meningioma with 
conventional radiotherapy, and combined photon and proton beams (55.8-71.6 Cobalt-Gray- 
Equivalent (CGE)) was conducted at Massachusetts General Hospital (MGH) between 1968- 
1986. The reported local control in patients treated with combined proton and photons 
showed no relapses after a median follow-up of 53 months. Another study to evaluate local 
control and morbidity after treatment of craniopharyngioma with combined photon and proton 
beams ranging from 52.7 to 63.4 CGE showed no tumour progression or complication after 
more than 5-years.
2.5.2 Paediatric CNS Tumours
Radiation therapy plays an essential role in the management of childhood CNS tumours [70]. 
By combining advances in brain tumour imaging with the technology to plan and deliver 
conformal radiation therapy, paediatric brain tumours can be treated successfully with protons 
whilst limiting the long-term side effects of conventional brain irradiation. Unlike photons, 
which enter the patient at a relatively high dose and deposit radiation at and beyond the target, 
protons enter the patient with a relatively low dose and, once the proton beam reaches the
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tumour target, all the remaining energy is absorbed by the tumour; no normal tissues distal to 
the target are irradiated.
These tumours cannot be entirely removed with surgery, either because of their 
location or because of microscopic tumour spread. Chemotherapy cannot eliminate all cancer 
cells either and so radiation therapy is frequently employed alone or as part of a multi-modal 
treatment approach in combination with surgery and/or chemotherapy. Some of the long-term 
side effects of conventional radiation therapy to the brain include hearing loss, interference 
with intellectual development, and hypothalamic-pituitary dysfunction. The radiation can lead 
to atrophy or inhibit growth of the irradiated tissues as well as causing organ dysfunction and 
fibrosis. In addition a radiation-induced second malignancy, years after treatment, can be 
fatal. Proton radiation therapy limits the mentioned radiation-induced toxicity.
Investigators at Loma Linda reported outcomes for 27 children treated with proton 
radiation therapy for intracranial low-grade astrocytomas [70]. The children were treated for 
either unresectable tumours or residual or progressive disease after subtotal resection (mean 
dose of 55.2 CGE) with standard fractionation (1.8 CGE/day). A mean follow-up of 3.3 years 
(0.6-6.8 years) showed that 6 out of 27 patients experienced local failure within the irradiated 
field, and 4 out of 27 had died. This translates into rates of local control and survival of 87% 
(13/15 patients) and 93% (14/15 patients) for central tumours, 71% (5/7 patients), 86% (6/7 
patients) for hemispheric tumours, and 60% (3/5 patients) for tumours located in the 
brainstem.
Another trial with proton radiation therapy [70] for childhood brain tumours was 
recently reported from the Centre de Protontherapie d’Orsay. Children with benign (6 
patients) and malignant (11 patients) brain tumours were treated with combined photon (~ 40 
Gy) and proton (20 CGE) radiation therapy. The reported local control after a mean follow-up 
of 27 months was 92%. However, long-term follow-up from this and other studies of proton 
radiation therapy is needed to document the expected reduction in late effects with proton 
radiation therapy.
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2.5.3 Ocular Melanomas
Protons have been used to treat uveal melanoma, a tumour made of melanin-pigmented cells 
occurring in the vascular middle coat of the eye that comprises the iris, ciliary body, and 
choroids [34, 69]. Uveal melanoma is the most common primary intraocular tumour in adults. 
Depending on the location of the tumour, this approach avoids irradiating critical structures in 
the eye such as the optic disc, macula, and lens, as illustrated schematically in Figure 2-23. 
The goal here is to destroy the reproductive capacity of the tumour while preserving whatever 
vision the patient may have in the affected eye. The conventional treatment for these tumours 
is enucleation of the affected eye.
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Figure 2-23: A schematic illustration of ocular melanoma treatment with protons [69].
In the beginning local irradiation using Co-60 plaques sutured by the choroid was 
used to destroy this type of tumour. However, this form of treatment was associated with 
morbidity and loss of visual function. Currently, the only other form of radiation therapy for 
uveal melanoma comparable to particle therapy is irradiation with a radioactive plaque, made 
by gluing radioactive seeds (e.g. 1-125) to a gold backing. The seeds and the backing are 
affixed to a plastic disk similar in shape to a contact lens, which is fabricated individually for 
each patient to fit his or her eye. The entire assembly is then sutured to the patient’s eye over 
the tumour and remains in place until the prescribed dose is delivered. 1-125 plaques are 
mainly used because they give less radiation dose to uninvolved normal tissues. The reported 
rate of local failure (i.e. continued tumour growth) observed with charged particles appears to 
be less than that reported for radioactive plaques. Various trials using different forms of 
radioactive plaques report local failures leading to enucleation in 10-40% of patients treated. 
In contrast, at MGH in Boston and at Lawrence Berkeley Laboratory (LBL) a 5-year actuarial 
local control rate of at least 97% are reported. However, a small number of patients (< 2% in 
the LBL series) required enucleations as a result of continued tumour growth or regrowth, and 
around 10% of the patients in both the MGH and LBL series underwent enucleations because
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of radiation-induced complications such as neovascular glaucoma. Munzenrider et al. and 
Egan et al reported a 5-year actuarial eye-retention rate of 89% for proton therapy at MGH 
[34].
2.5.4 Arterio-Venous Malformations (AVMs)
Arterio-Venous Malformations (AVMs) of the brain are congenital lesions [69] that manifest 
themselves clinically through intracranial bleeding, seizures, headaches, and progressive 
neurological defects i.e. an AVM is a set of tangled and malformed blood vessels in the brain 
that is at risk for haemorrhage. AVMs may be surgically removed, embolized, or treated with 
radiation using conformal techniques. AVMs are often inaccessible for surgery because of 
their size or location in critical regions of the brain. As in conventional radiotherapy, the dose 
selected should be high enough to be effective on abnormal blood vessels, and at the same 
time, low enough to spare normal brain tissue surrounding the AVM. Beam diameters varying 
from 7 to 50 mm, modified to conform to the size and shape of the AVM are generally used. 
Kjellberg treated more than 1300 AVM patients at the Harvard Cyclotron Laboratory (HCL), 
and reported that 91% of 896 AVM patients treated with protons showed the same or 
improved neurological status following treatment The 24-year actuarial survival rate for this 
group of patients was 98% for those with AVMs < 3 cm in diameter and 93% for all patients 
whereas for an untreated control group, the 24-year actuarial survival rate was 77%.
In another study at the Burdenko Neurosurgical Institute for Theoretical and 
Experimental Physics (BNI-ITEP) in Moscow, Minakova and colleagues treated 66 AVM 
patients with protons between 1983 and 1990. Of these patients, 28 had follow-up 
angiographic examinations, which revealed a complete or partial obliteration rate of 71%.
AVMs are also treated effectively with specialized conformal techniques using 
photons, such as gamma-knife or linear accelerator based radio-surgery. In general, the dose 
distributions for small lesions are essentially the same for the photon and charged- particle 
techniques, whereas for large irregularly shaped lesions, one can obtain superior dose 
distributions by using particles. However, clinical results for all of these techniques are 
relatively comparable.
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2.5.5 Treatment sites within the thorax, abdomen, and pelvis
Limited clinical studies have been performed with protons for sites outside the head and neck 
region [69]. Tsujii et al at the Proton Medical Research Centre at the University of Tsukuba in 
Japan reported preliminary results for proton radiotherapy for 147 patients. Most of the 
patients in this study received large total doses (> 70 Gye), where indications of improved 
local control and survival rates were found for lung, oesophageal, liver, uterine cervix, and 
prostate cancers. Some of these results, in particular those for oesophageal carcinoma, 
contradict earlier findings reported by Castro et al. (1983), who observed no improvement in 
local-control rates of proton therapy over that of conventional photon therapy. These 
differences have been attributed to the higher total doses used by the Japanese group (70-87 
Gye vs. 62-70 Gye in the study by Castro et al., and to improved imaging techniques for 
identifying tumour volume.
2.5.5.1 Clinical indications for heavy-ion therapy
The above mentioned advantages of proton therapy confirm a general rule in radiotherapy, 
that better conformity of the irradiated volume with the target volume yields better results 
[66]. This also holds true for heavy-ion beams, where a superior conformity compared to 
protons can be achieved. The main advantage of heavy ions is the increase in biological 
effectiveness that should provide a greater tumour control probability, especially for radio­
resistant tumours.
Heavy-ion therapy began in 1974 at the Lawrence Berkeley Laboratory. There, 
patients were treated with argon ions at the Bevalac accelerator complex where a limited 
number of patients could be irradiated in time-sharing with physics experiments. However, 
after a few treatments the observed side effects proved to be not acceptable [66]. This is 
because the reduction of the repair process varies with the LET (section 2.3.3.2); it is usually 
greater in the Bragg peak area than in the entrance plateau for carbon and neon beams [41]. 
With very heavy ions, however, such as argon, there is very little repair in the plateau or the 
peak. Curtis et al. (1981), using a rat rhabdomyosarcoma have evaluated the RBE and OER in 
the plateau and the 4 and 10 cm extended Bragg peaks of carbon, neon, and argon beams. 
They observed that the RBE for the carbon and neon beams was lowest in the entrance 
plateau and increased from the proximal to the distal positions of the extended Bragg peak.
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However, the argon RBE decreased from the proximal to distal positions of a 10 cm extended 
peak as a result of cell "overkill" in the high-LET mid and distal peak regions.
Treatments were then shifted to the lighter silicon and further on to neon beams (RBE 
is about 3.5). The type of tumours treated were radio-resistant tumours close to critical organs 
and extended from brain tumours and other head and neck tumours to tumour incidences all 
over the human body. Because of the large diversity of the tumours treated a quantitative 
analysis is not yet possible; however the results were so convincing that they motivated the 
construction of a dedicated Heavy Ion Medical Accelerator (HIMAC) at Chiba, Japan.
However, neon ions present some negative characteristics as they are fragmented in 
smaller ions, which as they have a longer path, go beyond the Bragg peak, producing a “tail” 
deteriorating the conformal beam property. Furthermore, as the LET is proportional to the 
square of z (effective charge), in the case of neon ions, its value is already higher by 250 
MeV/cm in the first layers of tissue, interacting with the healthy cells at the “entrance 
channel”. Therefore, the effective charge, z, in the case of ions must be chosen with great 
care. This led to the belief that the optimal is around z = 6, thus defining the carbon ion where 
the LET -1 0 0  MeV/cm at the entrance, and is over 200 MeV/cm in the last five centimetres 
of their path.
Since 1994 about 1000 patients have been treated with carbon ions for a variety of 
tumour sites in a carefully conducted phase I/n and phase II trials. The sites treated with 
carbon ions at the HIMAC include patients with head and neck cancer, lung cancer, liver 
cancer, prostate cancer and tumours of the gastrointestinal tract. The most promising data are 
found in patients with base-of-skull tumours, head and neck cancer, soft tissue sarcoma and 
early stage lung cancer in the Japanese trials [see Table 2-2]. The incidence of treatment- 
related toxicity was found to be quite limited in the phase II trials.
Tumor site 12-months local control rate
head and neck cancer 83%
lung cancer 75%
primary liver cancer 92%
uterine cervix cancer 70%
prostate cancer 85%
Table 2-2: Local control rate of clinical trials of different tumour sites with carbon beams at HIMAC [71].
In another trial at GSI, patient treatments with carbon ions started in December 1997. 
So far the reported results are promising [72], where radio-resistant tumours close to critical
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organs are treated. But for the first time the active scanning systems are used in connection 
with a biology-based treatment planning system. This causes a dramatic reduction of dose to 
the normal tissue outside the tumour and consequently a significant decrease in early side 
effects. Although the physical dose could be decreased because of a realistic RBE estimation, 
at the moment no tumour regrowth within the treated area has been observed in the Phase I/n 
study. Due to a short follow-up time and limited number of patients it is too early to draw 
final conclusions from the heavy-ion treatment, but the results achieved so far are motivating.
2.5.5.1.1 Skull base and paraspinal tumours
At GSI, 37 patients with chordomas (24/37 patients) and low-grade chondrosarcomas (13/37 
patients) were treated with carbon ion radiotherapy within a phase VS. trial from year 1998 to 
2000 [73]. The patients with low-grade chondrosarcomas, and 22 of the 24 patients with 
chordomas had local disease control after 2 years. The two recurrences were located outside 
the boost volume. The results showed a progression-free survival of 100% for 
chondrosarcomas and 83% for chordomas over the 2 years, and a mild treatment-related 
toxicity. Acute radiation-induced reactions occurred in 16 patients and included mild skin 
reactions, mucositis, nausea, sinusitis, and otitis/middle ear effusion. One patient with low- 
grade chondrosarcoma of the petrous bone developed neurosensory hearing loss after the 
treatment. A more recent update on 152 patients confirmed these results with an actuarial 3- 
year local control of 81% for chordomas, 100% for chondrosarcomas, and 62% for adenoid 
cystic carcinomas without any grades IV and V toxicity.
The results obtained with ion therapy are quite similar to those of proton therapy but 
the preliminary data from GSI show that a potential improvement in local control could be 
found when longer follow-up will be available.
2.5.5.1.2 Prostate tumours
The characteristics of these neo-plasms typically of slow-growth, lead to the trial of treatment 
with high-LET particles [73]. At LBL, 23 patients affected by locally advanced prostate 
adenocarcinoma underwent radiotherapy with neon ions; the therapeutic scheme included 
only a boost to the prostate volume after a treatment of 45-50 Gy by conventional 
radiotherapy at the pelvic level. The results showed a of local control rate 85% over a period 
of 7 years and an actuarial survival rate 64% over a period of 5 years. However, the results 
were partially obscured by the observation of serious proctitis requiring colostomy in three
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cases. As a result, a boost with lower dose in the range of 15-20 Gye was suggested for 
further studies.
At the Chiba centre, patients with B2 and C stages carcinomas underwent carbon ion 
treatment, delivered in 20 fractions of 3.3 Gye to a total dose of 66.0 Gye over 5 weeks. The 
reported local control and biochemical disease-free survival rates were 100 and 90.5% at 3 
years and 98.3 and 87.2% at 7 years, respectively.
2.5.5.1.3 Head and neck tumours
At the Chiba centre, 130 patients underwent carbon ion therapy [73] in a carefully conducted 
phase m  trial. The dose ranged from 48.6 to 70.2 Gye in 16-18 fractions. The local control 
rate varied between 80 and 85% at 1 year and 58 and 80% at 3 years for the various treatment 
groups.
At GSI, recent data became available regarding the use of carbon ion boost of 18 Gye 
after conventional photon radiotherapy with a total dose of 54 Gy in 16 patients affected by 
adenoid-cystic carcinoma. A median follow-up of 12 months showed actuarial local control 
rates of 80.8 and 64.6%.
2.5.5.1.4 Bone and soft tissue sarcomas
In a study of 57 patients with bone and soft tissue sarcomas not suited for surgery, carbon ion 
radiotherapy [73] was used in a dose-escalation study with the total dose ranging from 52.8 to 
73.6 Gye (3.3-4.6 Gye/ffaction) over a period 4 weeks at Chiba. The results showed that 41% 
of patients had acute grade HI skin toxicity and the dose-escalation was stopped. The reported 
5-year actuarial local control rate was 72% and the overall survival was 46%. The study 
shows that compared to treatments with other types of radiotherapy including other particle 
beams, carbon ion therapy might provide good local control and survival advantage without 
unacceptable morbidity.
Although, the clinical experiences with ions are without a doubt numerically lower 
than those corresponding to protons and refer mostly to case histories of some years mainly
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with neon and helium ions, the results are nonetheless highly positive and comparable to 
those obtained with protons for the same pathologies.
2.6 Implications for treatment planning
The improvement in dose distributions for high energy photon beams became possible and 
widely achievable through the use of sophisticated treatment planning systems and by the 
development of computer directed dynamic therapy techniques. However, for large tumours 
or tumours that are located very close to critical normal structures, it becomes very difficult to 
deliver a tumouricidal dose to the entire tumour volume without compromising the function 
of these adjacent organs.
Charged particles such as electrons, protons, negative pi-mesons and heavy ions are 
capable in varying degrees of improving the dose distributions by eliminating the exit dose 
for each radiation portal [74]. However, electron beams available in most radiotherapy 
facilities have a maximum useful depth of penetration ranging between 5 and 6 cm in tissue, 
and the depth-dose fall-off at higher electron energies is more gradual and is analogous to the 
exponential absorption curve characteristic of x-ray beams. Heavier charged particles, such as 
pions and heavy ions such as neon, argon, silicon and carbon have more favorable dose 
distributions than electrons because they are scattered less and have a well-defined range [74]. 
Moreover, they offer both improved dose distributions because of a relatively rapid fall-off of 
dose with depth beyond the target volume and an improved biological efficiency of cell 
killing in the target volume relative to that achieved in the entrance region (see section 2.3.3).
2.6.1 Physical Properties of Hadron Beams
In conventional radiotherapy, the high-energy photon beams used are characterized by a 
“skin-sparing” build-up region followed by a near-exponential decay of dose with depth as 
shown for a 10 MV x-ray beam in Figure 2-23 [75]. This fact causes the delivery of a 
significant dose to structures in the exit region of individual beams. In addition, structures in 
the entrance region (exclusive of the skin that lies in a region of dose build-up) receive an 
equal or greater dose than the target volume, while the dose is greater in the proximal region 
of the target volume than in the distal region. By contrast, a mono-energetic beam of protons, 
show an increasing energy deposition with penetration distance leading to a maximum (the
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“Bragg peak”) near the end of the range. This region is shown in Figure 2-23 for an 
unmodulated incident 160 MeV proton beam entering a water equivalent phantom. It is 
obvious that such narrow distributions of increased dose (7 mm wide at the 80% level) would 
be of limited use in the treatment of most commonly occurring human tumours. Therefore, 
passive and dynamic beam delivery techniques (section 2.4.2.4.4) have been developed for 
producing a spread-out Bragg peak (SOBP), which is an area of uniform ionisation at depth 
sufficient to cover the intended target volume thickness.
Figure 2-24 shows a typical SOBP with a width of 7.5 cm. It should be noted that the 
process of spreading out the Bragg peak considerably increases the entrance dose.
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Figure 2-24: Central axis depth-dose curve for for unmodulated and modulated (spread-out) 160 MeV proton 
beam compared with that for a 10 MV x-ray beam. The pure 160-MeV proton beam (lower curve) displays the 
great buildup of dose in the final few millimeters of the proton's range—the Bragg peak. The upper curve is the 
energy modulated 160 MeV proton beam to achieve the "Spread-out Bragg Peak" (SOBP) or the flat isodose 
region covering the tissue depth of interest. The middle curve is that of a 10-MeV (MV) x-ray beam from a linear 
accelerator exhibiting the exponential decrease in dose with depth in tissue, after the initial ~ 3 cm for electron 
buildup [75].
The lateral sharpness of a charged particle beam is largely dependent on multiple 
coulomb scattering that the charged particles undergo during their interaction with the 
absorbing medium. The amount of scattering that a particle undergoes is strongly dependent 
upon the mass of the incident particle and thus, is less for heavy particles than for light 
particles. For this reason, the lateral sharpness or penumbra of an electron beam is very poor 
relative to that which is achievable with a proton beam (Figure 2-25 and Figure 2-26); heavy 
ion beams will have even greater lateral sharpness than proton beams.
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Figure 2-25: Isodose curves for a 35 MeV electron beam compared to a 160 MeV proton beam [76].
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Figure 2-26: A comparison of isodose contours for parallel-opposed fields for a (a) Co-60 (b) 20 MeV x-ray and 
(c) 160 MeV proton beam [76].
A cross-field dose distribution is shown in Figure 2-27 for the 160 MeV proton beam. 
It can be seen that the dose falls off laterally from 80 to 20% (penumbra region) in a distance 
of approximately 6 mm, at a depth in a water phantom of 10 cm. This lateral fall-off is similar 
to that of a conventional 10 MV photon beam collimated close to the patient surface. Also
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apparent is the excellent dose uniformity (± 4%) achievable for beams up to 30 cm in 
diameter.
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Figure 2-27: Transverse field scan of a 160 MeV proton beam in water illustrating sharp lateral fall-off and 
uniformity of beam [74].
Range straggling for monoenergetic particles is also dependent on scattering effects 
and is, therefore, larger for light particles such as electrons and smaller for heavier particles 
such as heavy ions. As shown in Figure 2-23, the maximum penetration of the 160 MeV 
proton beam is 16 cm in water, with the distal fall-off in dose at that depth going from the 
90% to the 10% level over a distance of approximately 6 mm. This distance is considerably 
larger for electrons while for ions heavier than protons the range straggling would be several 
times smaller.
The potential advantages of proton beam radiotherapy are due almost entirely to the 
physical properties of the beam because the region of maximum energy deposition can be 
positioned within the target for each beam direction. This creates a highly conformal high 
dose region, with the possibility of covering the tumour volume with high accuracy. Noted in 
section 2.3.3.1, a small high-LET component is present in the proton beam, which makes it 
slightly more effective biologically than conventional photon radiations (RBE -1.1).
The rapid fall-off of dose both laterally and distally permits better localization of dose 
in the treatment volume and better control of the dose delivered to neighbouring normal 
structures. However, to use this dose distribution pattern to the greatest benefit, it is necessary 
to know the three-dimensional distribution of tissue densities and stopping powers for the 
entrance region and the target volume when the patient is in the treatment position. According
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to Bethe’s formula (Equation 2-3), for a given charged particles beam whose energy is in the 
therapeutic range, dE/dx is roughly proportional to the electron density (pe) of the material 
[69]. The electron density at each point in a patient are calculated from CT data that provide a 
measure of the linear-attenuation coefficients for the diagnostic x-rays produced by the 
scanner as linear-attenuation coefficients are proportional to the electron density of the 
material at each location. In practice, CT units are calibrated by scanning materials with 
different electron densities and then measuring the water-equivalent range of the charged- 
particle beam in these materials.
One of the major uses of CT data is the design of tissue compensators or boluses that 
control the beam penetration so that the distal surface of the dose distribution conforms to the 
distal surface of the target volume for each beam orientation [69]. To do this, the water- 
equivalent distance along the beam trajectory to each point on the distal surface of the target 
volume is determined from the CT data. From this, the thickness of the compensator at each 
of these points is calculated by subtracting this water-equivalent distance from the beam 
range.
These considerations are applicable to the general problem of treatment planning for 
both heavy-ion and proton radiation therapy.
2.6.2 Intensity Modulated Radiation Therapy (IMRT)
Three-dimensional conformal radiation therapy (3D-CRT) was developed in the 1980s [26] 
and resulted in a significant improvement in the tumour to normal tissue protection ratio in 
external beam photon radiation therapy. The term 3D-CRT refers to treatments that are based 
on 3-D anatomic information and the use of a sophisticated treatment planning system that 
allows the optimisation of dose distributions that conform an adequate dose to the target 
volume and minimise the dose to normal tissues. 3D-CRT employs a multi-leaf collimator to 
shape the radiation beam to conform to the outlines of the tumour. Unfortunately, a result of a 
static treatment beam is that the same dose of radiation is delivered to both the tumour and the 
small amount of normal tissue covered by the beam. This fact limited the amount of radiation 
that could be delivered to malignant tissue because the side effects of high radiation doses to 
normal tissue were too severe to be tolerated.
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On the other hand, IMRT takes radiation therapy one step further by using computer 
programs to design the dose distribution, control the radiation therapy treatment delivery 
system, and allow collimator leaves to move during treatment [37, 77]. The principle of 
IMRT is to treat a patient from a number of different directions with beams of non uniform 
fluence, i.e. varying beam intensities, which have been optimized to deliver a high dose to the 
target volume and acceptably low dose to the surrounding normal structures, and hereby 
dramatically reducing the side effects at higher radiation doses.
This control of the ratio between the dose to tumour volume of treatment and the 
normal surrounding tissue volume renders intensive dose escalation a real possibility, and 
with dose escalation comes a higher likelihood of long-term tumour control. Therefore, the 
advantage of the IMRT technique is not just delivering a high dose of radiation to the tumour 
volume, which can be accomplished by methods of lesser sophistication, but the ability of 
IMRT to protect normal critical structures nearby while still delivering a tumouricidal level of 
radiation to the targeted malignancy.
Because the leaves of the collimator are in constant motion during treatment, IMRT 
planning involves the calculation of thousands of specific dose points across a treatment 
volume, a daunting task that can only be accomplished by sophisticated computer programs 
that design the treatment beams as well as control the equipment delivering the radiation. 
IMRT also employs a larger number of beams than conventional or conformal radiation 
therapy.
IMRT is commonly delivered using one of two techniques [77]. The first is called 
segmental or binary delivery where multiple treatment ports are established. Each of which 
requires the linear accelerator to stop and adjust the multileaf collimator for that port. The 
linear accelerator adjusts the collimator leaves, delivers the radiation dose, advances a few 
degrees, stops, and adjusts the collimator leaves again until the entire radiation dose has been 
delivered. This method of IMRT is also known as the “step-and-shoot” or “stop-and-shoot” 
method ([37], p.481-484). The second technique is referred to as dynamic IMRT where the 
collimator performs a rotational sweep over the patient, and during the rotation continuously 
changes the shape and configuration of the radiation beam and varies the rate of treatment 
delivery without stopping.
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2.6.2.X Comparative Treatment Planning
As mentioned earlier, the rationale for the clinical use of proton beams is the feasibility of 
delivering higher doses to the tumor, leading to an increased tumor control probability (pTc)-
Treatment plan comparisons show that protons offer potential gains for many sites. 
Comparisons of treatment modalities (protons vs. photons) have been made on the basis of 
P tc and pNcr calculations. Also, advantages of proton plans compared to photon plans have 
been investigated by many authors where it became evident that proton therapy offered a high 
degree of conformity to the target volumes and steep dose gradients; thus, leading to 
substantial normal tissue sparing in high- and low-dose areas (see references within [58]).
A most interesting study was performed by Lomax et al. [78] of treatment plan 
comparison for conventional photon, scanned proton, and intensity modulated photon 
radiotherapy using CT scans and planning information for nine patients with varying 
indications and lesion sites. The results were analysed using a variety of dose and volume 
based parameters also termed dose-volume histograms (DVHs). The results indicated that the 
use of protons could lead to a reduction of the integral dose by a factor of three compared to 
standard photon techniques and a factor of two compared to intensity modulated photon 
plans. In another study by Yeboah and Sandison [79], optimised treatment plans for intensity 
modulated x-ray therapy (IMXT), VEEHT (very high energy electron therapy), and intensity 
modulated proton therapy (IMPT) were compared for prostate cancer. It was found that using 
intensity-modulated proton beams for inverse planning instead of intensity-modulated photon 
beams improved target dose homogeneity by up to 1.3% of the prescribed target dose, while 
reducing the mean rectal dose, bladder dose, and normal tissue integral dose by up to 27%, 
30% and 28% of the prescribed target dose, respectively. The comparison of optimised 
planning for IMPT and VHEET showed that the quality of target coverage achievable with 
EMPT is comparable to or better (by up to 1.3% of the prescribed target dose) than that 
provided by VHEET, and that IMPT delivered a mean rectal dose and a bladder dose that was 
lower by up to 17% and 23% of prescribed target dose, respectively and also reduced the 
integral dose to normal tissues by up to 17% of the prescribed target dose. The study indicates 
that IMPT delivered a mean rectal dose and a bladder dose that is much lower than achievable 
with the other two modalities, and that the target coverage is far superior. Figure 2-28 
demonstrates the conformality achievable with conventional proton therapy for various body 
sites [80].
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Figure 2-28: Proton dose distributions with dose maps in Cobalt Gray Equivalent (CGE): Upper row (left to right): 
Adenocyctic carcinoma of the lacrimal gland prescribed to a Clinical Target Volume (CTV) and Gross Tumour 
Volume (GTV) [81] dose of 56 and 72 CGE respectively, minimizing the exposure of the nearby temporal lobes; 
Paranasal sinus tumour prescribed to a CTV and GTV dose of 54 and 76 CGE respectively, minimizing the dose to 
the temporal lobes, brainstem, orbits, optic nerves and chiasm; Skull base chordoma prescribed to a CTV and GTV 
dose of 50 and 80 CGE respectively, avoiding the brainstem. Lower row: Lumbar spine chordoma prescribed to 60 
CGE avoiding the kidneys and small bowel; Hepatoma prescribed to 42 CGE minimizing the dose to the normal 
portion of the liver [80].
The reduction in integral dose with protons is most beneficial for paediatric patients 
as there is much to be gained in sparing normal tissue that is still in the development stages. 
An example is a typical meduloblastoma dose distribution shown in Figure 2-29 where the 
central nervous system including the whole brain and spinal canal are irradiated while sparing 
the cochlea, pituitary gland and hypothalamus. The obvious benefits of protons are the 
reduced heart, lung and abdominal doses compared with x-rays.
Dose (cGy)
Figure 2-29: Sagittal colour-wash dose display in the treatment of meduloblastoma including the CSI to 23.4 CGE 
as well as the posterior fossa boost to 54 CGE [80].
Even with the rapid development of intensity-modulated dose delivery with electrons 
and photons, protons are capable of much higher dose conformity, in particular for intensity 
modulated proton techniques [82-84].
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As with photons and electrons, proton treatments use multiple portals to reduce the 
overall skin dose. The sharp distal dose fall-off of protons makes it more critical than with 
photons to understand and limit the uncertainties used in determining the penetration depth 
required to cover a target. These must be incorporated in the treatment planning margins 
around the target volume. The accuracy of proton beam delivery allows tighter margins than 
used conventionally. However, higher accuracy also means that dose delivery is more 
affected by uncertainties caused by beam delivery, patient set-up and immobilization, tissue 
heterogeneities, and organ motion.
Imaging studies and the information gained with modem diagnostic techniques (CT, 
MRI and PET) prior to treatment planning and the process of delineating target volumes and 
stmctures of interest are identical in proton therapy and in conventional therapy. The 
difference lies in the planning and delivery strategies.
The recent technological advances in IMRT have challenged proton therapy as 
whether IMRT might render proton therapy obsolete. The above mentioned treatment 
planning comparison study by Lomax et al [78] indicates that the use of protons has been 
found to reduce the medium to low dose load (below about 70% of the target dose) to Organs 
At Risk (OARs) and all non-target tissues compared to both standard and inversely planned 
photons; nevertheless, the use of intensity modulated photons result in similar levels of high 
dose conformation to that afforded by protons, and in some cases, even more target-conformal 
dose distributions are achieved by IMRT in the high-dose region than protons. In addition, 
when considering the volume of an OAR irradiated to 70% or more of the target dose, little 
difference could be shown between proton and intensity modulated photon plans.
This debates whether the higher cost of proton therapy is justifiable if integral dose 
was the only advantage of protons.
However, this study is relatively incomplete as it compares IMRT photon therapy 
with conventional passive scattering proton techniques. The dose conforming potential of the 
latter is limited and this has mainly technical reasons as all the necessary hardware must be 
adapted and in part created individually for each single field, thus making the beam delivery 
with multiple dose fields on a scattering gantry rather laborious. This method produces a 
homogeneous dose field with a fixed SOBP thickness in depth (fixed range modulation); 
which makes the implementation of IMRT a rather difficult and unpractical task. This, 
however, has nothing to do with the physical dose conformation potential of protons.
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To fully exploit the physical potential of proton therapy and to permit a fair 
comparison with IMRT, a novel irradiation technique by dynamic beam shaping has been 
introduced for protons at PSI, Villigen, and for carbon ions at GSI, Darmstadt [85]. This 
technique is called IMPT, intensity modulated proton therapy. Note that, the term is 
somewhat misleading because intensity modulation is always required in proton therapy, even 
for the generation of an SOBP. What is meant by IMPT is a treatment technique that, in 
analogy with IMRT, delivers intentionally non-uniform dose distributions from each 
treatment field at a given direction. Here, individual pencil beams are sequentially deposited 
under computer control, where high conformity is achieved by changing the dosage and the 
position of each pencil beam individually under computer control. In the lateral direction the 
beam is usually scanned through magnetic deflection of the beam ahead of the patient, and the 
modulation in depth is achieved by changing dynamically the energy of the protons. Also, the 
range can be adjusted as a function of the beam position in both transverse directions 
(variable range modulation). The desired uniform dose in the target volume is obtained after 
superimposing the dose contributions from all fields. The additional degrees of freedom, as a 
uniform dose is not required from each direction, can be used to optimise dose distributions.
A major disadvantage is the higher sensitivity of this method to organ motion during 
scanning; thus, the treatments at some facilities are confined only to tumours in the head and 
in the lower pelvis. The potential use of the spot scanning technique for delivering intensity- 
modulated therapy with protons (IMPT) is shown in Figure 2-30.
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Figure 2-30: (a) Dose distribution of intensity modulated therapy with photons obtained through the superposition 
of 9 convergent photon fields. The yellow lines represent the visible tumour and the treatment volume with 
involved lymph nodes. The red lines represent organs at risk (salivary glands, brain stem); (b) Dose distribution of 
intensity modulated therapy with protons obtained with only 4 fields showing the reduction of the dose outside the 
target volume [85].
Here only 4 modulated fields is required to deliver a highly conformal dose to the 
primary target and a reduced dose to the affected lymph nodes (the secondary target) with a 
maximal sparing of the organs at risk (brain stem and parotid glands). This can be designed
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and delivered just under computer control without the need of patient specific hardware. It is 
obvious with protons one can avoid the "dose bath" outside the target volume typical of 
photon-IMRT. Therefore, in order to remain competitive with the most advanced photon 
techniques, beam delivery by active beam scanning is a necessity for any future proton 
therapy facility.
A comparative treatment plan of 9-photon fields is compared to a 2-field carbon 
therapy both using intensity-modulated techniques (Figure 2-31). The carbon plan has lesser 
dose in the normal tissue outside the target volume and steeper dose gradients to critical 
structures such as the brain stem. As mentioned earlier, this is due to the smaller lateral 
scattering of carbon beams and - most important - due to the inversed dose profile i.e. the 
increase of dose with penetration depth into the body up to a sharp maximum at the end of the 
particle range.
Figure 2-31: Treatment plan with 2 carbon ion fields versus 9 photon IMRT fields [66],
2.6.2.2 Treatm ent Planning Techniques
Two basic types of IMRT treatment planning used are forward and inverse planning [77]. In 
forward (also known as conventional treatment planning) treatment blocks are designed and 
treatment beams are added until a reasonably satisfactory dose distribution is achieved. A 
target tumor volume is determined, and the clinician identifies critical structures, and multiple 
treatment beams (with appropriate blocking) are directed by trial and error to completely 
cover the tumor. Unfortunately, this type of forward planning is not considered a practical 
option.
Inverse treatment planning; however, starts with the final desired dose distribution in 
the tumor volume and the specified doses that cannot be exceeded in critical nearby
78
structures. The computer then delivers as many treatment beams and as many different levels 
of intensity as necessary to achieve both desired end results.
IMPT treatment plans are optimized using a similar "inverse" treatment planning 
system to that of photon IMRT inverse planning mentioned above. The difference is that in 
IMPT the energy of each pencil beam can be varied in addition to its intensity. This increases 
the number of degrees of freedom, which increases its dose shaping potential but at the same 
time it also increases the computational and delivery complexity.
2.7 Hadron beams Dosimetry
2.7.1 Quantities and Units
Radiation dosimetry deals with the quantitative determination of energy deposited in a given 
medium by directly or indirectly ionising radiations. A number of quantities and units have 
been defined for describing the radiation beam. The most commonly used dosimetric 
quantities and their units are defined below.
The following quantities are used to describe a monoenergetic ionising radiation 
beam: particle fluence, energy fluence, particle fluence rate and energy fluence rate. These 
quantities are usually used to describe photon beams as well as charged particle beams [86].
The particle fluence <3> [86] is the quotient dN by dA, where dN is the number of 
particles traversing a sphere of cross-sectional area dA:
^  dN#  = -—  2-25dA
The unit of particle fluence is particles/cm2. The use of a sphere of cross-sectional 
area dA expresses the fact that one considers an area dA perpendicular to the direction of each 
particle and hence that particle fluence is independent of the incident angle of the radiation.
The energy fluence T  [86] is the quotient of dE by dA, where dE is the energy 
incident on a sphere of cross-sectional area dA:
The unit of energy fluence is J/cm2. The energy fluence [86] is further calculated 
from particle fluence by a simple relationship:
2-27
where E is the energy of the particle and dN represents the number of particles with energy E.
In practice, all photon and particle beams are polyenergetic and the concepts defined 
above need to be modified for such beams. Consequently, the concepts of particle fluence 
spectrum and energy fluence spectrum replace the particle fluence and energy fluence, 
respectively. These are defined as [86]:
where (pE(E) and T e(E) defines the particle fluence spectrum and the energy fluence 
spectrum, differential in energy E, respectively.
- g a s ) 2-28
and
¥ e (E) s — (E) = ^  (E) X  E 2-29
The particle fluence rate 9  [86] is the quotient of d<3> by dt in units of particle cm'V1 
where d<f> is the increment of the fluence in the time interval dt:
The energy fluence rate (i.e. intensity) [86] is the quotient of d\|/ by dt, where d\|/ is 
the increment of the energy fluence in the time interval dt:
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with units of W/m2 or J cm'2 s'1.
2.7.1.1 Kerma
Kerma is defined as the Kinetic Energy Released per unit Mass [86]. It is a non-stochastic 
quantity applicable to indirectly ionizing radiations, mainly photons and neutrons. It quantifies 
the average amount of energy transferred from the indirectly ionizing radiation to directly 
ionizing radiation but does not consider what happens after this transfer.
In general, the energy of photons is imparted to matter in a two-stage process. First, 
the photon radiation transfers energy to the secondary charged particles (electrons) through 
various photon interactions (photoelectric-effect, Compton effect, pair production, etc). Then, 
the charged particle transfers energy to the medium through atomic excitations and 
ionisations. Consequently, the kerma is defined as the mean energy transferred from the 
indirectly ionizing radiation to charged particles (electrons) in the medium dEtr per unit mass 
dm:
The unit of kerma is joule per kilogram (J/kg), what is also known as the gray (Gy), 
where 1 Gy = 1 J/kg.
2.7.1.2 Cema
Cema is defined as the Converted Energy per unit Mass [86]. It is also a non-stochastic 
quantity applicable to directly ionizing radiations, such as electrons and protons. The cema 
(C) is the quotient of dEc by dm in Gy (J/kg), where dEc is the energy lost by charged 
particles, except secondary electrons, in electronic collisions in a material of mass dm:
K = dE5.
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2.7.1.3 Absorbed dose
Absorbed dose, a non-stochastic quantity, is applicable to both indirectly and directly ionizing 
radiations [86]. For indirectly ionizing radiations, the energy is imparted to matter in two- 
steps. First, the indirectly ionizing radiation transfers energy as kinetic energy to secondary 
charged particles. Then, these charged particles transfer some of their kinetic energy to the 
medium (resulting in absorbed dose) and lose some their energy in the form of 
bremsstrahlung losses. The absorbed dose is related to the stochastic quantity energy
imparted, and is defined as the mean energy e imparted by ionizing radiation to matter of 
mass m in a finite volume V by:
D = —  2-34
dm
The energy imparted e is the sum of all energy entering the volume of interest minus 
all energy leaving the volume, taking into account any mass-energy conversion within the 
volume. For example, pair production decreases the energy by 1.022 MeV, while electron- 
positron annihilation increases the energy by the same amount. Because the electrons travel in 
the medium and deposit energy along their tracks, this absorption of energy does not take 
place at the same location as the transfer of energy described by kerma. The unit of absorbed 
dose is joule per kilogram (J kg'1) or the gray (Gy).
2.7.1.4 Exposure
Exposure (X) [86] is the quotient of dQ by dm, where dQ is the absolute value of the total 
charge of the ions of one sign produced in air when all the electrons and positrons liberated by 
photons in mass dm of air are completely stopped in air:
v  dQ
X = T ^  2-35dm
The unit of exposure is Coulomb per kilogram (C/kg). Another unit used for exposure 
is the roentgen R, where 1 R = 2.58 x 1CT4 C/kg. The concept of exposure applies only to
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electromagnetic radiation, and the roentgen is no longer used in the SI system of units; the 
unit of exposure is simply 2.58x1 O'4 C/kg of air.
2.7.2 Measurement of Absorbed Dose
One of the main goals of dosimetry is the determination of the absorbed dose in tissue 
exposed to radiation.
The Bragg-Gray principle provides the means of relating ionisation measurements in 
gas to the absorbed dose in a dosimeter. To obtain the dose in tissue, either the material is 
tissue equivalent or else the ratio of the absorbed dose in the material to that in tissue is 
inferred from calculations or calibration measurements ([38],p.355).
Consider a gas in a walled enclosure irradiated by photons (Figure 2-32). The photons 
lose energy in the gas via the production of secondary electrons there, and the ratio of the 
energy deposited to the mass of the gas is the absorbed dose in the gas. This energy is 
proportional to the amount of ionisation in the gas only when electronic equilibrium exists 
between the wall and the gas.
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Figure 2-32: Gas in cavity enclosed by wall illustrating the Bragg-Gray principle [38].
Equilibrium implies that an electron, ei, that is produced by a photon in the gas and 
enters the wall before losing all its energy, is compensated by another electron, e2, produced 
by a photon in the wall which subsequently stops in the gas. If the walls and gas have the 
same atomic composition, then the energy spectra of such electrons will be the same 
irrespective of their origin, and a high degree of compensation is realized. The situation is 
then analogous to the air wall chamber where to reach electronic equilibrium requires that the 
wall thickness be at least as great as the maximum range of secondary charged particles but 
not so great that the incident radiation is appreciably attenuated.
SCATTERED
PHOTONS
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The Bragg-Gray principle states that, if a gas is enclosed by a wall of the same atomic 
composition, and if the wall thickness meets the conditions just given, then the energy 
absorbed per unit mass in gas is equal to the number of ion pairs produced there multiplied by 
the W value (average energy required to produce an ion pair) divided by the mass m of the 
gas. In addition, the absorbed dose Dg in the gas is equal to the absorbed dose Dw in the wall. 
Denoting the number of ions in the gas by Ng ([38],p.356):
N„W
Dw =D„ = —-—  2-36
m
If the wall and gas are of different atomic composition, the absorbed dose in the wall 
is still obtained from the ionization in the gas. Here, the cavity size and gas pressure must be 
small, so that secondary charged particles lose only a small fraction of their energy in the gas. 
The absorbed dose then scales as the ratio Sw/Sg of the mass stopping powers of the wall and 
gas [38]:
^ DgSw NgWSw 
D» = ^ —
Condenser-type chambers (air-wall chamber) that satisfy the Bragg-Gray conditions 
are used to measure absorbed dose. Prior to exposure, the chamber is charged and the dose is 
the inferred from the reduced potential difference across the instrument after exposure.
2.7.3 Determination of Absorbed Dose of Protons in Reference 
Conditions
For a beam of protons of energy E and fluence <F, cema (Kellerer et al., 1992) is defined as 
([87],p. 15):
C(E) = <$(E)S(E)m / p 2-38
in Gy where S(E)m/p is the mass electronic stopping power for medium m in units of J 
cm2/kg, and d> is the fluence in cm'2, and <bE(E) is the fluence in cm'2/ J.
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As mentioned above, cema represents the energy lost by heavy charged particles 
through electronic interactions in a manner analogous to the way the term kerma represents 
the energy transferred to directly ionising particles by indirectly ionising particles [Roesch, 
1958; ICRU, 1980]. This quantity is equal to the energy lost in electronic interactions by 
fluence of charged particles per unit mass of an irradiated specified material.
As mentioned earlier in section 2.2.2, the transfer of energy from a charged particle to 
a medium is a two stage process, that is, (1) energy loss by the charged particle in ionisations 
and excitations and (2) the subsequent absorption of this energy which is largely transmitted 
by 8-radiation. In the case of protons, the generated secondary electrons are of low energy and 
short range, so cema and absorbed dose are approximately equal. Elastic and non-elastic 
nuclear interactions occurring at low proton energies are of secondary importance for 
determining the absorbed dose in clinical situations ([87],p. 16). Nuclear interactions 
contribute less than a few percent to the absorbed dose except near and just beyond the 
primary proton range. Amongst the nuclear processes that occur, neutron production is the 
most significant as it contributes to the absorbed dose due to the large mean free path of these 
neutrons combined with the productions of heavy charged particles generated by subsequent 
neutron interactions. Nuclear secondaries are important when considering the biological 
effectiveness as it elevates their dosimetric impact. In addition, the slowing protons near the 
Bragg peak is expected to produce an enhanced biological effect.
The process of determining the absorbed dose for energetic proton beams is far 
simpler than for indirectly ionising radiation or for electrons as in the latter case the response 
of the dosimeter is dependent on the surrounding media [87]. The dosimetry for photon 
radiation is complicated by the sensitivity of the response to the atomic composition of the 
dosimeter (section 2.7.2) as the elemental composition should closely approximate that of the 
material in which absorbed dose is determined, such as water. For electrons, the difficulty lies 
in the frequent scattering caused by electron-electron collisions and the considerable energy 
loss in single event radiative processes. Consequently, the dosimeter for electron beams must 
respond to a large range of electron energies as well as a spectrum of photon energies. The 
dosimeter must replicate the elemental composition of the material in which the absorbed 
dose is to be determined, as well as it must not perturb the fluence of electrons and photons 
traversing the dosimeter. For protons, measurements might be made in a water medium using 
a gas-filled ionisation chamber constructed with walls of some other material such as plastic. 
The absorbed dose to soft tissue is inferred from the response of the dosimeter that is not 
composed of tissue. The ionisation produced in the filling gas is related to the absorbed dose 
in the material of interest. Under the cema approximation, interactions in the chamber walls
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and the surrounding media produce no direct response in the gas. The relationship between 
absorbed dose in that material and the absorbed dose in the medium of interest is determined 
by the ratio of the mass electronic stopping powers for the two materials. If the ratio of these 
stopping powers is independent of proton energy, the ionisation response determines the 
absorbed dose to water or tissue in a straightforward manner.
Moreover, the response of a radiation detector to a proton beam is influenced by the 
geometry of the detector. This is because the energy deposited by a particle in the detector 
depends on both the effective stopping power of the medium and the path length of the 
particle in the medium.
2.7.4 Microdosimetry
Although the absorbed dose is a useful macroscopic concept defining the average energy 
concentration at the site of interest, it does not specifically reflect the stochastic nature of 
energy deposition by ionising radiation in matter. Statistical aspects are important when one 
considers dose in small regions of an irradiated target, such as cell nuclei or other subcellular 
components. Microdosimetry deals with these phenomena.
2.7.4.1 Specific Energy
When a particle or photon of radiation interacts in a small volume of tissue, the interaction is 
regarded as an energy-deposition event. The energy-deposition by the incident particle and all 
of the secondary electrons in the volume is called the energy imparted, and is given the 
notation e . Due to the statistical nature of radiation interaction, the energy imparted is a 
stochastic quantity. The specific energy in Gy is defined as:
z =e /m 2-39
where e is the energy imparted to matter of mass m, and has the dimensions of absorbed dose 
([38],p.375). The irradiated volume experiences one or more energy deposition events, which 
are characterised by the single-events distribution in the values of z that occur. The average
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absorbed dose in the volume from a number of events is the mean value of z, and is defined as 
([87],p. 12):
oo
z = Jzf (z)dz = D 2-40
0
where D is the mean absorbed dose in the mass for which f(z) is determined, and f(z) is the 
probability (density) distribution and is mass dependent. The term energy absorption event 
refers to energy deposition by one charged particle or a group of correlated particles (e.g. a 
proton and its delta rays). Microdosimetry is a study of the distributions in z from different 
radiations in different-size small volumes of tissue.
One can also regard an ensemble of identical small volumes throughout an irradiated 
body and the distribution of specific energy in the volumes due to any number of events ([38], 
p.375). For example, for low-LET radiation, 2/3 of the cell nuclei have z = 0 whereas in the 
other 1/3, z varies with a mean value of ~ 3 mGy. In the case of fission neutrons, 99.8% of the 
nuclei have z = 0 whereas in the other 2%, z varies by many orders of magnitude with a mean 
value of ~ 500 mGy. Although protons are regarded as low-LET radiation a small portion of 
the energy loss of protons is through nuclear interactions, leading to a small probability of 
large local depositions of energy.
2.7.4.2 Lineal Energy
The lineal energy is defined at the quotient of the energy imparted e from a single event in a 
small volume and the mean length 1 of isotropic chords through the volume in J cm"1 or keV 
pm'1 ([38],p.376):
e
y ~ T1 2-41
Lineal energy, a stochastic quantity, has the same dimensions as LET, which is 
nonstochastic (being the mean value of the linear rate of energy loss). Lineal energy is the 
microdosimetric analogue of LET. But, unlike specific energy, it is only defined for a single 
event.
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A clinical proton beam indicates that not more than about 2% of the absorbed dose is 
due to these types of events for energies less than 250 MeV but, because of their high 
biological effectiveness, their contribution is not negligible (see reference within [87]). The 
volume is usually taken to be a sphere of diameter d, and then 1 = (2/3) d [38, 87].
2.7.5 Detectors
Different types of detectors have been used to measure and monitor heavy charged-particle 
beams. In this section, the discussion will only include ionisation chambers, Faraday cups, 
chemical dosimeters, solid-state integrating detectors, photographic emulsions, and 
calorimeters, which are the most extensively used, and semiconductor detectors, which offer 
an extremely useful method for energy and energy-loss measurements. Limiting the 
discussion to these detectors does not imply that other detectors are not also useful for 
measuring heavy charged-particle beams. Proportional counters, scintillation detectors, 
secondary emission monitors, and activation dosimeters are all applicable in this connection 
([88], p.168).
2.7.5.1 Faraday Cup
The Faraday cup is a device that can determine the number of particles or particle fluence in a 
charged-particle beam and is often used as a primary standard (Figure 2-33) ([88], p. 171). The 
main advantage here is that the charge-collection efficiency of a well-designed cup is 
independent of the beam intensity.
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Figure 2-33: The TERA Faraday cup [89],
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The Faraday cup consists of an absorber block, thick enough to stop the entire 
primary beam and its secondary charged particles. This block, which is generally cup-shaped, 
is supported by insulators within an evacuated chamber. The basic design of the Faraday cup 
is such that the net charge collected is only that delivered by the beam.
The following factors are considered in the selection of the material for the Faraday 
cup: (1) the mean free path in the material should be long enough to minimise the nuclear 
secondaries (such as secondary protons, deuterons, tritons, 3He and a-particles due to nuclear 
recoils, and neutrons) [90]. The density of the material should be high, to minimise the linear 
range and the beam spread, (2) the material should have a low coefficient for the emission of 
secondary electrons from the surface, (3) the inner radius of the cup should be large enough 
so that the primary beam does not strike the cup wall, and (4) the outer radius of the Faraday 
cup should be greater than the beam radius by at least three times the radial beam spreading.
For high-energy primary beams, in which the particles have a fairly high probability 
of having an inelastic nuclear collision with the subsequent emission of energetic secondary 
particles, the radius of the cup must be even larger, since the secondary particles will have a 
greater angular spread than the primary beam.
The cup should also be deep enough so that the solid angle through which back- 
scattered secondary electrons may escape is acceptably small. The wall thickness is not an 
important factor as most of the secondary electrons, which escape from the surface of the cup, 
are below 50 eV.
Another important factor is that secondary electrons should be prevented from 
entering or leaving the collection block. In order to achieve this, a magnetic field of 
approximately 1000 gauss, oriented perpendicular to the axis of the beam is sufficient to 
cause low-energy secondary electrons to return to the surfaces from which they were emitted.
In practice, the use of Faraday cups for charged-particle dosimetry has been limited to 
the calibration of proton beam [91], and the absorbed dose to water in Gy is calculated 
through the following relation [89]:
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where A is the effective beam area in cm2, (S(E)/p)w is the mean stopping power in water in 
MeV cm2 g_1 at the considered energy E; Q is the total charge transported by the beam in 
Coulomb, e is the elementary charge in Coulomb. For dose determination with the fluence 
method using a Faraday cup, a large parallel plate transmission ionization chamber is 
included which remains in the beam at all times and gives a signal proportional to ionization; 
the parallel plate chamber is used as a relative monitor of beam intensity during the 
calibration process. Other monitors such as toroidal transformers and secondary emission 
monitors (SEM) may also be used [91].
2.7.5.2 Calorim eter
A calorimetric measurement is a direct determination of the energy imparted to a sensing 
element as indicated by a temperature change ([87], p. 17). When all the deposited energy is 
thermalised, absorbed dose may be directly determined in a calorimetric measurement (Figure
2-34). Knowledge of certain radiation parameters such as the mean energy needed to create an 
ion pair, W, or the chemical yield per unit energy deposited, G, and the dependence of these 
quantities on ionising particle species and energy, is not required. Therefore, a calorimetric 
absorbed dose determination can provide an independent confirmation of ionisation 
determinations that is especially important for absolute results.
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Figure 2-34: Schematic diagram of the small-body portable graphite calorimeter (left, not to scale) and cross 
sections of the core and the jacket (right, approximately to scale) [92],
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Many such devices operate in an adiabatic condition where a core of material is 
surrounded by one or more insulating jackets. Before, during, and after irradiation, the core 
and surrounding jackets, which are irradiated simultaneously, are maintained at equal 
temperatures. The net temperature change of the core, relative to the pre-irradiation period, is 
then proportional to the energy deposited by the ionising radiation. To ensure that the signal is 
derived from the material of interest, even for large imparted energy density, a core mass of 
several grams is usually employed. The imparted energy per unit mass represents the average 
absorbed dose to the core material. Conversion of the measured temperature change to energy 
imparted is accomplished by measuring the mass of the core, combined with either calibration 
of the temperature response of the core with resistive heating or by knowing the core’s 
specific heat value. The core and jacket material is usually made of graphite or A-150 tissue 
equivalent plastic. A typical temperature change is in the order of 10~3 °C per Gy. Thermistors 
(metal oxide semi-conductors with a negative temperature coefficient) are commonly used in 
conjunction with a Wheatstone Bridge to determine this temperature change with great 
precision. Water calorimeters have been developed to provide a more accurate and direct 
determination of absorbed dose to water (Domen, 1980) as most graphite calorimeters are 
difficult to construct, and are considered impractical for clinical dosimetry. Water 
calorimeters are operated in non-adiabatic conditions and the temperature in a small region of 
the water calorimeter surrounding the thermistor temperature-sensing element is directly 
measured. Negligible conduction and convection heat losses occur; therefore, the temperature 
rise is directly related to the energy imparted per unit mass.
The plastic material, A-150, considered to be tissue equivalent, actually has a 
composition in which the concentration of carbon and oxygen are almost the reverse of those 
in muscle. Also, a significant thermal defect is noted of A-150 for protons, which has been 
measured in the energy range of 0.5 to 4 MeV and is reported to be 4% ± 1.5% (McDonald 
and Goodman, 1982) [87, 93]. The thermal defect for graphite is assumed to be 0% [87]. The 
heat defect depends on the type of particle and its energy [91].
Despite the recommendation that heavy charged particle beams be calibrated in terms 
of dose to muscle, similar to x-rays and electron beams, this can only be done indirectly. A 
truly tissue equivalent calorimeter with a small thermal defect is not yet available; thus, a 
procedure in which the calorimetrically determined dose to water is transferred to the dose to 
muscle by the application of a stopping power ratio would introduce less uncertainty than any 
of the presently recommended methods [93]. The absorbed dose to water is as follows [87]:
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D w = ATk(l + Td )s wcal 2-43
where AT is the temperature rise due to radiation in °C, k is the specific heat of the sensitive 
element in J kg‘loC '\ TD is the thermal defect (or excess) due to deposited energy that does 
not end up as temperature increase (or decrease), and SW;Cai is the ratio of the mass stopping 
power of water to the calorimeter material (± 1% uncertainty).
The water calorimeter described by Schulz et al (1987, 1991) suggests that the 
thermal defect of water is the single largest uncertainty in the dose recorded by the water 
calorimeter [93]. The accuracy of the water calorimeter is affected directly by the thermal 
defect of the irradiated water. This is equal to the expected temperature change minus the 
observed temperature change, the difference divided by the expected temperature change. The 
experimental data (Schulz et al. 1991, Ross et al., 1989) support a thermal defect of hypoxic 
water that is less than 1% endothermic for low-LET radiations, and a thermal defect for water 
exposed to intermediate LET radiations, such as protons, at 4 °C is approximately one half for 
that of low-LET radiations, it is indirectly determined to be 1.00±1% [87, 93].
The performance of a dedicated small-body portable graphite calorimeter (PGC) as a 
reference dosimeter has been studied for clinical low energy proton beams at Clatterbridge 
Centre for Oncology (Figure 2-34) [92]. Perturbation correction factors for the gap effect, 
volume averaging effect, heat transfer phenomena and impurity effect were calculated and 
applied in a comparison with ionization chamber dosimetry following the IAEA protocol 
[94]. The ratio of absorbed dose to water obtained from the calorimeter measurements and 
from the ionization measurements varied between 0.983 and 1.019, depending on the beam 
type and the ionization chamber calibration modality, this is not significantly different from 
unity. The uncertainties that varied from 1.9% and 2.5% were dominated by contributions 
from the calibration factors, beam quality correction factors and water to graphite stopping 
power ratios. The (Wai/e)p values inferred from the measurements varied between 33.6 J CT1 
and 34.9 J C_1 with similar uncertainty values. More improvements are underway for the PGC 
and the measurement set-up in general to further reduce the overall uncertainty.
2.7.53 Ionisation chamber
Gas filled ionisation detectors are widely used conventional radiotherapy. The instrument 
most commonly used to measure dose delivered by heavy charged particle is the parallel-plate 
chamber. Figure 2-35 shows two types of such chambers ([88], p. 168).
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Figure 2-35: A view of large-area and limited-area parallel-plate ionization chambers [88].
The collection volume for such a chamber is usually limited to the central part of the 
beam by making the collection electrode small. This can be done by making a circular 
“scratch” through an evaporated aluminium coating on a Mylar substrate. Electrical 
connection to this collection electrode is made from the backside of the electrode with a fine 
wire or an electrically conducting film. A sufficiently large guard-ring electrode surrounds the 
collection electrode, and the electric field may be assumed to be uniform and parallel. The 
area of collection electrode and the distance between the high-voltage and collection electrode 
define the collection volume. The electrodes are usually made of thin metal foil, or Mylar foil 
coated with an electrically conducting film.
As heavy-particle beams from accelerators fluctuate in intensity, the current from the 
ionisation chamber is usually integrated by charging a capacitor, and measuring the potential 
thus developed across it with the aid of an electrometer. It is advantageous to use an 
electrometer with nearly 100% inverse feedback so that the collection electrode is held 
effectively at ground potential. This helps in reducing (a) collection of stray ions from regions 
of the chamber outside the intended sensitive volume, (b) leakage of charge from the collector 
to ground, and (c) response time of the electrometer circuit.
For heavy charged particles, the primary interactions that result in ionisation of the 
gas occur principally in the gas (rather than in the wall of the chamber as for x- and y 
radiation); hence the atomic composition of the wall of the chamber is not as critical.
If the charge Q (Coulombs) is collected from an ionisation chamber, the dose D (Gy) 
in a target located at the same position is D = QWSm/pV where V is the collection volume 
of the ionisation chamber (cm3), p is the density (kg/cm3) of the ionisation chamber gas at
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ambient temperature and pressure, W is the energy per ion pair (eV) for the gas, and Sm is the 
ratio of the mass stopping power of the target material to that of the gas, for the heavy 
particles present.
Sources of error in calculating the dose from ionisation chamber measurements are 
dependent on the following factors: (1) recombination of positive and negative ions before 
they are collected; (2) uncertainty in the value of energy required for formation of an ion pair 
in the gas (W), and (3) uncertainty in the relative mass stopping power of tissue compared to 
the gas (Sju). The recombination effect is minimised if the negative-charge carriers are 
electrons instead of ions because the drift velocity is about 103 times faster and the coefficient 
of recombination is about 104 times smaller for electrons compared to ions; unless they 
combine with neutral atoms to form negative ions. In the case of protons, dry nitrogen is most 
commonly used as they have negligible electron attachment; hence recombination errors are 
minimal and W and Sm values are almost independent of proton energy. However, though 
recombination is unlikely to be a problem in proton dosimetry, some corrections may need to 
be applied for charged particles heavier than protons.
2.7.6 Solid State Detectors
Any solid material that exhibits at least one measurable parameter varying as a function of 
absorbed dose or absorbed dose rate deposited in the material by some type of ionising 
radiation can serve as the basis for a solid-state dosimetry system.
There are two types of solid-state detectors: (a) integrating type detectors such as 
thermoluminescent crystals, radiophotoluminescent glasses, optical density type detectors, 
and (b) electrical conductivity detectors such as semiconductor junction detectors, diamond 
detectors and induced conductivity in insulating materials. The most widely used devices for 
the measurement of absorbed dose are the thermoluminescent dosimeter (TLD), diodes, and 
film, which are described below ([37], p. 144).
2.7.6.1 Film
2.7.6.1.1 Radiographic film
A radiographic film can be a convenient method of relative dose measurements ([37], p. 151). 
It consists of a transparent film base (cellulose acetate or polyester resin) coated with an
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emulsion containing very small crystals of silver bromide. When the film is exposed to 
ionising radiation, a chemical change takes place within the exposed crystals to form what is 
referred to as a latent image. The development process of the film reduces the affected 
crystals to small grains of metallic silver; while the fixing process of the film removes the 
unaffected or un-irradiated granules, leaving a clear film in their place. The metallic silver, 
which is not affected by the fixer, causes blackening of the film. Therefore, the degree of 
blackening of an area of the film depends on the amount of free silver deposited and 
consequently, on the radiation energy absorbed.
The degree of blackening of the film is measured by determining optical density with 
the use of a densitometer. This instrument consists of a light source, a tiny aperture through 
which the light is directed and a light detector to measure the light intensity transmitted 
through the film. The optical density, OD, is defined in the following relation:
OD = log ia . 2 44
h
where Io is the amount collected without film and It is the amount of light transmitted through 
the film.
2.7.6.1.2 Radiochromic Film
The advantages of radiochromic films include tissue equivalence (Z ranges from 6.0 to 6.5), 
high spatial resolution, large dynamic range (10'2-106 Gy), relatively low energy dependence, 
insensitivity to visible light and no need for chemical processing ([37], p. 153).
Radiochromic film is made of an ultra thin (7- to 23-pm thick), colourless, radio­
sensitive leuco dye bonded onto a 100-pm thick Mylar base. The unexposed film is colourless 
and as a result of a polymerisation process induced by ionising radiation changes to shades of 
blue. No physical, chemical, or thermal processing is required to bring out or to stabilise the 
colour. The degree of colouring is usually measured with a spectrophotometer using a narrow 
spectral wavelength of the nominal value of 610-670 nm. Presently, commercially available 
laser scanners and CCD-microdensitometer cameras are used to scan the films. The 
measurements are expressed in terms of optical density as defined by Equation 2-44.
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Although radiochromic films are insensitive to visible light, they exhibit some 
sensitivity to ultraviolet light and temperature, and therefore should not be exposed to 
fluorescent light or to sunlight. The sensitometric curve shows a linear relationship up to a 
certain dose level beyond which its response levels off with increase in dose.
2.7.6.2 Silicon Diodes
Semiconductor diodes are routinely used for absorbed dose measurements in heavy charged- 
particle beams. Because of their higher sensitivity, instantaneous response, low temperature 
dependence, small size and ruggedness silicon p-n diodes offer special advantages over 
ionisation chambers [37, 42]. They are particularly well suited and often used for depth-dose 
distribution measurements of small collimated beams, output constancy checks and in vivo 
patient dose monitoring.
A temporary change in electrical conductivity is induced when ionising radiation is 
absorbed in solid materials, by the production of electrons or “positive holes” having 
sufficient energy to be free to move through the solid. This “induced conductivity” is a 
function of the absorbed dose rate in the material and can used as a measure of dose rate if 
appropriate calibrations are made. In certain materials (e.g. silicon diodes) a permanent 
change in conductivity may be produced by radiation damage to the crystal; in these materials 
the change is a function of total absorbed dose in the material.
A diode dosimetry system consists of a silicon diode crystal, which is mixed or doped 
with impurities to make p- and n-type silicon. The radiation-induced current generated in the 
diode by radiation exposure is measured using an electrometer with very low impedance. It is 
unnecessary to apply external voltage to the diode (photovoltaic mode); this plays a role in 
improving the signal-to-noise ratio ([87], p.33).
The main advantage of diodes is that they are far more sensitive than ion chambers. 
For example, the energy required to produce an electron-hole pair in Silicon is 3.5 eV 
compared to 34 eV required to produce an ion-pair in air and because the density of Silicon is 
1,800 that of air, the current produced per unit volume is about 18,000 times larger in a diode 
than in an ion chamber. Therefore, a diode, even with a small collecting volume, can provide 
an adequate signal ([37], p. 150). However, a diode can suffer permanent damage when 
irradiated by ultra-high doses of ionising radiation. The damage is generally caused by the
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displacement of Silicon atoms from their lattice positions. The extent of damage will depend 
upon the type of radiation, energy and total dose, with greater damage resulting from more 
massive particles (Rikner, 1983). Because of the possibility of radiation damage, due to 
prolonged use, diode sensitivity should be checked routinely to assure stability and accuracy 
of calibration [37].
Although in the case of protons, the response of these diodes was found to be 
independent of proton energy (Raju, 1966; Koehler, 1967; Rikner, 1972), small but 
significant discrepancies with ionisation chambers measurements have been seen (Koehler, 
1967; Verhey et al., 1979) [42].
2.7.6.3 Thermoluminescent Dosimetry (TLD)
Thermoluminescence (TL) is the phenomenon by which certain crystals are able to store 
energy transmitted to them by radiation and then emit this energy in the form of visible light 
when heated ([37], p. 144). For dosimetry purposes, a TL material must have a relatively 
strong light output and be able to retain trapped electrons for reasonable periods of time at 
temperatures encountered in the environment. Some thermoluminescent detectors often 
require crystals that are purposely flawed by adding a small concentration of impurity as an 
activator while other detectors do not require the addition of an activator but rely instead upon 
inherent impurities and defects in the natural crystal.
In an inorganic perfect crystal lattice the outer atomic electronic energy levels are 
divided into a series of continuous allowed energy bands separated by forbidden energy 
regions (Figure 2-36 (a)). The uppermost filled band is called the valence band and is 
separated by several electron volts from the lowest unfilled band called the conduction band. 
When a crystal is exposed to ionizing radiation electrons are may receive sufficient energy to 
be removed from an atom at a particular lattice site and thus be excited out of the valence 
band into the conduction band, leaving a vacancy in the valence band called a hole. Both 
electron and the hole are free to wander independently throughout their respective bands. The 
presence of lattice impurities gives rise to discrete local energy levels within the forbidden 
region between the valence and conduction bands. These discrete energy levels trap electrons 
which on subsequent heating and recombination causes the emission of light 
(thermoluminescence). A graph depicting the light emitted as a function of time or 
temperature is called a glow curve (Figure 2-36 (b)).
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Figure 2-36: (a) Thermoluminescence; (b) Glow Curve [37].
An advantage of TLDs is that they may be reused. To prepare the dosimeter material 
for reuse, it must be heated again at a high temperature {annealed), to empty all of the traps.
The reading process is fast, approximately 20 seconds per chip, and can be 
automated. While the reusability of TLDs is one of their major advantages, the annealing 
process destroys any information stored in the dosimeter and thus does not allow any form of 
record keeping.
There are several different TLD crystals in use depending on their application. The 
most frequently used TLD material is lithium fluoride (LiF) because (1) it exhibits a nearly 
flat energy response, (b) the light emitted shows little fading (e.g. only 10 to 15% for photons 
within 3 weeks after irradiation) with storage time at room temperature, and (c) the response 
versus absorbed dose is linear.
Despite that, the response of TLD phosphors as a function of absorbed dose must be 
carefully calibrated for all doses of interest. This is essential because the response deviates 
from linear above a threshold dose, different for each phosphor, and, ultimately, the TL signal 
saturates and the phosphors suffer irreversible damage at very high doses. The TL response 
per absorbed dose as a function of energy, for low-LET electromagnetic radiation (gamma ray 
and x-ray), is generally fairly uniform whereas the efficiency for higher LET radiation can 
vary and should be calibrated as a function of energy.
The efficiency, rj, of thermoluminescent detectors (TLD) to heavy charged particles 
strongly depends on the atomic number and energy [95]. The TLD efficiency decreases with 
decreasing energy, and cannot be assumed constant even for hydrogen ions. This is due to
98
saturation effects caused by the high ionisation density around the ion path, which increases 
with decreasing projectile energy. For a given energy the efficiency decreases with atomic 
number, which is also due to the increase in ionization density.
2.7.6.4 Diamond detectors
The mechanism of a diamond dosimeter is a change in their resistance upon radiation 
exposure [96]. When a bias voltage is applied, the resulting current is proportional to the dose 
rate of radiation. The dosimeter consists of a natural diamond crystal sealed in polystyrene 
housing with a bias applied through thin golden contacts. The advantages of diamond 
detectors are that: (a) they have a small sensitive volume, on the order of a few mm3, which 
allows the measurement of dose distributions with an excellent spatial resolution that makes 
them well suited for the use in high dose gradient regions, e.g., for stereotactic radiosurgery 
(b) they are tissue-equivalent and require nearly no energy correction, (c) they have a flat 
energy response, (d) a small physical size, (e) they exhibit negligible directional dependence, 
(e) the temperature dependence is very small in the order of 0.1% °C'1 or less, (f) high 
sensitivity and resistance to radiation damage are other important features of the diamond 
dosimeter, and (g) is waterproof it is used for measurements in a water phantom.
Nonetheless, in order to stabilize their dose response, diamonds should be irradiated 
prior to each use to reduce the polarization effect, as they tend to exhibit some dependence of 
the signal on the dose rate that has to be corrected for when measuring e.g. depth doses.
2.7.7 Chemical Dosimetry
In chemical dosimetry, the energy absorbed from ionising radiation may produce a chemical 
change, and if this change can be determined, it can be used as a measure of absorbed dose.
In aqueous dosimeters, one can generally assume that radiation interacts with water, 
producing chemically active primary products in about 10'10 s or less. These products, 
including free radicals like H and OH which have an unpaired electron, and molecular 
products such as H2 and H20 2, are distributed heterogeneously, close to the charged-particle 
tracks.
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After the initial interaction (1C)"6 s), the spatial distribution of these primary products 
tends to homogenise due to diffusion, simultaneous with their chemical interactions with the 
solutes present. The LET dependence (if any) of the dosimeter depends on the reaction rates 
during this interval before the initial spatial distribution is obliterated. High-LET tracks 
usually encourage competing reactions or back reactions (corresponding to initial 
recombination in gases), thus reducing the yield of the desired product to be measured. The 
radiation chemical yield of the measured product is expressed as G(x) in units of moles/J, 
with respect to the product X and represents the number of chemical entities e.g., molecules 
produced, destroyed, or changed by the expenditure of 100 eV of radiation energy.
Gel dosimetry systems are the true 3-D dosimeters suitable for relative dose 
measurements [96]. The dosimeter is simultaneously a phantom that can measure absorbed 
dose distribution in a full 3-D geometry. They are almost tissue-equivalent and can be shaped 
to any desirable shape or form. Chapter 3 gives a more detailed explanation of the various 
types of gel dosimeters. Gel dosimetry is a highly promising relative dosimetry technique that 
may prove particularly useful for dose verification in complex clinical situations (e.g., 
intensity modulated radiotherapy) in anatomically shaped phantoms.
2.7.7.1 Alanine/EPR dosimetry system
Alanine, one of the amino acids, comes in the form of rods or pellets with an inert binding 
material. It is typically used for high dose dosimetry [96]. When exposed to radiation, the 
interaction results in the formation of alanine radicals whose concentration is measured using 
an electron paramagnetic resonance (EPR), also known as electron spin resonance (ESR), 
spectrometer. The intensity is measured as the peak-to-peak height of the central line in the 
spectrum, and the readout is non-destructive.
Alanine is tissue-equivalent and therefore requires no energy correction within the 
quality range of typical therapeutic beams. It also exhibits very little fading for many months 
after irradiation, but the response during irradiation depends on environmental conditions (i.e. 
temperature) and storage (i.e. humidity).
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2.7.8 Clinical Dosimetry
Institutions currently follow one of three existing protocols for determining absorbed dose in 
proton therapy beams: the American Association of Physicists in Medicine (AAPM) Task 
Group 20 protocol for heavy charged-particle therapy beam dosimetry [91], the European 
Clinical Heavy Particle Dosimetry Group (ECHED) code of practice for clinical proton 
dosimetry [97, 98], and the International Commission on Radiation Units and Measurements 
(ICRU) for clinical proton dosimetry protocol [87]. All these protocols recommend the use of 
calorimetry or an ionization chamber as primary dosimetric standards.
But a calorimeter is considered the most accurate method due to its absolute dose 
response without calibration using a radiation source. The ICRU 59 protocol [87] 
recommends using ionization chambers calibrated in a Co-60 beam in terms of air kerma or 
absorbed dose-to-water, and provides dosimetry worksheets and updated physics data to 
derive the absorbed dose in a proton beam from ionization chamber measurements.
The use of air-filled ionization chambers requires the use of several radiation- 
dependent parameters, including water to air stopping power ratios and the mean energy 
required to produce an ion pair (W). The uncertainty in the W values reduces the accuracy of 
dose determination in proton therapy.
The results of a previous international proton dosimetry intercomparison between 13 
proton therapy centers [99] showed that using ionization chambers with Co-60 calibration 
factors traceable to standard laboratories, and institution-specific conversion factors and dose 
protocols, a distribution of stated absorbed dose is achieved with a maximum difference of 
6%, due mainly to differences in assumed conversion factors needed to obtain proton 
chamber factors from Co-60 calibration factors. The participants in the inter-comparison 
proposed the adoption of uniform conversion factors and a single ionization chamber 
dosimetry protocol to achieve consistency in the dose delivered to patients at all institutions; 
hence came out the ICRU 59 protocol [87].
Another international proton dosimetry inter-comparison was held at Loma Linda 
University Medical Center (LLUMC) on April 12-14, 1998 in conjunction with the proton 
therapy cooperative group meeting (PTCOG XXVIH) [100]. The goal was to estimate the 
level of consistency in absorbed dose delivered to patients when proton beams were calibrated
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with the new ICRU protocol [87], and to evaluate the differences in absorbed dose 
determination due to differences in Co-60 based ionization chamber calibration factors.
The results of this second international proton dosimetry inter-comparison have 
shown that with use of thimble ionisation chambers with Co-60 calibration factors traceable 
to standard laboratories, and the ICRU proton dosimetry protocol, the distribution of stated 
absorbed dose is achieved with the difference between ± of 2.9%. A comparison of proton 
doses derived from the measurements with different chambers suggests that differences in the 
results cannot be explained only by differences in the Co-60 calibration factors; thus more 
studies in proton beams is suggested to provide accurate correction factors for different 
ionisation chambers.
Andreo et al. [94] proposed a new protocol (IAEA protocol) to determine absorbed 
dose to water based on unified formalism. The IAEA protocol covers beams of Co-60, low- 
and high-energy photons, electrons, protons and heavy ions. The protocol-updated data is set 
for the use of ionisation chambers to evaluate absorbed dose to water. A heavy-ion beam 
generally includes many different particles that have fragmented from the injected heavy ions 
as they penetrate a water phantom. As a result, W-values, the stopping-power ratio of water to 
air and so on for the various particles must be accurate in order to obtain the quality factors in 
the calculation of absorbed dose to water [101].
In heavy-ion dosimetry, parallel plate ionisation chambers are often used, and the 
calibration coefficient based on absorbed dose to water for the chamber is obtained by three 
methods. The first method is to calculate from the Co-60 calibration coefficient, NDw, the 
second method is to calibrate the parallel plate ionisation chamber at the plateau region of the 
mono-energetic beam, where the absorbed dose to water is determined by a cylindrical 
chamber. The third method is to calibrate the parallel-plate ionisation chamber at the middle 
of the SOBP of the therapeutic beam, where the absorbed dose to water is determined using a 
cylindrical chamber [101].
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3 A preliminary analysis of LET effects in the 
dosimetry of proton beams using PRESAGE™ 
and optical CT
3.1 Introduction
The onset of new and highly complex treatment modalities in radiation oncology such as 
stereotactic radiosurgery, conformal radiation therapy, the dynamic wedge, scanning electron 
beams, and energy-modulated proton beams, has initiated the need for an accurate and 
versatile method for measuring and verifying three-dimensional dose distributions which are 
beyond the capabilities of currently available dosimetry systems. Hence, whereas significant 
and rapid advances in the technology of treatment delivery are being realised, in comparison 
the same criteria in the treatment verification are not being met.
Traditional dosimeters are still being utilised to verify and commission complex new
3-D delivery techniques. Examples are point-based devices such as ion chambers, diodes and 
TLDs or planar imagers such as film and portal imaging that can be used in arrays, but still it 
is only possible to measure the dose at a few selected points in the distribution. This approach 
has its limits when trying to quantify complex beam geometry as in IMRT where water 
phantoms with rigid geometry are used and thus insufficient flexibility is available to verify 
patient-like treatment situations. Film dosimetry has excellent spatial resolution but phantoms 
available to measure dose in multiple planes are in general complex and time consuming and, 
despite recent advances in film technology [102], uncertainties are still introduced in the 
calibration process [103].
Oldham et al. [104] proposed that an ideal 3-D dosimetry system should meet the 
RTAP criteria (Resolution lx lx l mm, Time 60 min imaging, Accuracy within 3%, and 
Precision within 1%). Though RTAP (1, 60, 3, 1) was mainly developed with reference to the 
verification of radiosurgery dose distributions, where high spatial resolution is most 
challenging, it is a convenient approximation for the ideal specification of a 3-D gel dosimeter 
with the addition of water equivalence. In practice, a relative dosimetry system that can
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achieve RTAP (1, 60, 3, 1) across the spectrum of treatments is not yet available; however, 
recent gel dosimetry systems are showing real promise.
Gel dosimetry is founded mainly on the work of Gore et al. who proposed that the 
radiation induced changes in an aqueous ferrous sulphate Fricke dosimeter could be probed 
with Nuclear Magnetic Resonance (NMR) [6]. For many years, the majority of investigations 
with different gel prototypes were to be undertaken with MRI. This all changed with the 
introduction of alternative techniques for evaluation [105-107], especially optical computed 
tomography (CT) in 1996 [7]. While MRI will likely remain the method of choice at some 
institutions for specific types of study, for many institutions there will be significant financial, 
administrative and logistical advantages to having a relatively low-cost tomographic optical 
density dosimetry system located in the radiation oncology department which can readily 
provide the bulk of the clinical and research data required by the radiation oncology 
physicists.
3.2 Three-dimensional dosimeters
Radio-sensitive volumetric dosimeters that have been developed and evaluated which 
offer unique advantages for three-dimensional optical dosimetry fall into two categories: 
absorbing (e.g. Fricke gels [108] and PRESAGE™ [109]); and scattering (e.g. polymer gels 
[HO]).
3.2.1 Fricke gel
In the Fricke dosimetry system, exposure to radiation converts aqueous ferrous ions Fe2+ into 
ferric ions Fe3+, and the dose absorbed by the irradiated Fricke dosimeter can be determined 
by measurement of the concentration change of Fe3+' In order to stabilize the geometric dose 
information, a gel matrix is incorporated to the aqueous Fricke solution that provides some 
spatial localization of the radiation-induced changes.
Most of the interest is in the verification of the dose related to non-uniform beam 
geometry such as in conformal dose delivery. Due to very steep dose gradients of Fe3+ in 
relevant clinical situations, there is a diffusion of the ferrous and ferric ions even with the 
presence of a gel matrix to spatially stabilize the ion concentrations, and thus, the spatial 
information is eventually destroyed [108]. Therefore, there are practical, finite, time 
constraints from the start of irradiation to the end of the dose measurement imposed by the
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ion diffusion. It has been noted that the diffusion coefficients of different preparations of 
Fricke gels are dependent on the type of gel, the gel concentration, the temperature and other 
properties of the dosimeter [111]. The constraints imposed by diffusion on the practical time 
during which an irradiated Fricke gel can be imaged were the main motivation for the 
development, and increased clinical use, of polymer gels.
The addition of chelators, organic chemicals that form two or more coordination 
bonds with a central ferrous or ferric ion, has improved the stability of the spatial dose 
information by reducing the diffusion coefficients of the iron ions and they have altered the 
absorption spectra of the Fricke gels so that irradiated gels give visible colour development 
that can then be probed using optical techniques. In addition, various gelling agents have been 
investigated but with limited success, and thus the diffusion problem remains a significant 
one in the advancement of gel dosimetry.
A 3-D dosimetry material that exhibits optical-contrast through light-absorbance 
rather than light-scattering has a clear advantage as it would negate the scattering artefacts. 
The first optical-CT dosimetry of a non-scattering gel was reported by Kelly et al. [112] 
where a gelatin based gel doped with Ferrous-Benzoic-Xylenol (FBX) exhibited a 
radiochromic colour change. The gel was scanned with a first generation in-house optical-CT 
scanner, and the results were quite promising. The only limitation was that the radiochromic 
distribution gradually diffused through the gel placing strict restrictions on the time available 
for imaging.
3.2.2 Polymer gels
Polymer gels are based on a different, though related, principle from that exploited in Fricke 
gels. The mechanism involved is that polymerised regions of the gel contain polymer micro­
particles that scatter light. As a result, with increasing dose i.e. increasing polymerisation the 
gel becomes increasingly opaque. The dose-response is linear until it reaches some threshold 
(whose exact value is composition dependent), after which the response is sub-linear, 
reaching saturation. Polymer gels are relatively stable (with time between irradiation and 
imaging), with high sensitivity to radiation, but are susceptible to light scattering artefacts and 
are difficult to prepare as the dose response is sensitive to the presence of free oxygen.
Maryanski et al. [8] investigated the optical properties of BANG polymer gels, and 
observed several events. First, was the absence of absorption bands in turbidity spectra of gel
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irradiated to different doses indicating that the gel is a predominantly light-scattering medium, 
with negligible light-absorption. Second, a correlation of increasing refractive index with 
increasing dose was revealed. These events, namely light-scatter and light-refraction, 
represent potential sources of error and artefacts in optical-CT dosimetry.
Fong et al. [113] introduced a new gel composition known as MAGIC (methacrylic 
and ascorbic acid in gelatine initiated by copper) which responds well to absorbed dose in the 
presence of normal levels of oxygen. The gel contains an antioxidant that binds to the oxygen 
and thus prevents oxygen scavenging of free radicals. In the MAGIC gel composition 
ascorbic acid is the antioxidant being used. Different antioxidants have been investigated with 
respect to gel characteristics such as dose-response, dose resolution, temporal and spatial 
stability and reproducibility by De Deene, who reported that the tetrakis (hydroxymethyl) 
phosphonium (THP) appeared particularly efficient [114].
3.2.3 PRESAGE ™
The radiochromic diffusion problem has been solved with the introduction of the 
PRESAGE™ dosimeter [109]. The PRESAGE™ 3-D dosimeter consists of an optically clear 
polyurethane matrix, containing a solvent, a halogenated hydrocarbon free radical initiator, 
and leuco dye that exhibits a radiochromic response when exposed to ionizing radiation [115]. 
Cursory observations indicate a number of attractive features and potential advantages over 
other gel dosimeters. First, PRESAGE™ is robust in a lab environment, being insensitive to 
the atmosphere, and not requiring an external container or phantom material, thereby leading 
to a potentially smaller wall artefact usually caused by reflection and refraction of light at the 
walls of the dosimeter [7, 10, 112, 116-118]. Dose response sensitivity can be adjusted by 
changing the proportions of the leuco-dye and initiating agent components. In addition, the 
radiochromic colour change absorbs light rather than scatters light, which facilitates high 
accuracy readout by optical-CT.
Upon irradiation, radiolytic oxidation occurs and the leuco dye, generally leuco 
malachite green (LMG) or a derivative, has a broad absorption band in a part of the visible 
spectrum (400-800 nm) while its oxidized product, malachite green, has maximum 
absorbance at 633 nm [115]. This is compatible with the output (633 nm) of the He-Ne laser 
in the OCTOPUS™ commercially available optical CT scanner (MGS Research, Inc., 
Madison, CT, USA), and also the output of the LED light source (LXHL-MD1D, Luxeon 
Star, 1W, red, Lumileds, CA, USA) in our in-house CCD-based optical scanner which has a
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minimum wavelength of 620.5 nm, a maximum wavelength of 645 nm and typical 
wavelength 625 nm ± 2 nm.
The accuracy of the optical scanning measurement is affected by various factors, 
including the optical quality and clarity of PRESAGE™ material. Surface scratches on the 
material walls, and bubbles in the PRESAGE™ could introduce significant artefacts.
Although protons show almost the same LET as conventional photon beams at the 
entrance channel, the LET slightly increases at the end of their path in tissues. Prior to the 
start of this thesis, insufficient data had been collected concerning the influence of the linear 
energy transfer (LET) to establish the behaviour of PRESAGE™. Previous studies have 
explored the use of gel dosimeters in proton [17-19,119] and heavy ion therapy [20].
Central axis depth dose distributions are essential characteristics in proton beam 
therapy. The purpose of this chapter is to investigate possible LET dependence for 
PRESAGE™ using proton beam absorbed dose measurements, and the linearity of response 
of the dosimeter. Therefore, special attention was focused on the expected lower response of 
the dosimeter to the dose deposited at the Bragg maxima caused by the high-LET at this 
point. The results will be later used to examine the use of PRESAGE™ for the verification of 
proton fields in ocular tumour therapy and to explore its applicability in a practical sense.
3.3 Materials and methods
Our dosimeters were provided by Dr. John Adamovics (Heuris Pharma, NJ, Skillman, USA). 
The batch of PRESAGE™ dosimeters used in this study (Batch # 90) has a nominal elemental 
composition of C 63.27 %, H 9.1 %, N 4.91 %, O 21.24 %, Cl 2.7 %, and Br 0.92% , with an 
empirical formula of C42iH722N280io6Cl6Br, giving an electron density of Zeff = 9.33 and a 
mass density of 1.08 g/cm3 measured by the manufacturer for our sample batch by gravimetric 
analysis [120].
In the following proton beam irradiation four samples of transparent solid plastic 
dosimeter PRESAGE™ were required. PRESAGE™ dosimeters 60 mm in height and 60 mm 
in diameter were used in this experiment. Proton irradiations were performed at Clatterbridge 
Centre for Oncology (CCO) in Wirral, Merseyside. The 62 MeV (measured nominal energy = 
60 MeV) proton beam was produced using a typical cyclotron (Scanditronix MC-60 PF)
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commissioned for fast neutron therapy [121], and the set-up was the same as that routinely 
used for patient treatments (Figure 3-1) [122].
The samples were irradiated with both monoenergetic and modulated proton beams, 
and as this was the first irradiation worldwide of PRESAGE™ by protons, the response was a 
priori unknown. A selection of doses was chosen based on prior experience with 6 MV x- 
rays. Optical tomography measurements were carried out with our in-house Optical-CT unit 
[123]. Due to the short range of 60 MeV protons in water (approximately 31 mm) no energy 
degradation was required and all irradiations were carried out in air with the maximum beam 
range.
Figure 3-1: (a) placement of the PRESAGE™ dosimeter in front of the collimator; (b) half-field A1 block attached 
to the brass collimator; (c) alignment for irradiation of the fourth sample with a wedged field; (d) the fourth sample 
viewed end-on using a light-box.
The number of monitor units required to obtain the prescribed irradiation absorbed 
doses was determined based on European Heavy Particle Dosimetry Group (ECHED) 
protocol [97, 98]. ECHED recommends that the reference positions for dose measurements to 
be at a water depth of 5 mm beyond the entrance point for the irradiations with unmodulated 
beams, and in the middle of the spread out Bragg peak (SOBP) for the irradiations with 
modulated beams. As direct proton reference dosimetry is not yet available, dose calibrations 
are obtained by comparing the proton ionization chambers (ICs), with a Secondary Standard 
IC, traceable to the National Physical Laboratory (NPL), in the CCO 60Co beam to obtain the 
air kerma, Nk. The physical factors from the ECHED protocol enable the calculation of a 
proton absorbed dose (to tissue) calibration factor in Gy/nC, for each thimble chamber (FWT
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IC-18, O.lcc). For a fully modulated proton beam, calibration of a flat Markus IC (0.043 cc) is 
obtained by cross-comparison with a FWT IC. Range and modulator measurements were 
taken with a flat diode BPW34 (3x3 mm sensitive area, Siemens) in Perspex™ (PMMA, 
p=1.17g/cm3) wheel with a stepped thickness (0.15mm steps) circumference, powered by a 
stepper motor [124]. The ionisation chamber used in Clatterbridge Centre for Oncology 
measured the ‘entrance’ dose of the Bragg peak, and the dose to the Bragg peak was 
estimated by using a ratio of 4.5 [125]. Thus, to obtain a dose of 4 Gy at the Bragg peak, the 
dose calculated at the entrance will be equal to 0.88 Gy.
The first sample was irradiated three times, using an unmodulated beam, collimated 
to a 12 mm-diameter circular cross-section with a minimum of 5 mm gap between fields to 
allow for beam scattering. The fields were placed at a distance of 10 mm from the sample 
edge to ensure that artifacts due to refractive index mismatches between the dosimeter and 
matching liquid did not obscure the collected data. The first sample was exposed to estimated 
doses of 4, 8 and 12 Gye specified at the Bragg peak. The second and third samples were 
irradiated four times, with the same dimensions, with an estimated dose of 1, 2, 16 and 20 
Gye. The dose-rate was about 11 Gy per minute at the entrance.
The third sample was irradiated with a modulated beam (Modulator no. = 769), 
reducing the Bragg peak range to 29 mm. Dose-rate was about 5 Gy per minute.
A fourth sample was irradiated four times with the proton beam modulated and 
collimated to a 12 mm x 12 mm square field. Two fields were half-blocked by placing a 3 
mm block of aluminium (i) at the exit of the collimator, and (ii) to the surface of the 
dosimeter. The other two were wedged fields with the following angles; (i) a 40.9° A1 wedge, 
and (ii) a 16.1° A1 wedge, both fixed to the dosimeter mostly used to reduce the full dose 
volume, and occasionally to shield the optic disc or nerve.
Prior to scanning, the samples were surrounded by a matching medium composed of 
25% dibutyl and 75% diallyl phthalates with a nominal (calculated) refractive index n = 
1.503. The reason behind using a matching liquid is due to the fact that reflection and 
refraction occur at the interface between materials of different refractive indices; even a 
relatively small difference in refractive index between the dosimeter and matching liquid 
gives rise to image artefacts due to refractive index mismatches [116].
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The dosimeter was rotated between projections in increments of 0.18° over 180°. For 
each sample, a set of several hundred two-dimensional slice images of the optical attenuation 
coefficients in the PRESAGE™ sample were obtained from the projection data utilizing the 
inverse-radon transform algorithm. The complete dataset is processed using DDL (Research 
Systems Inc, Boulder, CO, USA).
3.4 Comparison of ion chamber and simulation data
As we hope to use the Clatterbridge ionisation chamber measurements as a “gold standard”, it 
is instructive to compare them with Monte Carlo simulations. SRIM-2006 [126] was used to 
calculate the rate of energy loss per unit length in MeV cm2 mg"1 and, using the known 
density, converted to the conventional units of MeV cm"1.
First, the percentage depth dose distribution was obtained from Clatterbridge Centre 
for Oncology (CCO) where measurements are taken in a water phantom with a PTW/Markus 
(parallel-plate) ionization chamber. To convert depths in the water phantom to equivalent 
depths in PRESAGE™, the values were simply divided by the ratio of densities; thus, the 
following expression:
„ _  P water „ _  l«00g[/cin _
Ppresage™ ^  “  1-OBg/cm3 ^  “  1.08
The general formula of the linear stopping power for any heavy charged particle in 
any medium is dependant, among other factors (see equation 2-3), on the medium’s electron 
density, i.e. the medium’s collective electronic structure and the inter-atomic bond structure. 
By inserting the percentage composition and physical density of PRESAGE™ and proton 
energy in the SRIM-2006 menu and specifying the target depth to be 40 mm, we were able to 
get a plot of the ionization versus depth (MeV/mm) of our sample. Figure 3-2 shows the 
lateral and transverse view of the energy loss in PRESAGE™.
The measured percentage dose response at CCO and normalised energy loss values 
are plotted against depth for both PRESAGE™ and liquid water in Figure 3-3. Figure 3-3 
shows a discrepancy in the calculated peak-to-entrance dose ratios compared to the measured 
dose response. The difference in both data sets is that SRIM (Stopping and Range of /ons in 
Matter) calculates the stopping powers, range and straggling distributions for any ion at any 
energy in any elemental target but does not include nuclear (inelastic) collision models or
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delta-e,lectron production. In addition, the percentage depth dose at CCO was measured using 
an ionisation chamber with an air cavity requiring correction factors due to effects of the 
water phantom, waterproof sleeve, or chamber material on dose measurements which was not 
implemented in our Monte Carlo simulations. These differences in the Monte Carlo treatment 
of the physical interactions will lead to different results in the calculation of dose distribution 
and proton range.
T ransv erse V iew
1
r
40 mm 0 40 mm
Figure 3-2: (a) Simulation of energy loss PRESAGE™ using SRIM-2006 versus depth (z-axis); (b) Transverse 
view of energy loss in PRESAGE™.
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Figure 3-3: Simulation of energy loss in water and PRESAGE™ using SRIM-2006 in comparison with relative 
dose (%) versus depth.
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3.5 Data acquisition
For the first sample, 1000 raw projection images of dimension 448 x 256 were acquired with 
4 signal averages. These were reconstructed onto square matrices of 224 x 224 pixels, giving 
an in-plane nominal pixel resolution of (0.36 x 0.36) mm2 and slice thickness of 0.18 mm. In 
the second sample, the corresponding parameters were: raw projection matrix size 384 x 160 
pixels, 1000 projections with 4 averages, reconstruction onto 96 x 96 pixels, in-plane 
resolution 0.84mm x 0.84mm and slice thickness 0.84mm. In the third sample, the 
corresponding parameters were: raw projection matrix size 448 x 224 pixels, 1000 projections 
with 4 averages, reconstruction onto 224 x 224 pixels, in-plane resolution 0.36mm x 0.36mm 
and slice thickness 0.18mm.
The fourth sample: 1000 raw projection images of dimension 384 x 160 were 
acquired with 4 signal averages. These were reconstructed onto 192 x 192 pixels, in-plane 
resolution (0.42 x 0.42) mm2 and slice thickness 0.21 mm.
The author gratefully acknowledges the help of Dr. N. Krstajic in making these 
measurements.
3.6 Results and Discussion
3.6.1 Unmodulated beams
12 Gy at Bragg peak,
8 Gy at Bragg peak
16 G y a t  B ra g g  p e a k
Entrance dose 4 Gy at Bragg peak
2  G y a t  B rag g  p e a k
1 Gy a t  B ra g g  p e a k
Sl ice  n u m b e r
Figure 3-4: Results of calibration experiment. The main graph illustrates the Bragg peak for the proton beams, 
while the inset shows a typical slice through the 3-D dataset.
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The initial result of calibration (Figure 3-5) suggests that the dosimeter responds 
linearly to increasing dose and that the optical dose response is within our scanner’s dynamic 
range since no noticeable saturation is evident at 20 Gye; however, despite this linearity in 
response, there is a difference in the slopes of calibration in samples from the same batch. A 
likely explanation is a possible sample-sample variation in the properties of PRESAGE™, or 
due to a time delay between the two acquisitions (~ 17 days), giving time for a change in 
response of the dosimeters [115]. Note that no absolute data for OD values was obtained in 
this study. We are now able to obtain calibrated OD values. Arbitrary units for OD values 
have been used on all the y-axis scales here.
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Figure 3-5: Results of the linearity of the samples versus dose.
The uncertainty was assigned using basic standard error theory where the standard 
deviation is defined as the root mean square (RMS) deviation of values from the arithmetic 
mean of the relevant slice (slice with maximum optical density).
It is evident from Figure 3-6 that the ratio of the Bragg peak dose to the entrance dose 
in our PRESAGE™ sample is approximately 2:1 whereas the measured ratio at Clatterbridge 
Centre for Oncology is approximately 4.5:1. We hope to explain this discrepancy with further 
experimentation and simulations. It has been already confirmed in other studies [17, 18, 119] 
that the Bragg peak dose is usually underestimated compared to the entrance dose using gel 
dosimetry.
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Figure 3-6: Comparison between the Bragg peak in PRESAGE™ ± SEM (black error bars) irradiated with a dose 
of 12 Gy obtained from our optical scanner and that of CCO in water, converted to equivalent depth in 
PRESAGE™.
Further investigations are necessary to understand the effect of LET on PRESAGE™, 
and to measure the uncertainties related to our Optical-CT. One of the uncertainties in the 
measured Bragg curve due to the Optical-CT was the accurate length of the plateau region. 
The edge of the dosimeter at which the proton beam entered was not visualised by the 
imaging experiment due to a poor setup; therefore, causing a partial loss of information. Here, 
the pixel value of the first point in the plateau region is an estimate.
3.6.2 Modulated beams
Figure 3-7 (a) shows the three-dimensional reconstructed image of the third sample 
irradiated using the modulated proton beams.
Figure 3-7 (b) shows that the response of the dosimeter for the modulated proton 
beams is also linear. Applying the depth scaling factor determined from TRIM database [126] 
and used to convert depths in the Perspex™ phantom to equivalent depths in PRESAGE™ 
gives the following expression:
x„ =
(dE/pdx)Presage
Pi (dE/pdx)
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where xpdenotes the depth in PRESAGE™, xpx is the depth in perspex™, and (dE/pdx) is the 
mass stopping power.
Figure 3-7: (a) Results of experiment to map the third sample irradiated with a modulated beam of estimated doses 
1, 2, 4, and 8 Gy, and (b) results of linearity of the sample versus dose.
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Figure 3-8: Results of SOBP in Perspex scaled to PRESAGE™ and compared to our Optical-CT.
It is evident from Figure 3-8 that for a range-modulated proton beam (SOBP), the 
absorbed dose close to the end of the proton range, i.e. at the Bragg peak, is underestimated 
with approximately 20% compared to the corresponding diode measurement. As the LET for 
a SOBP is lower than for the unmodulated beam; consequently, the mean LET does not
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change dramatically until close to the end of the range [127]. This will result in a good 
agreement between relative absorbed dose as measured with the ionization chamber and the 
PRESAGE™ until this increase in LET. This is consistent with the monoenergetic beam 
measurements where the largest differences were present at, and beyond, the depth of 
maximum dose. This under-response has been observed in other studies [18, 19, 119] where it 
is thought that the effect of an increased LET is a decreased sensitivity of the PRESAGE™ 
[119]. Note that, the SOBP curves were matched at the end of the proton range, i.e. the zero 
dose point.
3.6.3 Beam  blocks and wedges
Figure 3-9 (a) shows the depth profiles of the fourth sample irradiated with two 8 Gye 
modulated wedged fields, one with 41° aluminium wedge, the other with 16° aluminium 
wedge, and two 8 Gye modulated half-blocked fields, with the aluminium block placed in 
front of the collimator, and in front of the dosimeter. The modulated proton curves were 
obtained from a profile in the slice direction where each point on the curve represents the 
mean value of a square region (~ 400 pixels) in the relevant slice. In Figure 3-9 (b), multiple 
slices of the three-dimensional data were used to create an iso-surface view with SLICER3 in 
IDL, thus getting a better three-dimensional visualization map of our fourth sample. Note that 
the profiles of the wedged fields are similar to spread-out Bragg peaks showing that wedges 
in proton beams have a different function than ones used in photon beams (steep profile 
across the beam). However, no data for the wedged and half-blocked modulated proton beams 
were collected from CCO for comparison.
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Figure 3-9: (a) Optical dose response of fourth sample versus depth irradiated with two 8 Gye modulated wedged 
fields (41° Al wedge (— ) and 16° Al wedge (— )), two 8 Gye modulated half-blocked field, one placed in front 
of the collimator (— ) and the other placed in front of the dosimeter ( ); (b) a three-dimensional map of the
reconstructed image of the sample using SLICER3 in IDL;(c) profile across the y-axis of several reconstructed 
image slices from the plateau region to the end of the Bragg peak showing the expected under-response at the 
Bragg peak (dashed box).
3.6.4 Iris treatments
In another set of experiments, samples of a different batch (Batch # 180) were used which 
were specifically formulated for proton beams. The dosimeters used had the same dimensions 
(60 mm in height, 60 mm in diameter) in this experiment. The first sample was irradiated 
seven times with range-modulated proton beams. Two fields were modulated to simulate an 
iris treatment, one with 4 mm range and the other 6 mm range, collimated to a 12 mm 
diameter cross-section. The third field was half-blocked with a 40.8 degree wedge placed in 
front of the collimator, and the fourth was a half-modulated beam. The corresponding field 
dimensions were the same, and the prescribed dose was 13.2 Gy for all four fields. The 
remaining fields were collimated to 2, 3, and 5 mm diameter circular cross-section with an 
estimated dose of 8 Gy to examine the point spread function (PSF).
For this sample, 800 raw projection images of dimension 256 x 256 were acquired 
with no signal averages, over a period of 1 hrs and 20 minutes. These were reconstructed onto 
square matrices of 256 x 256 pixels, giving an in-plane nominal pixel resolution of (0.27 x 
0.27) mm2 and slice thickness of 0.27 mm.
Figure 3-10 shows the percentage dose response of the modulated iris field with 6 
mm range plotted against depth from CCO and the optical response of our scanner.
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Figure 3-10: % Dose response of an energy modulated beam for a typical iris treatment with a range of 6 mm 
measured with ionisation chamber at CCO ( ) scaled to PRESAGE™ (-■-■-■-) and compared to our Optical-
CT results; (b) raw projection and reconstructed image of our sample (inset).
Again, for the combination of superimposed range modulated beams, the absorbed 
dose close to the end of the proton range, i.e. at the Bragg peak of the unmodulated 
component, is underestimated by approximately 15% compared to the corresponding diode 
measurement.
3.7 Effect of dosimeter formulation
Three PRESAGE™ dosimeters with different formulation (Table 3-1) were irradiated in a 
modulated proton beam with the same field dimensions mentioned above. The three 
dosimeters of each formulation were irradiated to doses of 18 (Sample 173/2 and 180/5) and 
20 Gye (Sample 90/2) and imaged five days later. Optical dose response curves for the three 
formulations are plotted in Figure 3-11.
Batch
no. C (% ) H ( % ) N (%) 0 (% ) Br (%) Cl (%) Zeff
Density
[g/cm3] Empirical formula
90 63.27 9.1 4.91 21.24 0.92 2.7 9.33 1.08 C421 H722N28 0 io6Cl6Br
173 63.27 9.1 4.91 21.24 1.45 3.1 10.14 1.09 C293H502N 1gO^ClsBr
180 62.89 9.0 5.27 2 1 . 2 2 1.55 . . . 9.60 1.08 C27oH46()N190 6gBr
Table 3-1: Elemental composition, effective atomic number, electron density and empirical formulae for various 
PRESAGE™ batches.
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— Batch no 173/2 [1:1.58] 
— Batch no. 180/5 [1:2.24] 
— Batch no.90'2 [1:1.86]
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Figure 3-11: (a) SRIM-2006 simulations of mass stopping power plotted against depth for Batches number 90 
( ) and 180 (-—) showing a slight difference in the energy loss at the Bragg peak; (b) Results of Bragg peaks of
different batches of PRESAGE™ with different sensitivities imaged with our Optical-CT.
The data show that the under-response of PRESAGE™ to unmodulated proton beams 
although still quite significant, show an improvement with the formulation used in Batch 
number 180 (1:2.24) which is quite promising.
3.8 Conclusion
For an unmodulated Bragg peak, Figure 3-6, the ratio of the Bragg peak dose to the entrance 
dose in our PRESAGE™ sample is approximately 2:1 whereas the measured ratio at 
Clatterbridge Centre for Oncology is approximately 4.5:1.
Figure 3-8 shows that, for the range-modulated proton beam (SOBP), the absorbed 
dose close to the end of the proton range (i.e. the Bragg peak) is underestimated by 
approximately 20% compared to the corresponding diode measurement. Both these 
observations can be explained via the hypothesis that the PRESAGE™ material has a 
different response at different LET values (i.e., although linear, the gradient of a graph such 
as Figure 3-5 is progressively reduced at high-LET). As the LET for a SOBP is lower than for 
the unmodulated beam, the mean LET does not change dramatically until close to the end of 
the range [127] and it is for this reason that the differences in the dose estimated by 
PRESAGE™ and dose as measured by the diode are not so severe in the SOBP sample.
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It has already been confirmed in other studies [17, 18, 119] that the Bragg peak dose 
is usually underestimated compared to the entrance dose using gel dosimetry and this 
phenomenon is well known in the field of film dosimetry. In the case of gel dosimetry, the 
exact cause of this under-response has not yet been fully clarified and further investigations 
are necessary to understand the effect of LET on PRESAGE™.
Whilst having excellent properties for 3-D scanning (Figure 3-9 (b)), currently 
PRESAGE™ does not faithfully reproduce the variation of absorbed dose at the Bragg peak 
confirming a dependence on LET for the proton beams. Further investigations and a revised 
formulation are necessary before PRESAGE™ can be used routinely for proton therapy 
dosimetry.
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4 A track structure model applied to 
PRESAGE™ irradiated with 60 MeV proton 
beam
4.1 Introduction
In the previous chapter, it was found to be evident that there is an LET dependence of 
PRESAGE™ dose response. A model that has successfully described and predicted the 
response to heavy charged particles for many different physical detectors and biological 
systems is the 5-ray track structure theory (TST) of Katz et al. [128]. In the early 1970s, the 
group of Robert Katz noticed the local darkening of grains in nuclear emulsions, produced by 
the passage of heavy ions, to be similar to that observed after high doses of 60Co y-rays. He 
drew the conclusion that radiation action in the close vicinity of the ion path is similar to that 
after high y-ray doses, causing the observed saturation effect in a variety of detectors (organic 
scintillator, TLDs, alanine, nuclear emulsion, and the Fricke dosimeter). The track structure 
theory is a radiological model based mainly on statistical (cumulative Poisson distribution) 
single/ multiple hit interaction of the dose deposition mechanism that predicts the relative 
effectiveness of high-LET radiation for most physical detectors once a few parameters 
obtained from low-LET irradiations are known.
Chemical reactions following the initial radiation induced physiochemical events 
include radical-radical interaction, recombinations, production of various chemical species, 
diffusion of radicals, and energy migration in large molecules. While these all contribute to 
the under-response of PRESAGE™ and provide a framework for physical interpretation on 
which the extracted parameters from TST can be based the process is extremely complicated 
as they each depend strongly on the density and the time scale of deposited energy [129]. 
Thus, if we are to get better understanding of the relative effectiveness of heavy charged 
particles, the track structure must include functions describing how energy deposition of 
charged particles influences the final chemical products. At present, only the delta-ray theory 
of track structure is applied on data in this thesis, providing physical insight into the under­
response of PRESAGE™ with high-LET radiation.
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In section 4.2, the concept of relative effectiveness of ionizing radiation is described 
as is the target and 8-ray theory of track structure used in theoretical treatment of the three- 
dimensional radiation detector dealt with in this work. First, it will be shown that the radiation 
sensitive element responds to the average dose absorbed in the element in accordance with an 
activation probability function fitted to mimic the dose-response curve for low-LET radiation. 
By folding the x-ray response (low-LET radiation) of the dosimeter with a dose distribution 
around the track of the heavy charged particle, a function of radial distribution of probability 
for the radiation effect surrounding a single heavy charged particle is estimated. An 
integration of the probabilities over the detector volume being activated by the secondary 
electrons generated by the particle will provide the total effect from a particle at all distances 
from the particle's path. This integration yields the total cross section (a) for an effect which, 
when normalized to the total energy deposited by the particle, leads to the radiation sensitivity 
of a detector to high-LET radiation. The relative effectiveness of high-LET radiation to a 
detector is then obtained from the ratio of the radiation sensitivities for high-LET radiation 
and low-LET radiation. Section 4.3 describes the radiation detector, and the experimental set­
up in determining the characteristic dose of the detector. Section 4.4 describes the track 
structure model calculations of the radial dose distributions. Section 4.4.5 deals with the 
experimental results and procedures of measuring the dose-response functions, and finally in 
section 4.5 concluding remarks summarize the applicability of the theory. Appendix A 
includes the input parameters and detailed calculation procedures.
4.2 Theoretical aspects
A heavy charged particle traversing matter loses energy mainly by inelastic collisions with 
bound electrons in the atoms and results in their ionisation and excitation. To a much lesser 
extent it loses energy by elastic collisions with the nuclei in which negligible amount of the 
heavy charged particle’s energy is transferred, but this interaction is only important below 20 
keV. Inelastic nuclear interactions also produce energy losses but are not included in the 
traditional definition of energy loss [130]. The moving particle exerts electromagnetic forces 
on atomic electrons and imparts energy to them. If the energy imparted is sufficient to knock 
an electron out of the atom then the atom is ionised, otherwise the atom will generally be left 
in an excited state. The collision process is well understood and in principle the stopping 
power can be calculated theoretically. The mean energy loss of an incident charged particle 
per unit path length in a medium can be described by the Bethe theory [131]. A full 
description of a charged particle loss process, however, requires more detailed information 
than is provided by the stopping power alone. This is not equal to the energy absorbed in a
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than is provided by the stopping power alone. This is not equal to the energy absorbed in a 
target, especially if the target is small compared with the ranges of the secondary electrons 
produced, as in for instance the DNA double helix with a diameter of 20 A°. Delta rays and 
secondary electrons can effectively transport energy beyond the primary particle’s original 
site. The amount of energy transferred from a proton to an atomic electron, as well as the 
number of interactions that occur per unit path length has a probability distribution. This 
causes statistical fluctuations in the energy deposition. Moreover, there is a certain probability 
that very energetic electrons are produced (5-electrons or 5-rays) which can travel a 
considerable distance on the atomic scale before their energy is deposited. Hence, although 
absorbed dose is a sufficient description of the radiation field in terms of response to the 
radiation action, the situation differs for high-LET radiations in that the radiation field within 
the absorbing medium now consists of different kind of radiations, e.g. protons produce 
secondary particles (5-electrons, nuclear reaction products or recoil nuclei) as a result of 
energy loss processes and there can be a difference between the local energy loss and the 
energy absorbed by the medium. The result is that the measurement of absorbed dose is no 
longer sufficient.
4.2.1 Target theory
The track structure theory model is patterned after the target theory of Lea [129] where the 
basic assumption is, that any radiation detector consists of radiation sensitive elements in the 
shape of cylinders or spheres, the size of which are characteristic for the individual detector, 
referred to as “targets”. These elements, which may be either atoms or molecules, are 
embedded in a more or less passive matrix acting as an energy transfer medium.
4.2.1.1 The stochastic process of radiation action
When energy is deposited in a target it has a probability of experiencing a “hit”, defined as a 
single quantized interaction whereby an event takes place in the sensitive element of the 
detector and initiates an effect i.e. radiation damage caused by the same chemical mechanism 
initiated by free radicals. Once activated, the sensitive element will in principle stay activated 
despite being hit several times. The amount of excitation and ionization energy deposited by 
secondary electrons, i.e. absorbed dose is a measure of the density of hits in the irradiated 
medium. According to the random and discrete distribution of energy deposition events in the 
case of low-LET radiation, the hits are assumed to be randomly distributed within the detector 
and the average number of hits per target increases linearly with dose such that:
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A = kD 4-1
Although the total number of hits increases in straight proportionality to the dose, the 
number of targets hit increases more slowly, so that the yield plotted against the dose gives a 
curve which is convex upwards tending asymptotically to 100% at large doses (i.e. 
exponential).
A target may need one or more hits to become activated. Hence, if the average 
number of hits per target is A and a target needs c hits in order to be activated then the 
probability that a given target will be activated is given by Poisson statistics [132]:
where A = D/Dc, D is the dose given to the detector and Dc is a characteristic dose of the 
detector. Thus, for a one-hit detector, the probability of activation:
where f  (Dc) = 1-e'1 = 0.63. Thus Dc is associated with the dose at which 63 % of the radiation 
sensitive elements are activated. Alternatively for a one-hit single target detector, the 
probability of survival:
4-2
P(l,A) = 1 - e -A  = 1 -e  D/Dc =f(Dc) 4-3
4-4
where f (Dc) = e'1 = 0.37 = D37 is the dose giving 37% survival. The probability of activating 
one or more targets given a dose D is taken as the ratio of the detector response, S(D), to the 
maximum response, S ^ .
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For a one hit detector, the above equation becomes
S
sq» = P i= i  c- d/ d ,7 4-5
max
where Pi (the one-hit probability) is linear at low doses where after it becomes sub-linear until
saturation. For a two-hit detector, a detector displays a sigmoid response and becomes supra- 
linear before saturation.
The response is given by
A detector that displays linear, supra-linear and sub-linear behaviour with dose 
indicates the presence of both one- and two-hit targets, and the response is a mixture of these 
two components:
where R is the relative contribution of the one-hit component (with probability Pi) and Sy(D) 
and Sy™* are the detector response at dose D and at the saturation dose, with P2 the two-hit 
probability.
4.2.1.2 Relation between target size and activation dose
In the “single-hit” type of action in which a single ionization on the target suffices to produce 
an effect, knowledge of the size and shape of the target should enable the 37% dose to be 
predicted, since we know sufficiently well the number of ionizations produced per unit 
volume in tissue by 1 Gy of any radiation, and the spatial distribution of the ionizations. 
Conversely, the size of the target can be deduced from the measured value of the 37% dose if 
we assume the target to have some simple shape, e.g. spherical. Calculations of the relation 
between the target size and 37% dose for any given type of radiation involve approximations 
and simplifications. Typically, the calculation is based on the assumption that an effect is
D
4-6
max 4-7
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produced when one or more ionisations occur inside a spherical or cylindrical target of 
definite radius r, and is not produced when ionizations occur outside the target. However, if 
the target has some other shape modifications to the basic theory described in this chapter 
would be needed.
4.2.2 Track structure theory
The 5-ray theory of track structure is based upon the observation that the radiation detection 
and damage phenomena of energetic heavy ions are mainly caused by the secondary (5-ray) 
and higher-order electrons (e.g. Auger electrons), ejected from the medium by the passing 
heavy ion. Subsequently, these secondary electrons transport the energy lost by the primary 
ion, traversing distances of many tens of microns. Radiation effects of low-LET radiations, 
e.g. y-rays and electrons are also caused by low-energy secondary electrons generated through 
interactions of the primary radiation with the medium. The theory proposes that the difference 
in radiation effect between low- and high-LET radiations is due to differences in dose 
distribution. Those arise either in the time scale with which the secondary electrons are 
generated, their spatial distribution, or both. It is hypothesised that, the response of a detector 
to high-LET radiation can be calculated from parameters of low-LET radiation, and the 
problem of determining the effectiveness of high-LET radiation concentrates on finding the 
dose distribution around the particle track and on determining the dose-response characteristic 
of the detector from experiments with low-LET radiation.
The dose imparted by high-energy photons and electrons is homogeneously 
distributed in the medium because of multiple scattering (Compton processes) and the 
relatively long range of the secondary electrons, the maximum energy of which can be up to 
half of that of the primary electrons. Electrons can lose a large fraction of their energy in a 
single collision with an atomic electron (because the latter have the same mass) and so they 
suffer relatively large deflections. Because of their small mass, electrons are frequently 
scattered through large angles by nuclei and generally do not travel through matter in straight 
lines. By contrast, heavy charged particles move essentially in straight lines for the majority 
of their path length losing only a small fraction of their energy in each collision. They lose 
energy almost continuously in small amounts through inelastic collisions with atomic 
electrons, leaving ionised and excited atoms in their wake. Occasionally, as observed by 
Rutherford, a heavy charged particle will undergo substantial deflection due to elastic 
scattering from an atomic nucleus; the dose is heterogeneously distributed in the medium
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through the ejected low-energy electrons (8-rays), the maximum energy and range of which 
are only small fractions of that of the primary particle.
VACUUM
Incident
Radiation
Field
Photon r
7 / MATERIAL
V /
y  Track 
/ /  Structures
Neutron ,
i \
Fost Ion f  . \<* V •
4  '■
Figure 4-1: Schematic representation of the track structure of different radiations in matter depicting spatial 
distribution of energy deposition events and the different paths of secondary electrons. The energy deposition 
along the trajectory of the primary heavy ion is localised as a consequence of the electrons being emitted in 
forward direction and that the overwhelming fraction of 5-electrons emitted at large angles has comparably low 
energies and thus short ranges [133].
The energy deposited by the electrons will cause further ionizations, excitations, bond 
rupture, radical formation, and physico-chemical changes which are detectable in different 
ways, depending on the observed endpoint. Direct atomic displacements and vibrational 
motion by the primary heavy ion at energies below 1 keV/amu have negligible effects in 
comparison to the previously described effects from 8-rays and will not be considered further.
The following example gives a better explanation of the all the ionization and 
excitation events surrounding the track of a charged particle. The average energy loss of a 1 
MeV proton beam in water is 26.1 keV per micrometer path length and the energy required to 
produce an ion pair is roughly 35 eV, so the average number of ionisations, n, per one 
micrometer path length of this particle in water is n = 26100 eV/35 eV = 745 ionisations. In 
the simplest description of the proton particle track one can assume that all ionisations are 
placed along a straight line, at equal distances. In that case the average distance between two 
ionisations is equal to A, = 1 pm/745 = 1.34 nm. The energy loss, dE/dx, of a 100 keV electron 
in water is equal to 0.41 keV/pm, which results in A = 90 nm. This example demonstrates that 
secondary electrons generated by photon radiation deposit on average only single ionisations 
whereas, heavy, densely ionising particles produce tens and hundreds of ionisations in a
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volume [134]. Therefore the spatial distribution of ionisation in a volume cannot be the same 
after low-LET and high-LET irradiation.
4.2.2.1 Radial dose distribution
The original delta-ray theory of track structure [128, 135-137] is based mainly on an 
approximation whereby the targets in any detector are bathed with a uniform field of 
secondary electrons following gamma irradiation. The resultant response of the detector to 
this given dose of gamma-rays is interpreted as the fraction of available targets which have 
been affected by radiation, or as the probability that a target will be activated at this gamma- 
ray dose.
In this scheme, the calculated radial dose distribution D(z,p,t,a0) around the path of a 
penetrating ion relates the inhomogeneous distribution of absorbed energy to a distribution of 
radiation effects, an integration of which over the whole irradiated volume expresses the 
average response of the medium.
By calculating the average radial distribution of dose from delta-rays about the ions’ 
path, the measured gamma-ray calibration curve serves to approximate the radial distribution 
of effect, i.e. the radial probability of target activation with complete disregard to the 
difference between the radially varying electron energy spectrum from delta-rays and the 
energy spectrum of the secondary electrons following gamma-ray irradiation. The expectation 
value of the single-particle action cross-section can then be specified as the integral of this 
radial probability over all radii, and the fraction of targets in the detector activated to the 
observed endpoint, i.e. the response of a detector after a measured fluence of particles, 
calculated.
The original model was constructed using a number of simplifying assumptions, 
among which were (a) 8-ray calculations are continuous instead of stochastic, (b) only energy 
deposition by 5-rays are considered (c) the number distribution differential in energy of the 8- 
rays, dc (w), were calculated from Bethe theory where the electrons of the medium are 
considered as free and the binding energies are neglected and the energy distribution 
calculations for the 8-rays were based on fitted parameters from published range-energy 
relations for electrons below 10 keV, and (d) the angular distribution of 8-rays ejected, when 
the ions undergo ionizing collisions with the atoms and molecules of the medium, were 
fundamentally based on the Rutherford scattering formulation so 8-rays are assumed to be 
ejected perpendicular to the ion's path. Ultimately, neglecting this difference is justified by the
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considerable success of this first-order model in describing the response of physical detectors, 
and the unavailability of actual measurements of the radial distribution of dose.
A Monte Carlo code was developed by Hamm et al. in 1985 which calculated proton 
and alpha-particle tracks, with the inclusion of all primary excitation and ionization events 
accompanying the passage of these ions through liquid water. From that, a semi-empirical 
analytic formula for the radial distribution of delta-ray dose was developed that adequately 
reproduces the results of these Monte Carlo calculations for the passage of a proton and all 
secondary electrons through the initial physical stage of interactions (10'15s) in liquid water.
The model extends continuously over a wide range of proton energies, and any ion 
species of any energy within the applicable energy range (0.1-1000 MeV/amu) was 
developed and which has been adjusted in the case of protons so that on radial integration it 
approximates the value of proton stopping power [138]. This formula has a better agreement 
between the track theory calculations and experimentally measured high-LET detector 
response than other semi-empirical calculations and other Monte Carlo calculations (see 
references within [138]).
According to the model initially proposed by Katz el al. [135], together with the 
power-law range-energy relation for the delta-rays as described by Hansen et al. [139], and 
the semi-empirical formula proposed by Waligorski et al. [138], the energy of the ejected 8- 
rays (i.e. electrons ejected with an energy which is large compared with the ionization 
potential) is given by:
w= 2e 4 £ 1 . cos>9 4.8
1-P2
where 0 is the angle of the ejected electron with respect to the incident direction of the heavy 
charged particle (HCP) and wmax=2mec2p2(l-(32)'1 is the maximal energy transferred to the 
ejected electron from the HCP in a head-on collision. Equation 4-8 shows that electrons of the 
highest energy are preferentially ejected in the forward direction, while those of lowest 
energy are emitted perpendicular to the ion's path. The majority of the electrons are ejected at 
angles above 45° so an assumption is made that all electrons are ejected perpendicularly to the 
path of the path of the HCP. This simplifies calculations and is in reasonable agreement with 
the experimental observations to a good approximation [140].
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The Rutherford cross-section for delta-ray ejection of an electron, bound with 
ionization potential I =10 eV, with energy between w and w + dw is given by:
27te4 z2 dwdo(w) = -------- —
mec2 p2 (w + l)2
4-9
and the number of delta-electrons ejected per unit path length of the moving heavy charged 
particle is the product of the cross section da(w) and N, the number of electrons per unit 
volume of the stopping medium
dn = N • da(w) = N. 2nc4 z 2  dw - q  2,2 hw 
mec2 p2 (w + I)2 “ y (w + I)2
4-10
where C=27tNe4/mec2 in J/cm.
A fitted power-law range (r)-energy (w) relation is used for the 8-rays where r is the 
range of the electron in cm, p is the density of the medium in g/cm3, w is the electron energy 
in keV, and k and a  are constants obtained by Monte Carlo simulation where k has the unit 
g/cm2keVa, and a  = 1.079 for p < 0.03 and a  = 1.667 for p > 0.03.
r = — kwa = — • 6xlO‘10 ■ wa 4-11
An electron with an initial energy wr and corresponding range r will have a residual 
kinetic energy 8 after travelling the distance t:
e = p r - t
\Ya f
=  P
7
ya r t N 
1 - -  
V ry
Ya r t^Ya
= p w r - 1 1 - - 4-12
The energy loss per unit length, the stopping power of the ejected 8-rays, by the 
electron in the interval dt at distance t from the track is the differential quotient:
de 1 1—  = — w_ • p -------
dt a r
f i - i l
I r )
4-13
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The total energy, E(z,p,t), deposited by the ejected 8-rays, in the interval between t 
and t + dt from the ion's path, is the product of the number of 8-rays and their respective 
stopping power integrated over all energies, and is expressed as:
E(z,p,t)= — ■— dtdw = - C - p ~ -  —-dt —
K -k dw dt K p2 a  -k wr r
z2 1 1 1 /  t \ “  - 1 1 - -  
r
dw 4-14
By substituting the 8-ray energy by the corresponding range the integration yields the 
following expression for the total energy, E(z,p,t), deposited by the 8-rays:
E(z,p,t) = C p ~ - 4 d t  p2 a  t
f  t \Ya
1  -
V ^max J
4-15
and the dose D(z,p,t) deposited in a cylindrical shell of area 2n dt and of unit length around 
the ion path is calculated in Gy, also termed point target dose distribution:
D(z,p,t) = E Ne4 z2 1 103 1
mec2 P2 P a t2
1-
Va.
4-16
where, the maximum range tmax of the 8-rays is obtained for cos 0 =1. 
The maximum range of the 8-rays given by:
4-17
where N is the number density of electrons of charge e and mass m in the medium of density 
p, a  and k = 6x 10'10 gcm"2keV'a are empirical parameters found by fitting to published data 
from the continuous slowing-down approximation (csda)-range i.e. range versus energy of 
electrons in material (p.R[g/cm2] versus energy [140]) where r = 6xlO'10Eagcm‘2, and E is in 
keV.
The corrected formula by Waligorski et al. (1986) of the radial distribution of delta- 
ray dose in water compared with results of the Monte Carlo calculation, calculated for protons 
of energies 1, 10, 20, 50, and 100 MeV, reproduces the proton stopping power to within 10%
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over the range of P from 0.015 to 0.9 (corresponding to proton energies in the range 0.05- 
1,000 MeV) while the original formula by Zhang et al. [141] yields about half of this value. 
After making some empirical adjustments to account for the “missing” radial dose, K(t), due 
to primary events in the region of t = 1-10 nm, the following parameterization is derived 
[138]:
K(t,P) = A
1 © <-*■ I ©exp-
< C j < C j
4-18
where for t > B = 0.1 nm, C = 1.5 nm + 5 nm x p, A = 8 x p 1/3 (P < 0.03), and A = 19 x p 1/3 (p 
> 0.03). The corrected expression for radial distribution of the point dose features a “hump” at 
radial distances t = 1-10 nm.
Dpoint (z>P>t) = D(z,p,t) • (l + K(t,p)) 4-19
D(z,p,t) = N z2 1 103 1 
2ji q2 a  p t
i - ^ L
V m^ax ^
t+5
Ya
4-20
where ^ is the ‘range’ of an electron of energy w = I, ^ = (1/p) x k x (0.010 keV)1'079 = (1/p) x 
4.17 x 10“8 g cm-2 . Note that the transition from the free to the bound electron case is made 
simply by replacing t and tmax within the final bracket by t + % and t ^  + respectively [138].
4.2.2.2 Extended target distribution of dose
The track of a heavy charged particle is usually approximated as a cylinder, constituted by a 
core of clusters, which consist mainly of very low-energy Auger electrons, excited atoms and 
ions, and a penumbra of more energetic 8-rays clearly separated from the core. The dose 
distribution profile of a heavy charged particle may be divided schematically into three 
concentric zones (Figure 4-2).
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Figure 4-2: Schematic representation of the radial distribution of delta rays and subsequent dose around the path 
of a heavy charged particle. In the core region, binary collisions and the creation of 8-rays takes place resulting in 
the deposition of saturation doses. In the penumbra, 8-rays deposit their energy approximately as the inverse 
square law [140].
The central zone, the core, is characterized by an area of high energy density where 
saturation of activation is dominant. A large fraction of the particle energy may be deposited 
within this area, but the contribution to the total effect is negligible, with only a small part of 
the observed effect being generated there. This is partly a result of the small number of 
sensitive elements contained within a cylinder of such small radius and partly because the 
damage done within a few tens of angstroms of the ion’s path removes this region from 
participation in the detected event. In the intermediary region, the penumbra, surrounding the 
central area the saturation effect diminishes. The energy density is high and may be above the 
characteristic D37-dose, making the dose-response sub-linear. Finally, one gets a large 
peripheral zone with low energy density where the dose-response is linear. The total effect of 
activation will be determined by the distribution of energy among these three zones. 
Therefore, the dose-response is determined by the average dose delivered to the sensitive 
element. Low effectiveness is highly probable in the central and intermediate zones, leading 
to a decreased total effectiveness of the ion when compared to the effect for the same 
absorbed dose from low-LET radiation.
In the extended target calculation the average dose function is then calculated by 
considering sensitive elements as cylinders of radius ao and length 1 with the axis aligned 
parallel to the track of the ion, at all radial distances travelled by the ejected electrons. The 
extended target formulation is derived from simple trigonometric considerations and is 
calculated by integrating the point dose function over the volume of the element as proposed 
by Jirasek et al. [19]:
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D(z,P,t,a0) = — -  f Fd  ^ (z ^ r ^ r d r d G  4-21
{ i
where 7tao2 is the total area of the sensitive element, and the length of the cylindrical element 
cancels in the calculation as it’s usually sufficiently small so that the speed of the ion is nearly 
constant over the length of the cylinder.
Hansen and Olsen [139, 142] proposed a calculated target dose distribution where the 
excess energy of the difference between the total and the delta-ray energy deposition is placed 
in a target positioned in the centre of the track.. It is characteristic that the dose distribution 
profiles have a flat top extending to a distance from the ion's path corresponding to the radius 
ao of the sensitive element. The ion path is assumed to penetrate the sensitive element at its 
centre, and the plateau of the dose distribution profile equals the average dose to that element, 
which is considered separately from the rest of the medium. The total energy of the 5-rays 
with energy large enough to have ranges greater than ao is calculated by an integration of the 
point target dose profile from the distance t = a0 to the maximum range W  of the 5-rays. This 
distance from ao to tmax is called the track. The energy deposited in the central element, the 
core, can then be calculated as the difference between the energy deposited in the track by the
5-rays outside the central core and the total energy deposited by the penetrating ion (as found 
from the collision stopping power). Therefore, the energy to the track is due only to 5-rays. A 
much simplified version of this distribution is proposed by Edmund et al. [132] whereby 
including the unrestricted mass-stopping-power, LET*,, of the penetrating HCP in the dose 
distributions, other types of energy deposition like vibrational together with the production 
and subsequent energy deposition of Auger and other low-energy electrons where the 
ionization potential of the material atoms must be taken into account, are included such that:
dE
pdx
l max
= 2jt jb slle(t)tdt 4-22
4.2.2.3 Activation cross-section of charged particles
The dose deposited to the sensitive elements of the medium after irradiation with heavy 
charged particles is calculated by grouping these elements into volumes which lie along iso­
dose contours (shells) as cylindrical volumes whose axis is parallel to the ion’s path (Figure
4-3).
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Figure 4-3: (a) Schematic representation of the radiation sensitive elements around the path of an ion for 
calculation of the average target dose [140].
The sensitive elements between these shells will respond to the local dose deposited 
there by the generated 8-rays, as if the elements were part of a larger system that is uniformly 
irradiated with low-LET radiation to the same dose. In other words the characteristic dose- 
response, experimentally obtained for the medium irradiated with low-LET radiation, is used 
to correlate the calculated dose in the shells with a produced effect. The high-LET dose is the 
result of combining the low-LET dose-response with the calculated dose distribution.
The probability that a sensitive element is activated by an ion is given by: 
P(z,p,t,a0,D37) = 1 -  exp( -  D(z,p,t,a0)/D37) 4‘23
where P (z, p, t, ao, D37) represents the fraction of sensitive elements of radius ao activated by 
the impinging ion, and which are lying between adjacent cylindrical shells at a distance t from 
the track axis, D37 is the characteristic dose of the medium, d ( z , P, t, ao) is the average dose 
deposited in the sensitive element at a distance t from the track axis. To find the total effect 
produced by a single particle or a beam of particles with effective charge z and velocity (3, an 
integration of P(z, p, t, ao, D37) must be performed over all distances t from the axis of the ion 
path to the maximum range of the 8-rays.
This integration yields the total activation cross section a  (z, B, a0, D37), which is the 
probability that a single particle activates a single sensitive element in a medium containing
one such element per unit area perpendicular to the path of the particle. The cross section is 
expressed as:
The upper limit of integration, tmax (the maximum range of the 8-rays), will be 
determined using Equation 4-17 (see Appendix A). The lower limit of integration, tmm is 
defined as a distance from the track axis at which there still is a physical entity with which the 
8-rays can react. An integration cut-off at 0.1 nm was chosen.
The sensitivity, kY, of a medium towards low-LET radiation is given by 1/D37. The 
sensitivity, kii towards high-LET radiation is given by g/E where a  is the total cross section of 
the average energy deposited by the moving ion and E is the average energy deposited per 
unit path length in a unit density material.
This energy may be obtained from the collision stopping power of the moving ion, 
which for a heavy charged particle at energy > 10  keV/amu is equal to LET*,. The relative 
effectiveness, RE, can be derived from the radiation sensitivities of the radiations involved 
such that [140]:
RE = k j / k y =gD 37/ E = gD37/LET 4.26
When considering a thick medium in which the ion either loses a major part of its 
energy or is brought to a complete stop, a track segment calculation is performed. The RE for 
the ion in the medium is found from an integration over the path of the ion, and the RE for 
each segment of integration is weighed with the energy deposited in the segment in 
proportion to the total energy deposited. Thus the individual segment RE's contribute to the 
total RE proportionately to the energy lost with a certain effectiveness. Looking at equation 
4-24, it is evident that the cross section depends both on parameters of the medium, a0 and 
D37, and of the penetrating ion, z and (3 (the ratio of the velocity of the ion in the medium to 
the speed of light in vacuo). This makes it evident that particle and medium parameters are 
not separable variables when speaking about the relative effectiveness of a radiation field.
2TtP(z,p,t,a0,D37)tdt 4-24
4-25
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Above 0.5 MeV the effective proton charge is unity [130] i.e. Zp=l for 60 MeV proton beam 
noting that at Clatterbridge Centre for Oncology (Wirral, Merseyside, UK), where the 
measurements reported in Chapter 2 were conducted, the energy is nominally 62 MeV).
For this model, we require 1) the average radial distribution of local dose around the 
path of a proton, 2) the size of the target volume, i.e. radiation sensitive element, and 3) the 
response of the detector to x-rays, measured as a function of dose. The radius of the target 
volume ao, the characteristic dose, D37, at which there us an average of one hit per target and 
c, the target number in the sense of cumulative Poisson distribution, determine the detector 
parameters used to approximate the dose-response function after x-irradiation. These 
requirements are experimentally determinable, in principle. Thus, D37 is determinable from 
the absorbance as a function of dose while ao is from knowledge of the radiation sensitivity of 
the medium and the mean energy necessary to create an ion pair in a spherical volume or 
simply from the size of a dye molecule. The target number is determinable by comparison of 
the shape of the dose response curve after x-irradiation with that of the cumulative Poisson 
distribution, where the shape can be measured.
4.3 Materials and methods
4.3.1 Polyurethane formulation
The molecular formula of PRESAGE™ used in this study is C27oH46oNi9068Br similar to batch 
no. 180 to give an electron density of Zeff ~ 9.6 with a mass density of 1.08 g/cm3 [120], For 
a physico-chemical detector the approximate size of the sensitive element ao may simply be 
the size of the sensitive leuco dye molecule Figure 4-4.
Leuco malachite Green Malachite Green
(LMG)
Figure 4-4: The molecular structure of the leuco dye, leuco malachite green and its oxidised product malachite 
green [115].
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The radius of this is approximately 0.5 nm derived from tabulated values of inter­
atomic distances or bond-lengths [143]. For example, the C-H bond is 109 pm, C-C bond in 
benzene are of the same length of 140 pm, etc. An approximate estimate of ao, however, may 
also be derived from greatly simplified calculations from target theory whereby a knowledge 
of the radiation sensitivity, ky, of the medium and the mean energy necessary to create an ion 
pair, determines the volume of the sensitive element considered as a sphere [139]. A single 
ionization event will deposit the dose = Ae/Am = As/ ApV where 1 ionization = 35 eV, 1 eV = 
1.602 x 10'19 J, and 1 Gy = lJ/kg. 1 Gy yields 6.24 x 1018/ 35 hits per kg material where 6.24 
x 1018 eV/kg is a conversion constant (the reciprocal of the elementary charge). At the 
characteristic dose, D37, all elements would have experienced an average of one hit. 
Therefore, 1 kg of material contains 6.24xl018x D37/ 35 elements being hit once. The radius, 
ao, of the sensitive element of a spherical target is then equal to (3 x 35/ (6.24 x 1018 x 
47tpD37) ) 1/3 m (see result in equation 4-27).
4.3.2 Experimental set-up to determine D37 value
16 ultra-micro sized UV-cuvettes (Brand, CXA-205-020F) with 2 mm optical pathlength 
were filled with PRESAGE™ and irradiated at the Royal Surrey County Hospital in 
Guildford, Surrey. Use was made of a nominal 6 MV x-ray beam (Varian Assoc, Palo Alto, 
CA) with a nominal dose rate of 400 cGy/min, 100 cm source to surface distance (SSD), and 
20 x 20 cm2 field size. These cuvettes were chosen to enable us to read out the PRESAGE™ 
samples irradiated with higher doses as the maximum measurable absorbance with the 
Camspec-350 (Camspec Analytical Instruments Ltd., Leeds, UK) spectrophotometer is 
approximately 3.0 A. The cuvettes were placed, abutting each other, surrounded with 10 mm 
bolus to ensure a uniform dose as several plates of solid water phantom of 15 mm thickness 
were placed on top of the cuvettes such that is reached at the surface of the cuvettes and 
secondary charged particle equilibrium is established. 100 mm of solid water slabs were 
placed beneath the cuvettes as we need to consider backscattered photons. The treatment table 
was then raised to 88 cm SSD to reduce irradiation time, and the monitor units were corrected 
for the new distance using the inverse square law (MU = Dose/((100cm/88cm)2xOutput 
factor)). The dose given was fractionated and after each fraction was given, one cuvette was 
removed, the sequence yielding the following nominal doses over the 16 cuvettes: 40, 50, 60, 
80, 100, 120, 140, 160, 200, 220, 240, 300, 400, 450 and 500 Gy. Two unirradiated control 
samples were measured to establish a base-line.
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The response of PRESAGE™ is calculated as specific absorbance AA= (A-A0) per 
unit of thickness (cm), where A0 and A are optical absorbances of the unirradiated “control” 
cuvette and the irradiated cuvettes, respectively. The response curves (Figure 4-5(b)) at 
different wavelengths indicate that the change in specific absorbance of the cuvettes as a 
function of the absorbed dose is linear before reaching optical saturation. The dose-response 
at 632 nm shows saturation to be reached at a dose of between 100 to 120 Gy even though the 
dynamic range of the Campsec-350 spectrophotometer allows for absorption values of up to 
3.0 cm’1 (-0.3 to 3.0 A) whereas the dose-response for instance at 706 nm shows a relatively 
low absorbance value for the relatively large dose of 500 Gy. To get an accurate value of the 
experimentally obtained D37 it is evident that the x-ray dose response of PRESAGE™ has to 
be measured at a different wavelength, other than 632 nm, where the optical absorbance is 
within the dynamic range. Another problem we encountered in this experiment was that the 
cuvette itself had a frosted window across the 2 mm pathlength which was not known prior to 
purchasing it causing the incident beam’s intensity to be largely attenuated thus, producing 
poor optical performance and affecting our measurements (Figure 4-5(c)).
4.3.3 Results 
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Figure 4-5: (a) Absorbance of cuvettes, irradiated to varying doses against wavelength in nm, (b) dose-response of 
PRESAGE™ at different wavelenghts, (c) attenuation of the incident beam with BRAND cuvette. Error bars are 
smaller than the size of the plot symbols.
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The above experiment was repeated using a different brand of cuvette as it was 
evident from visual inspection that saturation had not been reached at a given dose of 500 Gy. 
15 ultra-micro sized UV- cuvettes (Eppendorf UVette® with adaptor of 1 x 1 mm2 aperture 
for stray light rejection) with 2 mm optical path-length were filled with PRESAGE™ and 
irradiated with an ID 17 Microbeam Radiation Therapy (MRT) beamline at the European 
Synchrotron Radiation Facility (ESRF) in Grenoble, France (Figure 4-6). Each cuvette was 
placed individually on a stand and irradiated. The sequence yielding the following nominal 
doses over the 15 cuvettes: 1, 2, 5, 8, 12, 20, 30, 50, 80, 140, 200, 300, 500, 2000 and 5000 
Gy.
Seam
Figure 4-6: (a) ID17 Microbeam Radiation Therapy (MRT) beamline at the European Synchrotron Radiation 
Facility (ESRF) in Grenoble, France, (b) Irradiated Eppendorf cuvettes filled with PRESAGE™ showing 
radiochromic response to increasing dose.
The author gratefully acknowledges the help of Dr. S J Doran and Mr. A. T. Abdul 
Rahman in making these measurements.
Two unirradiated control samples were measured to establish a base-line (Flatness 
(Abs) = +/- 0.001 (at 200 to 3000 nm). The optical absorbances of the samples were measured 
using a CARY 5000 UV-Vis-NIR spectrophotometer (Varian, Inc) with wavelength range of 
175-3300 (0.01 nm steps) with an accuracy of +/- 0.1. The colour of the samples change 
gradually to deep green with increasing dose (Figure 4-6 (b)) and subsequently the amplitude 
of optical absorbance at 440 and 632 nm (Figure 4-7 (a)).
Figure 4-7 (b) shows the dose-response curve obtained with x-ray irradiation at 700 
nm where the measured optical absorbance is still within the dynamic range. From the 
exponential curve (Figure 4-7 (b)), the derived D37 is equal to 1000 Gy and from that the 
radius, ao, of the sensitive element is then calculated such that:
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Figure 4-7: (a) Optical absorbance curves of cuvettes irradiated to varying doses against wavelength in nm 
obtained with Cary 5000 UV-Vis-NIR spectrophotometer, (b) dose-response of PRESAGE™ at 700nm showing 
D37= 1000 Gy (at specific absorbance = 0.63 c m 1). Error bars are smaller than the size of the plot symbols.
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4.4 Track structure calculation results
4.4.1 Point dose distribution
The point distribution of dose deposited by delta-rays at variable radial distance, t, from the 
proton beam with charge, z, and relative speed to light, (3, in PRESAGE™ material of density 
p=1.08 g/cm3 is calculated using the equation proposed by Waligorski et al. and Zhang et al. 
[138, 141] which is a semi-empirical formula derived from a combination of theoretical 
considerations, fitting to experimental data, and by comparison to results from Monte Carlo 
simulations of particle tracks in liquid water (Figure 4-8).
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Figure 4-8: (a) The point distribution of dose deposited by the 8-electrons in the liquid water as a function of 
radial distance from a proton track using Zhang el al. formula (—-), Waligorski’s et al. analytical corrected formula 
(— ), and over-plotted from Waligorski’s result (—-) for 100 MeV proton beam; (b) the point distribution of dose 
deposited by the 8-electrons in the dye molecule as a function of radial distance from a proton track using 
Waligorski’s analytical corrected formula for different P values equivalent to energies 60 (red), 40 (blue), 20 
(green), 8 (magneta) and 2 MeV (cyan), respectively.
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4.4.2 Extended target dose distribution
Figure 4-9 shows the calculated target dose distributions deposited by electrons in the 
dye molecule as a function of radial distance from a proton track with several radii, a0 = 
0.5nm, 5nm, and 10.5 nm at different (3 values where the radial dose distribution at t < a0:
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Figure 4-9: The target dose distributions deposited by electrons in the dye molecule as a function of radial 
distance from a proton track with several radii, ao=0.5nm (red), 5nm (blue), and 10.5 nm (green) at different (3 
values equivalent to energies 60, 10 and 1 MeV, respectively.
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4.4.3 A ctivation cross-section calculation
The probability of activation is essentially, unity close to the proton track as the doses are 
much higher in that region, and the probability of activation becomes negligible at large 
distances from the track because the average dose drops off rapidly as a function of radial 
distance (Figure 4-10). To calculate the effect on the sensitive elements from a single proton 
track, we integrate the activation probability over the whole track and call this the activation 
cross-section.
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Figure 4-10: Probability of activating a sensitive element as a function of radial distance from the proton track. 
Plots are for sensitive element radii (a) ao= 0.5 nm and (b) ao= 10.5 nm at different P values equivalent to proton 
energies 60 (red), 20 (blue), 8 (green) and 1 MeV (magenta), respectively at D37= 1000 Gy.
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Figure 4-10 (b) illustrates how the extended target dose distribution depends on the 
size of the sensitive element in the medium and varies inversely with the square of the radius 
ao. Close to the proton track the sensitive elements can be expected to be saturated as the 
doses are quite high in that region, thus, the probability of activation is, essentially, unity in 
this region. When a0 increases an increasing amount of dose from a high-LET particle is 
deposited at a level below saturation i.e. below the characteristic D37-dose for y-rays. Hence, 
the probability of activation decreases as a function of the LET.
4.4.4 Relative effectiveness of PRESAGE™ dosimeter
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Figure 4-11: Relative effectiveness as a function of LET of varying proton energies (1-60 MeV), sensitive element 
radii ao= 0.5 nm (green), and 10.5 nm (blue) at D37= 1000 Gy.
Figure 4-11 shows the relative effectiveness as a function of LET of varying proton energies 
from 1 to 60 MeV with the different calculated sensitive element radii, a0= 0.5 nm obtained 
from tabulated values of inter-atomic distances or bond-lengths [143], and ao= 10.5 nm 
obtained by an independent estimate of the radius from target theory (Equation 4-27). The 
results show a huge discrepancy in the calculated relative effectiveness between the two 
methods and that the target theory is far more accurate in estimating the size of the sensitive 
element such that the calculated response mimics the experimental behaviour of the relative 
effectiveness of PRESAGE1-TM
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4.4.5 Experimental relative effectiveness of PRESAGE™  dosimeter
4.4.5.1 Experiment set-up
In this experiment, one sample of the transparent solid plastic dosimeter PRESAGE™ in the 
form of cylinders of diameter 60 mm and height 60 mm was irradiated with a nominal beam 
energy of 60 MeV, collimated to a 12 mm diameter cross-section, at the proton beam facility 
of the Douglas Cyclotron, at the Clatterbridge Centre for Oncology (Wirral, Merseyside, UK) 
and was stored in the refrigerator (~ 3°C). Five days later, another sample from the same 
batch was irradiated with 6 MV x-ray beam (Varian Assoc, Palo Alto, CA), 400 cGy/min, 100 
cm source to surface distance, and l x l  cm2 field size (using facility of St Luke’s Oncology 
Centre, Royal Surrey County Hospital, Guildford, Surrey). Note that there was an uncertainty 
of + 7.3 % in the calculated monitor units (1 Gy = 125 MU) as the output factor were only 
calculated for field sizes from 3 x 3 to 40 x 40 cm2 (explained in detail in section 6.2.1).
After irradiation the sample was stored in the refrigerator, and the optical scanning of 
both samples was performed 24 h after the x-irradiation using our in-house CCD-based 
optical scanner. A total of 400 raw projection images of dimension 256 x 256 were acquired 
with no signal averages. These were reconstructed onto square matrices of 256 x 256 pixels, 
giving an in-plane nominal pixel resolution of (0.27 x 0.27) mm2 and slice thickness of 0.27 
mm. It is to be noted that another factor causing error in the dose-response measurement is the 
time delay between the two irradiations, giving time for a fading dose response overtime (~ 4 
% per 24 hr) in the proton irradiated dosimeter, especially in the plateau region (low-LET 
region).
4.4.5.2 Results and discussion
To determine the experimental RE, the gradient of the curve measured with the optical 
scanner is used (Figure 4-12) i.e. the measured relative effectiveness of the monoenergetic 60 
MeV proton beam at the plateau/ entrance region (after correction for colour fading (see 
Figure 6-7)) to that of the 6MV x-ray beam is derived from the ratio of the slopes. The ratio, 
however, is not equal to unity but is approximately equal to 0.69 caused by perturbations in 
the manufacturing process. The measured relative effectiveness of the proton beam at the 
Bragg peak region to that of the plateau region and the 6MV x-ray beam is equal to 0.23 and 
0.33, respectively.
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Figure 4-12: Dose -response of 6MV x-ray beam and 60 MeV proton beam at entrance and Bragg peak regions. 
Error bars are smaller than the size of the plot symbols.
A more detailed plot of the experimental relative effectiveness of 60 MeV proton 
beam against depth is shown in Figure 4-13 (b) where the entrance region of the Bragg curve 
imaged with our CCD-based optical CT scanner in PRESAGE™ sample was scaled by a 
factor of 5800 (optical response to relative dose percentage) to match the entrance region 
measured at Clatterbridge Centre for Oncology with PTW/Markus (parallel plate) ionization 
chamber since the response to 60 MeV protons at the entrance channel and x-rays are 
expected to be similar as they are both considered to be low-LET radiations; depths in the 
water phantom were converted to equivalent depths in PRESAGE™ simply by dividing the 
ratio of densities.
Considering the calculated relative effectiveness in Figure 4-11, it is observed that 
compared to experimental data calculations shows a similar effect at distances close to the 
ion's path, i.e. at low proton energies. We know that as the proton slows down, the energy and 
range of the 8-rays decrease and relatively more energy is deposited very close to, the ion's 
path in regions of saturation doses; however, there is a discrepancy between calculated and 
experimental relative effectiveness at the entrance region because although in theory the 
relative effectiveness should be equal to unity, the first point chosen for comparison is not 
exactly the entrance point. The linear energy transfer (LET) in PRESAGE™ was calculated 
using an Energy-LET-Range converter software in MeVcm2/mg [144], by entering the
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elemental target densities weighted by their relative stoichiometry. This was implemented in 
order to provide a comparison between both experimental and theoretical relative 
effectiveness plotted against depth (Figure 4-14).
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Figure 4-13: Comparison of the relative dose versus depth of the Bragg peak of 60 MeV proton beam in 
PRESAGE™ irradiated with a dose of 12 Gy obtained from our optical scanner ± SEM (black error bars) at 
University of Surrey and the dose-response in liquid water using PTW/Markus (parallel plate) ionization chamber 
at CCO scaled to equivalent depth in PRESAGE™. Error bars are smaller than the size of the plot symbols.
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Figure 4-14 shows that by obtaining an independent estimate of the radius from target 
theory (ao= 10.5 nm), it has been possible to obtain better overall agreement between theory 
and the present experimental results rather than simply measuring the molecular size of the 
dye molecule from tabulated values of inter-atomic distances or bond-lengths.
4.5 Conclusions
Track structure theory attempts to understand in a part theoretical/ part empirical model the 
pattern of dose deposition that leads to activation of the chosen dosimeter by the relevant 
physico-chemical events (e.g., the development of colour in a PRESAGE™ leuco dye 
molecule). However, these physico-chemical reactions themselves are largely regarded as 
black-boxes. The internal mechanisms of these events are considered to be affected from 
influences of nothing but average absorbed dose in the volume of the sensitive element and 
the number of hits or targets; however, it is evident that the mechanisms in media due to the 
radiation action are not fully described by these mathematical models, which on the basis of 
experimental knowledge from low-LET irradiation of a medium predict the dose-effect curves 
for the medium irradiated with high-LET particles. The theory of track structure illuminates 
the causes of differences in dose-response which are attributed to the large doses deposited by 
delta rays close to the track of a proton, causing detector elements to saturate. However, the 
theory does not specify the nature of the sensitive element, though the size of the element is 
an important parameter for the model. In spite of these shortcomings the experimental and 
theoretical results of relative effectiveness of PRESAGE™ at the entrance and Bragg peak 
regions of an unmodulated Bragg peak are in good agreement using this model that separates 
physical stochastics from radiation induced physico-chemical events in a mathematical 
treatment.
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5 Performance of CCD-based optical scanner 
with 3-D radiation phantom
5.1 Introduction
Gel dosimeters for three-dimensional optical dosimetry fall into two categories: absorbing 
(e.g. Fricke gels [145] and PRESAGE™ [109]); and scattering (e.g. polymer gels [146]). In 
DOSGEL (2006), De Jean et al. [147] investigated the use of a Vista cone beam optical-CT 
scanner (Modus Medical, London, Canada) in conjunction with various polymer gel 
dosimeters. Gels irradiated to uniform but high doses with significant opacity exhibited 
‘cupping’ in CT numbers across the reconstructed images which he attributed to multiple 
scattering conditions in polymer. This represented, effectively, a breakdown in Beer’s Law 
(an implicit assumption of the CT method). However, Bosi et al [148] evaluated a novel 
phantom in which radiation-exposed polymer gels were simulated by the addition of colloidal 
suspensions of varying turbidity. The tests revealed some phenomena peculiar to light- 
scattering gels that need to be taken into account when calibrating polymer gel dosimeters, 
most importantly, that the measured extinction coefficients of the produced 2.5 cm ‘finger 
phantom’ appear to saturate at high turbidity with similar ‘cupping’ artefact. This saturation 
was not seen in the spectroscopic data from 1 cm cuvettes, which led to the conclusion that 
had these experiments been conducted via optical-CT alone, this saturation may have been 
interpreted as the degree of radiation induced polymerisation saturating, rather than an optical 
artefact that must be avoided or corrected.
This chapter investigates the behaviour of both an optically absorbing radiochromic 
dosimeter and an optically scattering gel dosimeter using our optical-CT apparatus with the 
aim of discovering the causes of various image artefacts and ultimately correcting them.
In order to establish an understanding of the manner in which light propagates 
through gel or solid dosimeters, a description of the mechanisms that govern light transport 
through physical media responsible for these processes is required. Section 5.2 describes the 
concept of light absorption pertaining to the Visible/ NIR region of the spectrum, introducing 
laws and definitions relevant to its quantification and measurement. Section 5.3 presents the 
basic theory behind light scattering and the parameters used to define it are introduced. The
152
discussion is limited to elastic scattering, in which there is no loss in energy of the scattered 
light, on the grounds that non-linear scattering effects are generally not significant in the 
Visible/ NIR region. Section 5.3 evaluates the accuracy of optical density measurements 
when imaging light-absorbing and light-scattering media. Section 5.4 gives the reader an 
overview of the experiments carried, with the reasoning behind each step, together with the 
contribution that they make to our understanding of the optical-CT process.
5.2 Light absorption
When a beam of light is incident on matter composed of discrete electrical charges, the 
charges are forced to oscillate at the frequency of the incident electric field. If the incident 
frequency, or equivalently the incoming photon’s energy matches that of one of the excited 
states, the atom will absorb the light, making a quantum jump to that higher energy level. 
Although the lifetime of the excited state is around 1CT7 to 10-8 seconds, the atoms or 
molecules will very likely lose their energy by colliding with one another within 10-12 
seconds, thereby raising the kinetic energy of the other particles involved in the collisions. 
Hence, the energy associated with the incident field is most often dissipated as heat within the 
medium. This commonplace process (the taking up of a photon and its conversion to thermal 
energy) was once known as “absorption” but now is better referred to as selective dissipative 
absorption at one frequency or another. That’s because a substance showing general 
absorption would reduce the intensity of all wavelengths of light by nearly the same amount, 
and the transmitted light would show no marked colour. There is merely a reduction of the 
total intensity of the white light, and such substances appear to be gray. Practically, all 
coloured substances owe their colour to selective absorption i.e. the absorption of certain 
wavelengths of light in preference to others in the visible spectrum.
5.2.1 Measurement of light absorption
The overall effect of absorption is a (usually wavelength-dependent) reduction in the intensity 
of the light beam traversing the medium [149]. The bases of quantitative measurements of 
absorption are two fundamental laws, which relate the intensities of incident and transmitted 
radiation [150].
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Lambert’s law
This was enunciated by Lambert a few years after being introduced by Bouguer in 
1729 and is sometimes referred to as Lambert-Bouguer law. The law states that the proportion 
of radiation absorbed by a substance is independent of the intensity of the incident radiation. 
The law can be expressed in the form that each successive layer of thickness dt of the medium 
absorbs the same fraction dl/I of the radiation of intensity I incident upon it:
dl— = -pdt 5-1
where p is a constant. Hence, the transmitted intensity I after incident light of intensity Io 
travels a layer of thickness t becomes on integration:
I = I0e_Mt 5-2
or alternatively:
I = I0 • 10-kt 5-3
where k is the extinction coefficient or absorbance index and p is the absorption coefficient, 
both expressed in cm'1.
Another important quantity A is defined as:
A = log10(Io/I) = kl 5-4
where VIq is the fraction of radiation transmitted and A is the absorbance directly determined 
from a measurement Instrument scales are often engraved with this unit.
Beer’s law
Beer’s law (1852) was based on quantitative and photometric observations on the 
absorption of red light by aqueous solutions of various inorganic salts. The law states the 
relationship between the intensities of the incident and transmitted radiations in a different 
way, namely that the absorption depends only on the number of absorbing molecules through
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which the radiation passes. If the absorbing substance is dissolved in a non-absorbing medium 
such as a laboratory cuvette, the optical density is then proportional to the concentration of 
the solution, c. In analytical applications we often want to measure the concentration of an 
analyte independent of the effects of reflection, solvent absorption, or other interferences, and 
as long as the analyte does not scatter light, the light travels through the medium in a straight 
line, covering a distance t. This loss of light intensity is referred to as attenuation (A) and is 
measured in units of optical density (OD) and thus, Beer’s law can be combined with 
Lambert’s law in the form:
A = log10(l0/l)  = £ct 5-5
where 8 is the specific extinction coefficient (molar1.cm'1) or molar absorptivity, c is the unit 
concentration (pmolar), and t the distance (cm) between light entry and light exit point. The 
product ec is known as the extinction coefficient of the absorbing medium (k). With several 
successive layers of absorbing material, or of a solution containing several absorbing 
components, the total transmission will be the product of the transmissions of the several 
components, and hence the optical density will be the sum of the optical density of the several 
components.
Another term, the absorption index,k is defined by the equation:
I = I 0 -e-4roclna 5-6
where X is the wavelength of the light for which the absorption is to be specified and n is the 
refractive index, and K=pA/47cn =0.183 c^8.
It is important to note, that the Beer-Lambert Law applies only for monochromatic 
radiation, though it must be appreciated that a ‘monochromatic’ light consists of a certain 
spectral bandwidth defined as the band of wavelengths adding up a range of exponentials with 
different decay constants contained in the central half of the entire band passed by the exit slit 
of the monochromater. It does not account for physical processes, which include reflection of 
the light at the surface of the medium and most importantly the scattering of the light whose 
effects are described in section 5.2.2. Therefore, the radiation quality as well as quantity will 
change on passing through an absorbing medium and the initial statement of the two laws no 
longer apply, giving rise to difficulties in the practical application of the law.
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Figure 5-1: Beer-Lambert’s law: Incident light of intensity Io travels distance x from a light source to the medium
without being absorbed in the air. The incident light intensity decreases exponentially with distance in the
absorbing medium of optical path length 1. Modified from [149,150].
5.2.2 Limitations of the Beer-Lambert law
The lineality of the Beer-Lambert law is limited by chemical and instrumental factors
including [150,151]:
■ Deviations in absorptivity coefficients at high concentrations (> 0.01M) due to 
electrostatic interactions between molecules in close proximity.
■ Scattering of light due to particulates in the sample as radiation will be diffused or 
scattered by a medium with a physical structure not small compared with the wavelength 
of the radiation. This occurs with colloidal solutions, a precipitate in a suspension, an 
emulsion, etc...
■ Fluorescence or phosphorescence
■ Changes in refractive index at high analyte concentration
■ Shifts in chemical equilibria, e.g., when examining solutions of cobalt slat, departures 
from Beer’s law may be explained by the fact that these salts form complexes and the 
composition is dependent on the concentration. Another cause is association in solution, 
which makes the proportion of the types of molecules present a function of concentration.
■ Non-monochromatic radiation. In practice a single wavelength is an unattainable ideal, 
especially if the light source has a continuous spectrum. The wavelength range included 
in this depends on the widths of the exit slits, which must be at least wide enough to give 
adequate intensity for measurement.
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■ Stray scattered light.
5.3 Light scattering
In air, the molecules (N, O, etc.) have no resonances in the visible, they cannot be raised into 
an excited state by absorbing a quantum of light, and the gas is therefore transparent. Each 
molecule behaves like an oscillator whose electron cloud can be driven into a ground-state 
vibration by the incoming photon, and simultaneously the molecule initiates the re-emission 
of light [152]. Elastic scattering of light, where the energy of the scattered photons is not 
changed, occurs when charged particles in a medium are set into oscillatory motion by the 
electric field of the incident wave, and re-emit light of the same frequency (and wavelength) 
as the primary wave. This is not to be confused with resonance radiation and fluorescence 
where an incident electromagnetic wave passes over a small elastically bound charged 
particle with a frequency equal to the natural frequency of free vibration of the particle. The 
particle will be set into motion by the electric field E, and the re-emitted light has the same 
wavelength as the incident light (resonance) or under certain circumstances the re-emitted 
light may have a longer wavelength than the incident light (fluorescence). Scattering, on the 
other hand, takes place at frequencies not corresponding to the natural frequencies of particles 
where the motion of particles is one of forced vibration. Obeying Hook’s law for a particle 
bound by a force, the vibration will have the same frequency and direction as that of the 
electric force in the wave. The scattering process occurring at non-resonance frequencies are 
relatively weak since the forced vibrational amplitudes of the particles are much smaller than 
those at natural resonances. The amplitudes of these ground-state vibrations, and 
consequently the amplitudes of the scattered light, increase with frequency because all the 
molecules have electronic resonances in the UV. The closer the driving frequency is to a 
resonance, the more vigorously the oscillator responds. Thus, violet light is strongly scattered 
laterally out of the beam whereas yellow is scattered to a lesser degree which explains why a 
beam that traverses a gas will be richer in the red end of the spectrum, while the light 
scattered out will be richer in blue. The phase of the forced vibration will differ from that of 
the incident wave, and this fact accounts for the difference of the velocity of light in the 
medium from that in free space (dispersion). However, intermolecular interactions in most 
solids and liquids broaden the absorption frequencies such that both scattering and absorption 
of light occur at all wavelengths [149].
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5.3.1 Scattering by small particles
The lateral scattering of a narrow beam of light mentioned in the previous section is closely 
connected both with reflection and with diffraction as seen in Figure 5-2. Figure 5-2 (a) 
depicts a parallel beam consisting of plane waves advancing toward the right and striking a 
small reflector. The successive wave fronts are one wavelength apart, so that here the size of 
the reflector is greater than a wavelength. The light coming off from the reflecting surface is a 
product of the vibration of the electric charges in the surface with a definite phase relation, 
and the spherical wavelets produced by these vibrations cooperate to produce short segments 
of plane wave fronts. These are not sharply bounded at their edges by the reflected rays from 
the edges of the mirror (dotted lines) but spread out somewhat, owing to diffraction (failure of 
light to travel in straight lines), the distribution equivalent to light transmitted by a single 
opening of width smaller than a wavelength-Huygens’ principle [149]. Here, the width of the 
reflector takes the place of the slit width, so that we have greater spreading the smaller the 
width of the reflector relative to the wavelength.
/
\
(b)
Figure 5-2: Reflection and diffraction of light by small-sized objects compared to the wavelength of light [149].
In Figure 5-2 (b), the reflector is much smaller than a wavelength, and the spreading 
is so great that the reflected waves differ very little from uniform spherical waves. In this case 
the light is said to be scattered, rather than reflected, since the law of reflection has ceased to 
be applicable. Scattering is considered a special case of diffraction. The wave scattered from 
an object smaller than a wavelength of light will be spherical, regardless of whether or not the 
object has the plane form assumed in Figure 5-2 (b). This follows from the fact that there can 
be no interference between the wavelets emitted by the several points on the surface of the 
scattering particle, since the extreme points are separated by a distance less than a 
wavelength. This phenomenon is frequently called Rayleigh scattering named after Lord 
Rayleigh (1871) whom made the first quantitative study of the laws of scattering by small 
particles. The mathematical investigation of the problem gave a general law for the intensity
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of the scattered, applicable to any particles of index of refraction different from that of the 
surrounding medium as long as the linear dimensions of the particles is considerably smaller 
than the wavelength:
2?tr
x  — I c  n
where the size of the scattering particle is parameterised by the ratio x of its characteristic 
dimension r and wavelength X [153].
When unpolarised light is incident on a small particle the intensity distribution of the 
scattered light is almost isotropic, since the secondary wavelets emitted by the oscillating 
charges are approximately in phase with one another. At an angle of 90° to the direction of 
propagation of the incident light, however, the charges oscillate linearly in one direction only, 
and thus the light appears to an observer to be linearly polarised. The most important aspect 
of Rayleigh scattering is its wavelength-dependence, which varies with the inverse fourth 
power of the wavelength of the illuminating light [149]. The scattered intensity is found to be 
proportional to the incident intensity and to the square of the volume of the scattering particle, 
and is dependant the wavelength such that:
_ I08tc4N<x2 2«\ , 1I s = :— (1 + cos 0) = k —  5-8
A,4R2 X4
where N is the number of scatterers, a  is polarisability, and R is the distance from the 
scatterer [153].
In an optically dense or homogeneous medium, i.e. one in which the molecular 
separation is much smaller than the wavelength (< A./15) of the incident light, individual 
atoms or molecules in a medium will scatter the incident radiation in all directions. As the 
orientation of the molecules is random, the photons are scattered everywhere in what looks 
like little classical spherical wavelets-energy streams out in every direction.
As a result of scattering, the velocity of light in all matter is less than that in vacuum. 
The phase difference of the scattered light relative to the primary wave will depend on the 
frequency of the primary wave. In any direction the total scattered field is then a 
superposition of all the scattered wavelets propagating in that direction. The scattered waves
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will interfere with the incident wave, modifying its phase and hence the velocity of the light 
through the medium. The refractive index of a medium is given by:
cn = — 5-9v
where c is the speed of light in vacuum and v the speed of light in the medium. The refractive 
index depends on the number of molecules per unit volume and their polarisability, since the 
total scattered wave that interferes with the incident wave depends on the amplitudes of, and 
phase relations between, the individual scattered wavelets. Furthermore, the refractive index 
for a given medium changes with the frequency of the incident light. This phenomenon is 
known as dispersion and is due in part to the frequency-dependence of the relative phase 
change between the incident and scattered waves. Theory has shown, however, that to explain 
dispersion in real media over a broad spectrum, including the resonance frequencies, the 
absorption of light must also be considered. Thus, the complex refractive index is defined as:
N = n + ik 5-10
where the real part, n determines the speed of the wave and the imaginary part, k, determines 
the absorption of the wave as it propagates through the medium. From Maxwell’s equations k 
can be related to the absorption coefficient, as defined in equation 5-6.
5.3.2 Effects of light scattering on measurements
Equation 5-2 states that the transmitted intensity I after incident light of intensity Io travels a 
layer of thickness 1 will decrease to a greater or lesser extent as the light penetrated farther 
into the medium where p. is called the absorption coefficient. However, in the case of 
scattering, most of the decrease in the intensity of I is not due to real disappearance of light 
but results from the fact that some light is scattered and thus removed from the direct beam. 
True absorption represents the actual disappearance of the light, the energy of which is 
converted into heat motion of molecules. Thus, we can regard p as being made of two parts, 
pa due to true absorption and ps due to scattering, but it is important to realize the existence of 
these two different processes and the fact that in many cases both may be operating. Light 
scattering arises due to relative refractive index mismatch at the boundaries of different 
media. The scattering coefficient (ps) for a medium containing a single type of scattering 
component is a measure of the likelihood that a photon will be scattered in the given medium.
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In the case of single scattering, therefore, a new exponential relationship can be defined for 
the collimated-beam intensity I, relative to the incident intensity Io, transmitted in an 
absorbing medium of length 1 [149]:
I =  Ioe_,M 5-11
where pt is the total attenuation coefficient and is equal to the sum of pa + ps. The reciprocal 
of the total attenuation coefficient, pt \  is known as the mean free path, and is the distance 
travelled by a light photon between interactions.
If we assume no absorption occurs and attenuation of light is only due to scattering 
then by analogy with absorption we have:
I = I0e"M 5-12
5.3.3 The transmission of light through dense media
A light beam encountering a uniform dense medium with no discontinuities, the scattered 
wavelets interfere constructively in the forward direction (that is independent of the 
arrangement of the molecules) but destructive interference predominates in all directions 
(Figure 5-3). Little or no light ends up scattered laterally or backwards in a dense 
homogeneous medium. All scattered wavelets add constructively with each other and 
propagate in the forward direction, i.e. the direction of propagation of the incident beam, are 
in phase with one another. Hence, the amplitudes of the scattered wavelets simply sum to give 
the total scattered field amplitude in the forward direction (<constructive interference). In all 
other directions constructive and destructive interference (a superposition of two or more 
waves producing an out of phase resultant disturbance that cancels the overlapping wave 
contributions) will occur [152].
A parallel beam of light composed of plane waves so-called primary wave fronts 
sweep over and successively energize and re-energize each molecule, in turn, scatters light in 
all direction, and in particular out to some lateral point P . Because the lengths of their 
individual paths to P differ greatly compared to the wavelength, the phases of the wavelets at 
P differ greatly. You get destructive, constructive interference, and the shifting random 
distribution of overlapping wavelets effectively averages away interference. The more dense,
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uniform, and homogeneous the medium is, the more complete will be the lateral destructive 
interference and the smaller the amount of non-forward scattering. Thus, most of the energy is 
in the forward direction, and the beam will advance essentially undiminished.
p’
Figure 5-3: The scattering of light from a widely spaced molecular distribution, (a) The wavelets arriving at a 
lateral point P have different phases and tend not to interfere in a sustained constructive fashion, (b) Scattering in 
the forward direction doesn’t change the light paths very much, and the waves will arrive at point P in-phase. 
Modified from [152].
Although a certain amount of the laterally scattered light is attributable to the 
scattering by individual molecules of liquids, the scattering per-molecule is extremely weak in 
view of the large concentration of molecules present. In a liquid, and even more so in a solid, 
the spatial distribution is more regular, and the inter-molecular forces act to destroy the 
independence of phases. The result is that the scattering in directions other than forward is 
very weak indeed. The forward-scattered waves are strong and play an essential part in 
determining the velocity of light in the medium. When the number of molecules in a particle 
is small, they are closely packed and act in unison so their wavelets interfere constructively, 
and the scattering is strong. As the size of the particle approaches a wavelength, the atoms at 
its extremities do not radiate wavelets that are in-phase; therefore, scattering decreases [149, 
152].
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5.4 Overview of experiments performed
A number of artefacts are still present in optical CT images of the scanners currently available 
and while careful image acquisition can usually eliminate these, their existence may reduce 
confidence in the technique. In the following experiments, we investigate the effect of 
matching the refractive indices of the phantom’s container, matching liquid and the medium, 
and apply a correction scan to correct for all effects that modify the intensity of the projection, 
other than the radiation-induced changes that we are trying to detect especially reflection and 
refraction at container walls. We also examine the “cupping” artefact described by De Jean et 
al. [147] at the 2006 DOSGEL meeting, whether the effect is only inherent to scattering gels 
and whether it is relevant only to cone-beam scanners.
Krstajic et al. [10] prepared a calibration ‘finger phantom’, similar to that proposed 
by Oldham et al. [154] but in this experiment the finger cavity was backfilled with both an 
optically absorbing and optically scattering medium, respectively. The results suggested that 
for the scattering ‘finger phantom’ a similar ‘cupping’ artefact is seen at a high level of 
turbidity, implying that this phenomenon does not only occur with the Vista cone beam 
optical-CT scanner. In this chapter, we set out to reproduce the effect and discuss other 
potential causes.
As will be shown in the following sections 5.5 and 5.6, these images demonstrated 
cupping artefacts. Since the effect appeared with both scattering and absorbing phantoms, we 
eliminated multiple scattering as a cause of the cupping in our case (although this may have 
been the origin in the case of De Jean et al (2006). It was hypothesised that this effect was 
caused by an erroneous estimation of the ambient light or dark image and the dynamic range 
extension method mentioned by Krstajic et al. [123] was employed. The results of this 
experiment showed that the hypothesis was incorrect. This led to a re-examination of the 
original hypothesis, viz. that with highly absorbing phantoms (and hence very low signal) any 
slight contamination with scattered light will have a significant impact on the measured 
absorption coefficients. Measurements presented in DOSGEL 2008 indicate that, even in the 
absence of a sample, the apparatus and matching medium cause a significant degree of 
scatter. Unfortunately, further tests to quantify the scatter component in our apparatus were 
inconclusive.
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5.4.1 Spectroscopy measurements
Extinction coefficients of 1 cm cuvettes were measured independently of the optical-CT with 
a spectrophotometer filled with gelatin gel doped with controlled amounts of blue food 
colourant and antiseptic liquid over a range of concentrations of blue dye and antiseptic from 
zero to ~ 0.6% v/v, the latter corresponding to the concentration causing saturation of our 
optical-CT scanner. This was to demonstrate the difference in the shapes of absorption spectra 
and to calculate the concentration at which optical saturation occurs at X = 632 nm (compared 
to He:Ne laser-based Optical-CT). The spectrophotometer measurements guided the choice of 
dye and antiseptic concentrations during subsequent production of imaging phantoms.
The main mechanism of optical attenuation in the blue food colourant (Super Cook, 
Dr Oetker (UK) Ltd, Leeds, UK) is optical absorption with maximum peak response at 632 
nm, which is quite suitable for simulating PRESAGE™. A readily available commercial 
antiseptic liquid (Dettol™, Reckitt Benckiser) was found by Bosi et al. (2007), when added to 
water, to exhibit similar opalescent turbidity in transmission and reflection to radiation- 
exposed polymerizing gel. This is because light-scattering is caused mainly by radiation- 
polymerized clusters of roughly colloidal size (~ 1 pm), and so they exhibit colloidal 
opalescence, i.e. they are milky, turbid in appearance, orange/red in transmission while 
internally scattered light is white with a slightly blue tint [155].
300 bloom porcine gelatin powder and de-ionized water were mixed in the 
proportions 14 g of powder per 400 ml of de-ionized water and heated to 40°C to produce the 
clear base gel. Nine cuvettes of the 1 cm optical pathlength were prepared and the extinction 
coefficients were measured using a double beam spectrophotometer (Camspec-350). Two 
cuvettes were filled with only gelatin solution for baseline measurements, the raw Io, which 
corrects for any reflection, absorption caused by the cuvette, gelatin, and the variation of the 
light intensity of light source, monochromator (in dispersive instruments are usually the 
diffraction gratings), etc. One cuvette was filled with gelatin solution mixed with a few drops 
of antiseptic (~ 0.6% v/v), and the rest of the cuvettes were filled with varying concentrations 
of the blue food colourant mixed with gelatin solution. A plot of the absorbance values 
against the wavelength (nm) is shown in Figure 5-4. The values of the optical absorbance of 
both gel-infused cuvettes at a wavelength of 632 nm were then plotted and a calibration curve 
was obtained from the data (Figure 5-5) in order to determine the concentration of blue food 
colorant required to match a given concentration of the Dettol™ solution.
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F igu re 5-4: Absorbance of Dettol™ sample and blue colourant samples versus wavelength in nm.
Thus, for Absoettoi = 1.502 at X = 632 nm (± 0.3 nm) the calculated ConcDettoi = 0.240 
g/ 40 ml gel solution, and from that the mass of the blue food colorant of known 
concentration in a 40 ml gelatin volume, massbiUe = 0.115 g/ 40 ml gel solution.
3.00
2.50 -
Es
2.00 -erj
so
cs
*  1.50 -
aa
|  l.oo -=
a
<
y = 1.30e+01x + 1.08e-01
0.50
0.00
0.000 0.050 0.100 0.150 0.200
B lue dye C on cen tra tion  [g per 40 m l w ater]
F igure 5-5: Calibration curve obtained to calculate the concentration of blue food colorant in g/40 ml of water 
required to match the absorbance, 1.052 cm'1, of 0.24 g Dettol™/40 ml of water at % -  632 nm ± 0.3 nm. Error bars 
are smaller than the size of the plot symbols.
The same experiment was repeated using cuvettes of two different designs, to test 
how changing the pathlength affects the absorbance, the effect of stray light on optical
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measurements, and the applicability and limitation of the Beer-Lambert law (Figure 5-7). 
Eppendorf UVette® cuvettes with two separate regions, having pathlengths of 2 and 10 mm 
(with adaptor of 1 x 1 mm2 aperture for stray light rejection) were filled with de-ionized water 
mixed with varying amounts of blue food colourant, and were then measured using a CARY 
5000 UV-Vis-NIR spectrophotometer (Varian, Inc).
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Figure 5-6: A plot of absorbance values against wavelength for varying concentrations of diluted blue food 
colourant (a) with 2 mm path length (b) 10 mm path length, and (c) A plot of absorbance values against varying 
concentrations in |il of diluted light absorbing blue food colourant with (i) 2mm pathlength Eppendorf UVette® 
with adaptor (•), (ii) 10 mm pathlength Eppendorf UVette® with adaptor (♦), and (iii)standard 10 mm pathlength 
cuvette (*). Error bars are smaller than the size of the plot symbols.
Figure 5-6 (c) shows that using 10 mm pathlength Eppendorf UVette® with adaptor 
(♦) allows a higher signal to be transmitted compared to just using a standard 10 mm 
pathlength cuvette (■), and that using a 2 mm pathlength cuvette (•) further reduces the 
optical saturation reached with a spectrophotometer.
Cuvettes (2 mm optical pathlength) were then filled with controlled diluted amounts 
of both blue attenuating food dye and Dettol™ antiseptic liquid until saturation was reached 
(Figure 5-7). The spectrophotometer extinction coefficients of cuvettes were plotted against 
both antiseptic and blue food gel concentrations at a wavelength of 632 nm ± 0.1 nm 
(compared to He:Ne laser-based OCTOPUS™ Optical-CT). As expected, the blue food 
colourant yields a straight line passing through the origin obeying the Beer-Lambert Law 
within the maximum range of the spectrophotometer, whereas for Dettol™, the law is no 
longer applicable at high concentrations because of scattering causing the saturation level 
reached for each media to be different.
o blue dye_ 10mm with holder 
° blue dye_10mm 
° blue dye_2mm with holder
O o  
o
3
c*
167
3.00
2.50
2.00
u 
& cs
£  1.50 © ce A
1.00 
0.50 
0.00
0 20 40 60 80 100 120 140 160 180 200 220
Concentration [ul/ 1200ul water]
F igure 5-7: A plot of sample absorbance values against varying concentrations in pi of light absorbing blue food 
colourant and light scattering Dettol™ showing (a) an absorbing substance does give a straight line until optical 
saturation, and (b) non-linearity or breakdown of Beer-Lambert’s law with colloidal suspensions. Error bars are 
smaller than the size of the plot symbols.
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5.4.2 Effects of reflection and refraction at the container walls
Usually, the preferred basic dosimeter geometry is circular, which makes calculating the ideal 
relative transmittance straightforward using equation 5-2 and leading to:
I(x)=I0e .2ji(r2-x2)V2 5-13
where I(x) is the transmitted intensity across the cylindrical phantom, Io is the incident 
intensity corresponding to the baseline reference phantom, x is the horizontal distance from 
the phantom centre and r is the phantom radius (Figure 5-8).
I(x)
X
Figure 5-8: A schematic diagram of a projection across a cylindrical phantom.
In order to obtain our values for the two dimensional absorbance, A(x,y), along the 
set of ray paths which end on the pixels of the CCD, we use the following equation [123]:
A(x,y) = log10 L (x,y)-D (x,y)
P(x,y)-D (x,y) 5-14
where P(x,y) is the projection image, a 2-D matrix of pixel values (grey levels) produced 
when the projection image is focused onto the CCD chip, corresponding to the quantity I in 
equation 5-13, L(x,y) is the projection image of the light field, corresponding to Io, and D(x,y)
169
is the dark image that is often referred to as the bias image or bias frame and may be thought 
of as constant offset to all measurements.
The logarithms of the projections are calculated and a two-dimensional image of the 
distribution of optical density is reconstructed using the method of filtered back-projection. 
Stacks of the two-dimensional images create a three-dimensional reconstruction. Note that, 
each pixel the CCD image projection needs to be an integral of optical attenuation along a 
known straight line, Pxy and this line needs to be parallel, and separate from other lines so as 
not to contribute to other pixels in a projection.
Doran et al. [116] have already simulated the effect of reflection and refraction on the 
reconstruction of optical densities in computed tomography of right cylindrical phantoms and 
established that careful adjustment of the refractive index of the matching medium would 
eliminate container wall artefacts between materials of different refractive indices, and that a 
correction scan accounting for the inhomogeneity of the light field, detector properties and 
imperfections in the container is much needed. In achieving this, the primary factor limiting 
the fraction of the profile that can be acquired is the Fresnel reflection. The (intensity) 
transmission and refection coefficients TE, TH, Re, and RH for partially polarized light (LED 
source) with the E- and H-field, respectively, describe the change in amplitude of reflected 
and transmitted ray and are as follows [152]:
R e -
Te =
f  \  2ntcos0i - iii cos 0t 
Hi cos0t +ntcos0i
ntcos0t 
n, cos0\  i
2n;cos0j Y2'
n;cos0t +ntcos0i
r h =
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f  \ 2njcos0i - n t cos0t
iq cos0i +ntcos0t
^nt cos0t v
l l j  COS0}
2n: cos 0,
iij cos0j +nt cos0t
5-15
5-16
where n; and 0} are the refractive index of the material and the angle on the incident side of the 
boundary and nt and 0t are the corresponding values on the transmission side. The final 
intensity of each light ray is found by multiplying appropriately the relevant transmission 
coefficients for each of the interfaces. Figure 5-9 shows the reflected light intensity of 
material to water interface for two different materials giving us an idea how close from the 
edge of the sample one can reasonably expect to scan.
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Figure 5-9: R|| and R±of PET (solid line) and Teflon container (dashed line).
Figure 5-10 illustrates the separate interfaces an incident ray of light has to encounter 
as it enters a sample in the scanning tank. It encounters six separate interfaces as it passes 
through the scanning tank: (a) anti-reflective coated glass entrance, (b) the matching liquid 
(with refractive index n0, (c) the container wall (n2), (d) the sample (n3) and (e) the exit glass 
end of the scanning tank.
At each interface, the Snell’s law determines the direction of the emerging ray. When 
the light beam hits the container wall tangentially, the beam is partially reflected and 
deflected from the forward direction; therefore, a proportion of the incident light is reflected 
and the remaining light is transmitted according to the Fresnel equations causing a sudden 
drop in the intensity of the transmitted signal. As one moves farther towards the interior of the 
cylinder, more light gets transmitted and collected, but the intensity of the transmitted light 
remains affected by multiple refraction and reflections along the container wall over a certain 
distance inwards from the wall. As we are dealing with a telecentric optical system, the 
sharpest image is obtained on the CCD as long as the object lies on the focal plane. Therefore, 
prior to hitting L2 by placing an aperture stop in the CCD lens in the beam path at the focal 
point of L2 causes the chief rays to be parallel. We now consider which rays emanating from a 
particular position in the sample will arrive at the CCD, following the correct positioning of
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the focal plane, in conjunction with the size of the acceptance angles. If the acceptance angle 
is too big then there may be an overlap of focusing cones; thus, complicating the image 
reconstruction [10].
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Figure 5-10: Light propagation through a cylindrical sample traced from left to right showing the different 
interfaces (a) the matching medium, (b) the container wall, (c) the absorbing or scattering medium, (d) the 
container wall again, and (e) the scanning tank widow. It first hits the container at an angle and refracts at angle to 
the normal following Snell’s law. The ray then hits the container again at an angle and refracts back at the new 
normal, exiting the scanning tank with a different angle before the ray hits L2. Only rays emerging within the 
acceptance angle a  will be imaged on the CCD. Modified from [116, 123],
The diameter D of the CCD lens aperture is obtained from the f-number setting on the 
CCD lens (f/#) and its focal length fCCD:
f/#= CCD
D
5-17
And from that the acceptance angle is derived using simple geometry:
a  = 2tan -l D
^ L 2-C C D  + d o b j
5-18
The effect of refraction at the walls is to deviate the light beam by more than a, 
which leads to dark walls.
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Figure 5-11 (a) and (b) demonstrates the resultant line profile of the reconstructed 
image across two containers with different refractive indices and the effect of using a 
refractive index as low as that of the tested sample, in this case, water (n=1.33), to minimise 
the problems of refraction and reflection of light at the walls of the container. Theoretically, 
line profile across a uniform-density cylinder and a refractive-index-matching liquid of 
identical unit-length optical density should be a flat line. However, by adding a cylindrical 
wall of uniform thickness and attenuation but of different unit-length optical density, the 
shape of the projection will be a superposition of two ellipses, depending on the relative light 
attenuation coefficients of the cylinder wall and the matching liquid.
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Figure 5-11: Results of image acquisitions to demonstrate the effect of wall artefacts. Profile across sample with 
image inset for (a) Teflon® FEP(r = 40mm) and (b) PET container (r = 35mm); the effect of the correction scan (c) 
using Teflon® FEP container and (d) PET container filled with very diluted Dettol™ on the inside and de-ionized 
water on the outside.
As long as the difference in the intensity of the transmitted light is caused solely by 
attenuation, the filtered back-projection (FBP) image reconstruction algorithm will 
reconstruct the unit-length optical density distributions correctly (In practice, the cylinder 
wall is sop thin that negligible disturbance in the profile due to attenuation would normally be 
seen). The situation is quite different when refraction contributes significantly to signal
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losses. The FBP image reconstruction algorithm will interpret the intensity change caused by 
reflection and refraction to be purely due to optical attenuation and create areas of 
significantly altered optical density values.
The first container consisted of clear plastic jar of approximately 70 mm diameter 
made of polyethylene terephthalate (PET, n=1.575), as used in the Vista scanner. The second 
container consisted of transparent, thermoplastic sleeve made of Teflon® FEP (DuPont) of 
approximately 79 mm diameter and a refractive index of 1.341 as specified by the 
manufacturer. Both containers were filled with de-ionized water (PET- 500 ml, and Teflon® 
FEP- 350 ml), then inserted in the scanning tank and surrounded by de-ionized water (Milli- 
DI® Systems, Millipore). The PET jar was secured to the tank by aluminium holders to 
ensure the container remains in the centre of the rotation axis as it tends to shift horizontally 
as it rotates 180°. This is not required with the Teflon® FEP container as a base-plate is 
already fabricated that locks to the rotation table via two locating pins. As The Teflon® FEP 
container is open from both ends, a thin layer of a warm gelatin gel (~ 0.025 w/w) was 
prepared to be poured into the container to seal the bottom end of the container. Bubbles were 
always removed around the edges of the container to minimise scatter artefacts. The gelatin 
mixture was kept in the refrigerator for about 30 minutes to allow it to set. Subsequently, 
another layer was added, approximately 1 cm in depth. This is also kept in the refrigerator for 
about 1 hour.
For the PET container, 300 raw projection images of dimension 256 x 256 were 
acquired with no signal averages. These were reconstructed onto square matrices of 256 x 256 
pixels, giving an in-plane nominal pixel resolution of (0.30 x 0.30) mm2 and slice thickness of 
0.30 mm. For the Teflon® FEP container, 300 raw projection images of dimension 256 x 256 
were acquired with no signal averages. These were reconstructed onto square matrices of 128 
x 128 pixels, giving an in-plane nominal pixel resolution of (0.72 x 0.72) mm2 and slice 
thickness of 0.36 mm. A number of the reconstructed images were averaged to help improve 
the signal-to-noise ratio.
The uncertainty was assigned using basic standard error theory where the standard 
deviation is defined as the root mean square (RMS) deviation of values from the arithmetic 
mean of the relevant slice (averaged slice).
Figure 5-11 (a) shows the resultant reconstructed image of 60 summed transverse 
slices of the Teflon FEP container filled with de-ionized water, along with a line profile 
across the reconstructed image (1 pixel -  0.7 mm). The field-of-view (flat line profile in the
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central region) for the Teflon FEP container over which reliable quantitative measurements 
can be made are at pixel values 15 to 105 of the container wall on the image, the equivalent of 
63 mm diameter, such that around 80% of the phantom’s diameter (115 pixels apart) is usable 
with no loss of data in the reconstructed image at the wall interface enabling us to derive 
absolute attenuation coefficients. Figure 5-11 (b) shows the resultant reconstructed image of 
60 summed transverse slices of the PET container filled with de-ionized water, along with a 
line profile across the central line (1 pixel ~ 0.6 mm). The field-of-view (flat line profile in 
the central region) for the PET container over which reliable quantitative measurements can 
be made are at pixel values 40 to 85 of the container wall on the image, the equivalent of 27 
mm diameter, less than 50% of the actual values of the phantom diameter (115 pixels apart). 
The effect of the reflection and refraction near the PET container wall is twofold. First, an 
apparently thicker wall is reconstructed as a result of significant loss of signal across a 
distance larger than the wall thickness. Second, the image intensity near the inner wall of the 
container is suppressed by the FBP image reconstruction algorithm in an attempt to reconcile 
the large differences in the intensity of the transmitted beam through the same volume 
element of the container wall. The result is a loss of projection on both sides of the cylinder 
which if not corrected, causes a “dome-shaped” artefact in the reconstructed image. This is a 
demonstration of the fact that the precision to which the refractive indices of the container, 
sample and the matching liquid have to be the same is very slight. On the other hand, Figure 
5-11 (c & d) shows how the correction scan not only corrects for the inhomogeneity of the 
light field, detector properties and imperfections in the container but also lowers the refraction 
effect considerably. This, in addition to a correct matching of the refractive indices at the wall 
interface, helps to slightly increase the usable field-of-view and thus allows better quantitative 
measurement.
5.5 Imaging a scattering phantom
The aim of this experiment was to investigate the optical properties of an optically scattering 
phantom. As shown previously, in a purely absorbing material a plot of absorbance against 
concentration yields a straight line passing through the origin, whereas for a scattering 
medium, the behaviour is somewhat like absorption, i.e. it obeys the Beer-Lambert Law for 
low concentrations of scattering centres but becomes nonlinear at high concentrations. Figure 
5-12 shows the attenuation of a scattering medium at varying degrees measured using a thin 
walled container with a refractive index close to that of our matching. Turbid solutions were 
prepared by adding small quantities of the antiseptic to 300ml of de-ionized water in the 
Teflon® FEP container until minimum signal was detected at the centre of the phantom by
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the optical-CT, which is only slightly above the level of the dark-current signal (~ 992.14, SD 
= 3.63 for 49 pixels area). Figure 5-12 (a)-(f) shows the corrected reconstructed images with 
the varying amounts of antiseptic in pi added to 300 ml of water where a correction scan was 
performed by filling the Teflon® FEP container with de-ionized water only and defining it as 
the light field instead of just the standard projection of the empty scanning tank filled with 
refractive index matching liquid (water, n = 1.33).
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Figure 5-12: (a-f) Reconstructed images of varying concentrations of diluted antiseptic solution (Dettol™ in ul 
mixed in 300ml of de-ionized water); (g) absorbance profile across the sample until saturation is reached, (h) 
corrected line profile of reconstructed optical density images showing the dishing artefact; (i) relationship between 
concentration of antiseptic in pi and mean pixel value (x) ± SD (I) of a square ROI (-3054 pixels) in the 
reconstructed image —  see 5-12 (f).
In Figure 5-12 (g), as the saturation level is reached at a concentration of ~ 0.0076 
v/v, the shape of the absorbance profile changes from the expected smooth arc of an ellipse to 
a profile of a collapsed ellipse as the projection signal, P(x,y), approaches the dark current 
signal, D(x,y). Consequently, a cupping artefact is observed in the resultant reconstructed 
image which is caused by more incident light being transmitted at the outer edge of the 
phantom where the optical density is low , thus the signal measured is still within the 
absorbance dynamic range whereas the central region of the phantom constitutes a low
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transmission region (absorbance > 2.0) below the minimum detected threshold (Figure 5-12 
(h)) i.e. dark-current causing an incorrect measured signal. Figure 5-12 (i) represents the 
mean optical density in each square region-of-interest (~ 3054 pixels) in the relevant slice 
plotted against the concentration of diluted liquid antiseptic, with error bars corresponding to 
the standard deviation of the mean of the data. The large ‘cupping’ artefact at high optical 
density is an entirely expected artefact of the inability of our optical system to measure optical 
densities higher than 3.0 —  in fact, this is a very good performance —  and is unrelated to 
scattering. Curiously we see no evidence of any cupping artefacts at lower concentrations.
A non-linearity is seen in Figure 5-12 (i) for low antiseptic concentrations, the curve 
being slightly concave-up. An explanation that was proposed by Bosi et al [155] is that the oil 
of which the scattering centres are composed is very slightly soluble, so at very low 
concentrations the solution is barely saturated, meaning a non-negligible percentage of the oil 
in the gel is actually dissolved and hence not scattering. This effect could be avoided 
altogether by using an even less soluble material to produce turbidity.
5.6 Imaging an absorbing phantom
Varying amounts of blue food colourant were added gradually in the phantom and mixed with 
300 ml of de-ionized water until minimum signal was detected by the Optical-CT unit. We 
expect to see a flat line profile across the sample, and a linear relationship between the mean 
optical density and the blue food colourant concentration corresponding to the straight line in 
the spectrophotometer measurements. Figure 5-13 (a) shows the results of increasing the 
concentration of the attenuating additive. In each case, profiles have been corrected by 
dividing by the zero-concentration {correction) scan. It is seen that, as the concentration 
increases, the shape of the absorbance profile changes from the expected smooth arc of 
elliptic form into a profile with much steeper sides and a flatter top. This, in turn, leads to an 
image, whose edges are much brighter than expected and whose middle is depressed (Figure
5-13 (c)). Figure 5-13 (d) represents the mean optical density in each rectangular region-of- 
interest (~ 900 pixels) in the relevant slice plotted against blue food colourant concentration in 
300 ml of water, with error bars corresponding to the standard deviation of the mean of the 
data. Here, the expected linear relationship between dye concentration and reconstructed 
optical density breaks down as saturation level is reached at a concentration of approximately 
0.0093 v/v (~ 280pl blue food colourant /  300 ml water). This result was very unexpected and 
is discussed further below.
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Figure 5-13: (a) absorbance profiles across sinogram data of uniform cylinder with gradually increasing dye 
concentration; profiles across (b) uncorrected and (c) corrected reconstructed optical density images; (c) 
relationship between quantity of dye added and reconstructed image intensity at the centre of the profile ± SD (I) 
—  we would expect this to be linear.
5.7 Hypotheses and further investigations
We started with the assumption that for an absorbing medium, the profile across the 
image would be flat whereas for a scattering medium, a ‘cupping’ artefact should be seen. In 
fact what we observed was almost exactly the inverse.
In this section, two possible hypotheses for the signal behaviour in the absorbing 
phantom are tested. Hypothesis 1: Incorrect value of dark image/dark current. Hypothesis 2: 
Unaccounted for additional signal caused by scatter. Both of these issues have the potential to 
cause problems such as seen here. It was hypothesised that cupping effect seen in the above 
figure could have been accentuated by the very low detected signal at the centre of the 
phantom, which is only slightly above the level of the dark-current image (whose mean
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intensity is 1051 ADC units, SD = 33). The consequence of this is that even slight increases in 
received signal (e.g., from a very small scattered component) can cause major changes in the 
measured value of attenuation. As shown in [123], the dynamic range of the CCD should have 
been sufficient to measure successfully the expected absorbance range encountered. However, 
any errors in the estimated value of the dark current, or ambient light reaching the detector not 
accounted for, would cause corresponding errors in the measured absorbance values.
5.7.1 Extended dynamic range method
Figure 5-14 analyses the results of an imaging experiment with normal light intensity level for 
a highly absorbing phantom. Owing to the quality of the CCD, low noise data are obtained 
even at high values of absorbance. However, the systematic error causing the wings is still 
evident (Figure 5-13 (c)). Data are expected to satisfy Eq. [5-14] (smooth green line), but this 
is patently not the case.
It can be shown that if 5 is the error in D(x,y) that the error in absorbance A(x,y) is 5 / 
(S-D).log]0e. If S »  D, then this poses little problem. However, for highly attenuating 
samples, P(x,y) approaches D(x,y) (i.e., the contribution made to the signal by the light we are 
actually trying to measure becomes small). Under these circumstances, any slight error in the 
estimation of D(x,y) (or equivalently, failing to take account of changes in ambient light) 
becomes very significant. The blue (middle) line in Figure 5-14 demonstrates how, by adding 
an appropriate (small) constant to the value of D(x,y) in Eq. [5-14] before performing the data 
processing “improves” the fit dramatically. A confirmation that this was the correct thing to 
do was the motivation behind the high light field experiment, because in this way the new 
signal measured would be much greater than the dark image level.
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Figure 5-14: Imaging experiment performed with normal light intensity, showing raw data (black line, bottom), 
theoretical data (green line, top) and data that would be obtained if we assumed there to be an error in the 
background light level and corrected this.
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In order to discover whether this was the cause of the discrepancy, a method to 
extend the measurable dynamic range absorbance in projections was adopted [123]. The 
general idea is to acquire another set of data where a neutral density filter of the nominal 
value 1.0 is inserted into the beam path during collection of the light-field data, while at the 
same time the light intensity coming of the LED is gradually increased until maximum 
absorbance is reached to prevent the CCD camera of becoming saturated (blooming effect). 
The data scan is then performed with the NDF taken out of the beam path, and the logarithms 
of the new set of projection images (-logio (I/Io) with dark-field correction is calculated. This 
allows optically dense objects to transmit more light and thus produce a detectable signal. 
Although, less optically dense regions saturate the detector during the data scan, these are 
automatically eliminated from calculations because they are registered as regions of “negative 
absorbance” (provided saturation does not cause spilling of charge into neighbouring 
regions).
To summarise, one set of projection images (Pi) with the normal light intensity level 
was acquired such that the largest signal value is close to the detector maximum, but no 
saturation occurs. For highly absorbing phantoms, the minimum transmitted light intensity 
will be very close to the detectable threshold. The logarithms of the projection images (-logio 
(Flo)) acquired with no filter with dark-field correction are calculated using Equation 5-14. A 
second set of images (P2) in which the light intensity is increased was acquired. The low 
absorption regions of the projection will now be saturated but bona fide data will now be 
detected. The optical absorbance was calculated using the same equation (5-14) but with the 
optical absorbance of the filter added, thus the following equation:
Composite projections (PCOmp) pixel-by-pixel, using data from Pb wherever the signal 
is above a pre-determined threshold (related to the dark current) and suitably scaled data from 
P2 where the data fall below this threshold were then constructed. Scaling may be 
accomplished either by adjusting the light intensity such that certain regions of the projection 
contain valid data for both Pi and P2 or by acquiring an additional light-field image with a 
calibrated neutral density filter in the beam path. If the cause of the problem was indeed an 
erroneous estimation of the ambient light or dark image, then projections P2 are obtained with 
a much higher light level than Pi and should be less affected by the artefact.
180
H onzontalpro<tes Vertical poliles
Dark current 
evelDark c v r e n :  level
Figure 5-15: Blooming — a cautionary tale. When attempting to implement the extended absorbance 
measurement method, it is vital to take account of the blooming effects that occur when the CCD is saturated, (a) 
image of the phantom at normal light level with blue-dye filled phantom; (b) high intensity light field and blue-dye 
filled phantom — values of attenuation are as expected in the sample centre, but incorrect at both edges; (c) 
masked region of CCD at normal light level; (d) same region with high intensity; (e) horizontal profiles through 
sample at locations shown in (d); (f) vertical profiles; (g)-(j) images of masked region at gradually increasing light 
levels — note how the portion of the image containing a signal gets wider and then exhibits the same behaviour as 
seen in (b).
5.7.2 Blooming
In implementing the extended dynamic range method, we expected to encounter the problem 
of blooming of the CCD and Figure 5-15 (c) - (j) shows graphically how serious this can be. 
When the CCD receives a light signal that is too high, i.e., too many photons are incident on a 
given pixel on the chip, the signal output saturates and the charge-accumulating well 
“overflows”. Photo-electrons are detected in adjacent wells (pixels). Although the method 
described above expects the saturation, the corruption of data in the pixels surrounding the 
saturated region is a problem. Furthermore, in extreme cases the output amplification stage of 
the camera may be overloaded causing complete breakdown and zero recorded signal, as 
illustrated in Figure 5-15 (b). The solution is straightforward for this experiment, with its 
simple cylindrical geometry; in the second set of projection images we simply masked the 
regions in which signal overflowed — but this would not be possible in the general case and 
this would limit severely the application of this method in the general case (Figure 5-16 (b)).
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Figure 5-16: (a) projection image at normal light field intensity (P,); (b) masked projection image at high light 
intensity of blue-dye filled phantom (P2); (c) Composite projections (PCOmp) pixel-by-pixel, using data from P,, 
wherever the signal is above a pre-determined threshold (related to the dark current) and suitably scaled data from 
P2 where the data fall below this threshold.
An independent measurement of the optical density value of the neutral density filter 
was performed by filling the scanning tank with de-ionized water and increasing the light 
intensity until the detected signal was just below saturation level. A single projection was 
taken and then a reflective neutral density filter (Edmund Optics NT43-815) of nominal 
absorption 1.0 and tolerance ± 5% was placed in front of the LED, and another projection was 
taken. The experimental optical density was 0.95165 (SD = 0.005, SEM = 5x1 CT5). This was 
used to correct the data in Figure 5-15 and it should be noted that there are no adjustable 
parameters in the scaling between the overlying red and green lines. The increase in light 
intensity leads to data that have higher signal-to-noise, as expected. However, the data 
demonstrate categorically that our hypothesis concerning the cause of our incorrect 
measurement of high absorbance values is incorrect.
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Figure 5-17: Data obtained from high light intensity image. Notice how this overlays the low intensity data 
exactly, but has higher SNR, just as expected [123], The deviation from the theoretical value remains unexplained.
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5.7.3 Effects of changing the field-of-view on transmission profiles
In this experiment, we were testing for scatter as a probable reason behind the ‘cupping’ 
artefact seen with highly absorbing phantom in Figure 5-13 (c). Jordan et al. [156] reported 
that unlike laser-based optical scanners, cone-beam optical CT scanners limited by low angle 
forward scattered light contaminating signals on nearby CCD detector pixels and devised four 
methods of scatter measurement. Here, we examine and quantify the scatter fraction 
(scatter/total signal) for both media using another approach with our parallel-beam optical-CT 
where our scanning tank’s entrance window is masked with pieces of black cardboard paper 
of varying rectangular regions. In an absorbing medium, scattered light would in effect cause 
an increase in the signal reaching the CCD detector.
Single projections of 260 jil blue food colourant mixed with 300 ml of de-ionized 
water, and single projections of 2 ml Dettol™ antiseptic liquid mixed with 300 ml of de­
ionized water at minimum detectable signal (normal light field intensity) with varying field 
sizes were acquired. Figure 5-18 shows absorbance profiles across the same horizontal line in 
the uniform cylinder with gradually decreasing fields-of-view for both media.
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Figure 5-18: absorbance line profiles of diluted blue food colourant against with field sizes of 100mm(w) x 43mm 
(—■), 100mm (w) x 35mm (—-), 100mm (w) x 20mm ( -), 100mm (w) x 5mm ( ), and 30mm (w)x 5mm(—■); (b) 
absorbance line profiles of diluted light scattering Dettol™ against varying fields-of-view, 100mm (w) x 48mm 
(—■), 100mm (w) x 40mm (—-), 100mm (w) x 20mm ( ), 100mm (w) x 50mm ( ) and 30mm (w) x 5mm (—•).
The calculated mean optical absorbance for a rectangular region-of-interest (~ 240 
pixels) of the blue food colourant and Dettol™ antiseptic liquid in the relevant slice are 
plotted in Figure 5-19. The results for the non-scattering, absorbing medium show that as we 
decrease the field size, getting closer to a collimated beam (comparable to the laser optical- 
CT), the signal reaching the CCD detector decreases confirming that the signal has a ‘primary
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beam’ and a ‘scattered’ component but this increase in absorbance is not sufficient in 
magnitude. On the other hand, for a scattering medium the results were inconclusive.
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Figure 5-19: Mean absorbance ± SEM of diluted blue food colourant and light scattering Dettol™ against varying 
fields-of-view. Error bars are smaller than the size of the plot symbols.
5.8 Conclusion
We have reproduced an artefact very similar to that demonstrated in [147] using different 
apparatus. Analysis has shown that the incorrect image profile is not specific to a scattering 
sample but occurs in other cases where high absorbance values are incorrectly measured by 
the scanner. The hypothesis that the cause of the effect is an incorrect measurement of the 
dark current or unaccounted for ambient light has been proved to be incorrect. Masking large 
areas of the projection images of the two phantoms gave inconclusive results and the origin of 
the artefact remains unclear.
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6 Calibration protocol for three-dimensional 
PRESAGE™ dosimeter
6.1 Introduction
A primary goal of radiation dosimetry has long been the development of an accurate, precise 
and efficient system that is able to yield three-dimensional dose maps that are of sufficient 
accuracy, resolution and precision to allow verification of complex stereotactic radiosurgery 
deliveries. The potential of the PRESAGE™/optical-CT system as a practical, three- 
dimensional, dosimetric quality assurance tool has been recognized since 2004 [157]. 
Though, no measurable diffusion of the malachite green in the polyurethane was detected as 
long as the dosimeters were refrigerated at low temperature (2-5°C) and stored in the dark to 
prevent exposure to ultra-violet radiation post-irradiation whilst scanning, a decreased fading 
dose response overtime (~ 4 % per 24 hrs at 22°C) or bleaching effect was noted [115]. 
Different dosimeter formulation protocols yield dosimeters with varying radiochromic 
characteristics affecting their temporal stability. To avoid this, Oldham et al. [158] has 
presented a method of calibrating gel dosimeters which has intrinsically higher accuracy than 
current methods. Another approach proposed by De Jean et al. [21] provides a calibration 
protocol in which a standard distribution is irradiated in the same phantom thus establishing a 
dose conversion for each phantom. In this chapter, the aim was to both calibrate our in-house 
Optical-CT using the latter method, thus creating a dose map for a particular batch with 
specific dose sensitivity and at the same time irradiate the sample with a number of 
unmodulated and modulated proton beams for a complete quantitative measurement. A 
methodological difficulty arose in accurate positioning of our dosimeters which encouraged 
us to fabricate a calibration jig to improve the reproducibility and accuracy of the optical 
approach.
6.2 X-ray calibration pattern
Although the effective Z  number of PRESAGE™ = 9.33, which is close to that required for 
tissue equivalent dosimetry (Z e f fmuscie = 7.46, Z e f fwater= 7.42 [159]), the physical and electron 
density (p= 1.08gcm'3) is far greater than that of tissue equivalence (p Water= 1-00 gem'3, p muscie
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= 1.04 gem'3 [159]) causing a shift in the percentage depth dose profile according to the 
expression Rm atenai = R waterx (p w ate /p m ateria l) [160]. The purpose of this experiment was (a) to 
generate the percentage dose distribution of a 6 MV external beam in PRESAGE™ 
examining the exponential fall-off in the percentage depth dose along the dosimeter’s z-axis 
(~ 40 mm), and (b) to test which multiple-field x-ray dose distribution would provide a 
reproducible and accurate calibration protocol for our in-house optical-CT.
In order to obtain a complete percentage depth dose curve, more samples are required 
as a typical range in water for a 6 MV x-ray beam is more than 30 cm whereas our sample 
was 6 cm in length.
6.2.1 Methods and materials
Two PRESAGE™ dosimeters moulded from the same batch (number 158, Heuris Pharma 
LLC, Skillman, NJ) in the form of cylinders of diameter 60 mm and height 60 mm were used 
for irradiation at the Royal Surrey County Hospital in Guildford, Surrey. The external beam 
unit was a Clinac® 600 C/D (Varian Medical Systems, Inc.) with nominal beam energy of 6 
MV and (the depth of maximum dose) at approximately 15 mm.
The first dosimeter was irradiated seven times with l x l  cm2 open square fields (SSD 
100 cm) with a 5 mm gap between each square field to minimise contaminant cross-scattered 
dose (Figure 6-2 (a)). The square fields were placed 10 mm away from the sample edge to 
ensure that artifacts due to refractive index mismatch between the dosimeter and matching 
liquid do not obscure the collected data. Several plates of solid water phantom of 15 mm 
thickness were placed on top of the dosimeter such that is reached at the surface of the 
dosimeter to establish secondary charged particle equilibrium, noting that the build up region 
has a very steep percentage depth dose gradient to D^x with most therapy beams reaching at 
least 90% of their Dmax dose within 1 cm of the surface. The dosimeter was exposed to 
nominal doses of 1, 3, 6, 9, 12, 15 and 18 Gy specified at an SSD = 100 cm. Note that there 
was an uncertainty in the prescribed monitor units (1 Gy = 125 MU) as the % PDDs and beam 
output factors were only available for field sizes from 4 x 4 to 40 x 40 cm2 (Figure 6-1 (a)) 
and 3 x 3 to 40 x 40 cm2 (Figure 6-1 (b)), respectively. The monitor units for 1 x 1 cm2 square 
field was calculated by fitting the data with fifth-order polynomial (1 Gy = 116.6 MU for an 
output factor of 0.858 extrapolated from Figure 6-1 (b)) and the relative error was equal to + 
7.3 %.
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Figure 6-1: (a) Percentage depth doses for field sizes 4 cm x 4 cm ( ), 10 cm x 10 cm (—), and 20 cm x 20 cm 
(—) and (b) output factors for field sizes 3 cm x 3 cm to 40 cm x40 cm of the Clinac® 2100 C from St. Luke’s 
Cancer Centre at Royal Surrey County hospital (RSCH) fitted with fifth-order polynomial.
For the second dosimeter, the linear accelerator head was rotated to a gantry angle of 
90 degrees, and the collimator jaws were set to square field of 1 x 1 cm2 at SSD = 100cm 
(Figure 6-2 (b)). The PRESAGE™ dosimeter was placed inside a 7 mm Perspex insert (p = 
1.17 g/cm3) with an equivalent path length of 0.819 g/cm2to shift the percentage depth dose 
in such a way so that our dose profiles are beyond Dmx with minimum uncertainty to the 
measured dose response profiles. The idea is to get some sort of a uniform dose gradient for 
our analysis. Two planes of varying dose points were irradiated separated by a gap of 1.5 cm 
from each central axis point, again to minimise contaminant cross-scattered dose. In the first 
plane, the dosimeter was irradiated twice with estimated doses of 1 and 2 Gy with 
approximately a 15 mm offset from the central axes of the square fields with source surface 
distance 100 cm adjusted accordingly. Then the dosimeter was rotated 90 degrees and 
irradiated twice to estimated doses of 3 and 6 Gy specified at 100 SSD. Similarly, the second 
plane was irradiated four times with estimated doses of 5, 7, 10 and 11 Gy specified at 100
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Figure 6-2: (a) Experiment set-up of (a) first sample, (b) schematic diagram of PRESAGE™ surrounded by 
Perspex insert, and (c) second sample irradiated with lx l  cm2 square fields using 6 MV photon beam (Clinac® 
600 C/D ,Varian Medical Systems, Inc.).
6.2.2 Data acquisition
For this experiment, the scanning tank mentioned in [10] was replaced by a large glass cell 
(700-0620G, Hellma Optik, Jena, Germany) of an optical light path approximately equivalent 
to 65 +/- 0.5 mm (Figure 6-3). The inner dimensions, according to the manufacturer, were 
about 88mm (H) x 130mm (W) x 65 mm (D). The rotation stage (PRS-110, MICOS GmbH, 
Germany) is also stepper motor driven, and is placed above the optical glass cell. The 
dosimeter is attached to the rod linked to the rotation stage and immersed in the matching 
liquid (mixture of diallyl-phthalate and dibutyl-phthalate) in the glass cell.
In the first sample, 400 raw projection images of dimension 256 x 256 were acquired 
with no averaging. These were reconstructed onto square matrices of 256 x 256 pixels, giving 
an in-plane nominal pixel resolution of (0.31) mm2 and slice thickness of 0.31mm. The scan
Perspex insert
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time was approximately 20-25 minutes for each sample (~ 20 projections per minute). In the 
second sample, 400 raw projection images of dimension 256 x 256 were acquired with no 
averaging. These were reconstructed onto square matrices of 256 x 256 pixels, giving an in­
plane nominal pixel resolution of (0.26) mm2 and slice thickness of 0.26mm.
Figure 6-3: Optical-CT scanner with (1) LED light source, (2) collimating lens (Ld, PRS-110 MICOS rotation 
stage with sample holder, (4) Hellma glass cell and Micos rotation stage, and (5) focusing lens (L2).
6.2.3 Results and Discussion
Figure 6-4 shows a loss in collected data (~ 30 pixels) at the interface between the 
PRESAGE™ sample and the matching medium which would require a correction factor to 
improve the scanning and reconstruction procedures. Figure 6-5 shows a single axial slice 
through the 3-D image of irradiated dosimeter and the resultant percentage depth dose of the 
x-ray beam along its z-axis (or depth). Each point on the curve represents the mean value of a 
rectangular region (~ 125 pixels) in the relevant slice. The region of averaging was chosen 
such that the beam penumbra (i.e. distance over which the dose falls from 80% to 20% of the 
central axis dose (Figure 6-6)), is avoided, thus minimising the dose variation across the field 
width. Averaging starting from pixel number 60 to 185 which is the viable scan area. The 
uncertainty was assigned using basic standard error theory where the standard deviation is 
defined as the root mean square (RMS) deviation of values from the arithmetic mean of the 
relevant slice. Prior to irradiation the dosimeter appeared to be visually clear with minor 
imperfections, but after scanning all the imperfections were quite visible as seen in Figure
6-5. This is probably caused by slight variations in the refractive index of the polymer, 
causing light to be refracted away from a parallel path (so-called schliere artefacts). Although 
smoother images are obtainable with a variety of smoothing algorithms, the use of such 
numerical filtering is to be restricted if the strict RTAP criteria are to be met. Whilst they
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reduce the noise in the image, smoothing algorithms also reduce spatial accuracy and the 
resolution in certain regions of steep gradients.
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Figure 6-4: (a) A line profile across the first dosimeter demonstrating a signal loss in the collected data (~ 30 
pixels) at the dosimeter and matching medium interface.
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Figure 6-5: (a) The percentage depth dose of 6 MV x-ray beam, 1 cm x 1 cm irradiated with estimated doses of 1, 
3, 6, 9, 12, 15 and 18 Gy with the reconstructed 3-D image of the irradiated sample (inset).
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Figure 6-6: Dose Profile curve across x-axis (°) and y-axis («) of x-ray beam irradiated with 18 Gy, SSD 100 cm, 
field size 1 cm x 1 cm, and depth in PRESAGE™ 12.5 mm from dosimeter front surface.
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Figure 6-7: Mean value of optical density ±  SEM of pixel number 5 (9.1 mm from dosimeter front surface) and 
pixel number 130 (41.6 mm from dosimeter front surface) showing the difference in % DD along z-axis and the 
mean value of optical density ± SEM at the same pixel number 38 days later. Error bars are smaller than the size of 
the plot symbols.
Figure 6-7 shows the initial result of calibration for the first sample irradiated 
with a 6 MV photon beam, 9.1 mm from the surface of the dosimeter and 41.6 mm deep. The 
mean of the pixel values was calculated for a rectangular region (~ 120 pixels) in the relevant
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slice and plotted ± SEM. The uncertainty in the gradient at 9.1 mm, m = (3.00 ± 0.07)xl0~4 
Gy and y-intercept, b = (-8.89 ± 0.67) xlO'4 OD, and at 41.6 mm, m = (2.18 ± 0.04)xl0~4 Gy 
and y-intercept, b = (-8.93 ± 0.42) x l O4 OD. The calibration curve suggests that the 
dosimeter responds linearly to increasing dose but as the central axis percentage depth dose 
decreases with depth as expected (Figure 6-1), the optical density varies up to 15% across the 
dosimeter’s length but has no significance at low doses (< 1 Gy). A likely cause is that at low 
doses, not enough energy is deposited for oxidation to occur, rendering the radiochromic 
change incomplete.
The dosimeter was kept refrigerated (~ 5°C) and at 38 days post-irradiation, the 
optical density of the dosimeter was measured again (400 raw projection images of dimension 
128 x 128 were acquired with no averaging). The author gratefully acknowledges the help of 
Dr. N. Krstajic in making these measurements.
The optical densities are plotted in Figure 6-7. The mean of the pixel values was 
calculated for a rectangular region (~ 45 pixels) in the relevant slice and plotted ± SEM. The 
rate of colour fading averages 56% over that period (~ 1.5% per day) for both slopes at 
different positions along the z-axis for all the doses.
Figure 6-8 shows a calibration irradiation for a 6 MV photon beam with doses 
ranging from 1-8 Gy in the first plane, and doses ranging from 5-21 Gy in the second plane. A 
program was written in IDF that calculates the mean of the pixel values in a rectangular 
region in the relevant slice, the penumbra effect from overlaying two planes on top of each 
other was taken into account. However, the dose response of the dosimeter was not linear at 
the circular regions where there was no dose overlap (the expected exponential dose fall-off 
was not observed). This could be due to the fact that the geometry of irradiated beams was far 
too close to each other causing inaccurate measured calibration curve.
a b
Figure 6-8: Calibration curve in the (a) first plane irradiated with doses ranging from 1-8 Gy in the first plane, and 
(b) second plane with doses ranging from 5-21 Gy.
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The experiment was then repeated, following the defined geometry initially proposed 
by [21] where a PRESAGE™ dosimeter (Batch# 180) was irradiated with a nominal beam of 
energy equal to 6 MV (Dmax = 1 5  mm) with a gantry angle of 90° at the Royal Marsden 
Hospital in Sutton, Surrey. The dosimeter was orientated to achieve a well defined equilateral 
triangular dose distribution with estimated doses ranging from 0.5 to 9 Gy. The PRESAGE™ 
dosimeter was immersed in a water phantom; this shifts the percentage depth dose in such a 
way so that our dose profiles are beyond Dmax with minimum effect to our measurements 
giving a uniform dose gradient for our analysis. Here, two planes of varying dose points were 
irradiated in the dosimeter and were separated by a gap of 2 cm from each central axis point. 
The first plane was irradiated three times with estimated doses of 0.5, 1, and 2 Gy specified at 
100 SSD. The second plane was irradiated three times with estimated doses of 2, 4, and 5 Gy 
specified at 100 SSD. The measured linearity of the dose response proved to be much better 
with this geometry (Figure 6-9). Again, all the imperfections in our dosimeter were quite 
visible post-irradiation which prompted us to apply the correction scan in section 6.4.
The author gratefully acknowledges the help of Dr. S J Doran in making these 
measurements.
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Figure 6-9: (a) R esults o f  the linearity  o f  the sam ple versus dose; (b) A calibration  d istribution  consisting  o f  three 
pencil x-ray beam s with different doses p roducing a  well defined dose pattern.
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6.3 Photon and proton calibration pattern
In  th is study, one PRESAGE™  dosim eter (Batch #  173), 60mm in  diam eter and height was 
irradiated to  test the app licab ility  o f irrad ia ting  PRESAGE™  w ith  both a 3-D  proton volum e 
and x-ray ca lib ra tion  pattern sim ultaneously. F irs t, the dosim eter was irradiated w ith  a beam
energy o f 62 M eV  at the proton beam fa c ility  o f the Douglas C yclotron, at the C latterbridge
Centre fo r O ncology (W irra l, Merseyside, U K ), but the experim ent had to  be executed in  
d iffe ren t locations; thus, the irrad iations were carried out in  tw o phases. Four days post­
proton irrad ia tion , the dosimeter was irradiated w ith  the above mentioned x-ray ca lib ra tion  
pattern separated from  the proton dose d istribu tion  causing uncerta inty in  the obtained 
ca lib ra tion  curves.
6.3.1 Materials and methods
In  the firs t phase, the sample was irradiated seven tim es, using both unm odulated beam and 
range-modulated proton beams (SOBP), co llim ated to  a 12 mm diam eter c ircu la r cross- 
section. The sample was exposed to estimated doses o f 2, 6 and 8 G y specified at the entrance 
fo r the unm odulated beam, and estimated doses o f 4, 12, 20 and 28 G y fo r the SOBP. The 
average dose rate was about 15 G y/m in. A fte r irrad ia tion  the sample was stored in  the 
re frigera tor fo r 72 hrs.
In  the second phase, the same sample was irradiated w ith  three pencil beams 15 mm 
away from  the irradiated 3-D  proton volum e at the R oyal Surrey County H osp ita l in  
G u ild fo rd , Surrey. A  nom inal beam o f energy equal to 6 M V  was used prescribed at the depth 
o f m axim um  dose, co llim ated to 10 mm square fie lds at 100 SSD w ith  estimated doses o f 2, 
8, and 12 Gy. The PRESAGE™  sample was placed on the treatm ent table w ith  the gantry at 
90° and surrounded w ith  15 mm bolus (tissue-equivalent m aterial) to  sh ift the percentage 
depth dose, thus creating a un ifo rm  dose gradient fo r our analysis. The dose rate was about 
400 M U /m in . A fte r irrad ia tion  the sample was stored in  the refrigera to r, and the optica l 
scanning was perform ed approxim ately 24 hrs a fter irrad ia tion.
6.3.2 Data acquisition
800 raw  pro jection images o f dim ension 256 x  256 were acquired w ith  no signal averages, 
over a period o f 1 h r and 20 m inutes. These were reconstructed onto square m atrices o f 256 x
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256 pixels, giving an in-plane nominal pixel resolution of (0.27 x 0.27) mm2 and slice 
thickness of 0.27 mm.
6.3.3 Results
The ratio of the Bragg peak to the plateau region in our experiment is approximately 2:1 
whereas the true measured ratio at CCO is approximately 4.5:1. For the range-modulated 
proton beams, the absorbed dose close to the end of the proton range, i.e. at the Bragg peak, is 
underestimated by approximately 20% compared to the diode measurement (Figure 6-10 (a)). 
The dose response was investigated at the plateau region for the pure Bragg peak and the 
anterior part of the SOBP as the LET of the proton beams is low at those regions, and thus 
possible LET dependence would not influence the dose response. The dose response 
measured exhibited an approximately linear correlation with absorbed dose for the 
investigated range of doses for the protons, and photons (Figure 6-10 (b)).
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Figure 6-10: (a) V ertical profiles through the 7 circular regions, dem onstrating  bo th  B ragg peak  (red profiles) and 
m odulated (blue profiles) irradiations. Inset: cross-sectional im age o f  the phan tom  w ith 7 irrad iated  reg ions. Each 
po in t on the curves corresponds to the m ean value o f  the relevan t R O I evaluated  in the re levan t slice; (b) a 
calibration  distribution  consisting  o f  three pencil x-ray beam s w ith d ifferen t doses producing  a  w ell defined  dose 
pattern. T he m ain graph illustrates the calibration  curves o f  6 M V  x-ray beam  ( ), 62 M eV  SB P pro ton  beam  at 
entrance (■), at B ragg peak  (■), and 62 M eV  m odulated  p roton beam  (■) w hile the inset show s a cross-sectional 
im age o f the x-ray calibration  pattern. E rror bars are sm aller than the size o f  the p lo t sym bols.
Ideally, we would hope that the low LET region of the proton irradiation (i.e., the 
entrance dose in the Bragg peak irradiation) would expose the dosimeter in the same way as 
the x-ray irradiation. Thus we would expect the calibration plots to have approximately the 
same gradient. This is indeed the case, notice that the point of the x-ray calibration with the 
highest dose lies well off the line and appears to be an outlier. If this is removed, the gradients 
are very similar.
We would expect that the calibration of the SOBP irradiations to have a very similar 
gradient to the Bragg peak irradiations, because the point at which the optical density values 
are recorded is at the proximal (left) end of Figure 6-10 (a) and, here, the SOBP irradiation 
consists primarily of low LET contributions. Again this proves to be the case.
Finally, we would expect the gradient of the calibration made at the Bragg peak to be 
significantly lower than that of the entrance dose calibration. Data for this calibration are 
taken from the red line in Figure 6-10 (a). The dose values on the x-axis are estimated by
196
multiplying the entrance dose by 4.5 (see Figure 3-6). The ratio between the gradient of the 
entrance calibration and the Bragg calibration should be approximately the same as the ratio 
between the Bragg peak height given by the CCO diode measurement and the optical CT 
measurement (as discussed in Sec. 3.6.1). However, the ratio of the gradients was about 1.66 
instead of the expected 2.4 (4.5/1.9) as only 3 points were available for generating the 
entrance calibration.
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Figure 6-10 (c) C orrected  dose response curves o f  62 M eV  SB P proton beam  at en trance (■), at B ragg  peak  (■), 
and 62 M eV  m odulated  proton beam  (■) com pared to calibration  curves o f 6 M V  x-ray b eam  ( ).E rror bars are 
sm aller than the size o f  the p lo t sym bols.
The dose response curves of the single Bragg peak (SBP) and modulated proton beam 
were corrected for the fading dose response overtime by approximately 6% (measured ~ 1.5% 
per 24 hrs in Figure 6-7). The corrected dose responses of the entrance region of the SBP and 
the modulated proton peak show a better overlap with the x-ray calibration curve (Figure 6-10
(c)).
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6.4 O ptical C om puted T om ography (CT) dose calibration
6.4.1 M aterials and m ethods
This experiment was performed using a jig fabricated at the Royal Surrey County Hospital, 
Guildford, Surrey with a standard PRESAGE™ holder with Perspex insert as build-up 
material where R m a t e r i a i =  15 mm x (1.00g/cm3/1.17 g/cm3) = 12.8 mm), and a Clinac® linear 
accelerator couch top extension (Figure 6-11). This jig provides a more practical solution to 
irradiating PRESAGE™ with both a 3-D proton treatment volume and x-ray calibration 
pattern simultaneously which would create a dose map for any sample with specific dose 
sensitivity.
Figure 6-11: P R E SA G E ™  calibration  jig  w ith  Perspex holder.
Prior to scanning, the samples were surrounded by a non-toxic matching medium (n =
1.504) composed of 10% Octyl Methoxycinnamate (CHEMOS, GmbH, CAS no. 83834-59-7) 
and 90% Octyl Salicylate (Sigma-Aldrich, W14500) with a few drops of an oil-based green 
dye added in order to maximise the dynamic range of the scanner. A correction scan was 
performed using the unirradiated sample projections as the light field L(x,y).
Two PRESAGE™ dosimeters 60mm in diameter and 75 mm in height were 
machined to fit the MICOS sample holder which reduced the actual height to 65 mm and 
were irradiated with a nominal beam of energy equal to 6 MV (Dmax = 1 5  mm). For the first 
dosimeter, the collimator jaws were set to square field of 1 x 1 cm2 at SSD= 100cm and the 
linear accelerator head was rotated to a gantry angles 340, 20 and 90 degrees to achieve the 
triangular dose pattern. Three planes of varying dose points were irradiated in the dosimeter
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and were separated by a gap o f 20 mm from  each central axis po in t (Figure 6-12 (a)-inset). 
The firs t plane was irradiated three tim es w ith  estimated doses o f 0.5, 1, and 2.5 specified at 
100 SSD. The second plane was irradiated three tim es w ith  estimated doses o f 4, 8, and 10 Gy 
specified at 100 SSD. The th ird  plane was irradiated three tim es w ith  estimated doses o f 2, 5, 
and 15 G y specified at 100 SSD (Figure 6-12 (b)).
The second dosimeter was irradiated seven tim es w ith  ve rtica l l x l  cm2 open square 
fie lds w ith  estimated doses o f 0.5, 1, 2, 4, 6, 10 and 15 G y specified at an SSD= 100 cm  
(Figure 6-13). No bu ild -up  was added on top o f the second dosimeter.
6.4.2 Data acquisition
The 1 mm diam eter LE D  lig h t source (part num ber L X H L-M D 1 D , Luxeon Star, 1W , red, 
Lum ileds, C a lifo rn ia , U .S .A ) was replaced by a un ifo rm  red LE D  backligh t (P H LO X -LE D R - 
B L-20X20-S-Q -1R -24V , 60 m A ) w ith  a higher lum inescence > 3000 cd/m 2 (~ 100W ) to  
ensure that the num erical aperture o f focusing optics is matched by num erical aperture o f 
illu m in a tio n  m aking the apparatus less sensitive to  schliere. 800 raw  pro jection images o f 
dim ension 256 x  256 were acquired w ith  no signal averages, over a period o f 40 m inutes. 
These were reconstructed onto square m atrices o f 256 x  256 pixe ls, g iv ing  an in-plane 
nom inal p ixe l resolution o f (0.27 x  0.27) mm2 and slice thickness o f 0.27 mm.
6.4.3 Results
Figure 6 - 1 2  (a) shows the ca lib ra tion  curve fo r the 6  M V  photon beam w ith  doses ranging 
from  0 .8 8 - 1 7  Gy. The mean o f the p ixe l values in  a c ircu la r region o f interest in  the relevant 
slice ±  SEM was calculated at d iffe ren t depths fo r each pencil beam iden tified  by the circles 
in  F igure 6 - 1 2  (b). Estim ated doses at these depths were calculated by measuring the distance 
from  the beam entrance at the surface o f PRESAGE™  to  the centre o f the c ircu la r region o f 
interest in  m illim etres (1  p ixe l = 0 .2 7  mm) and m u ltip ly in g  the nom inal doses w ith  a 
correction facto r = [ O D depth in m m /O DDmax (~7 mm)] obtained from  F igure 6 - 1 3 ,  and from  that the 
actual optica l CT values were p lotted against dose. The uncerta inty in  the gradient, m = ( 3 .3 4  
±  0 .1  ^ x lO "4 Gy and y-in tercept, b = ( 6 .0 3  ±  0 .7 5 )  xlO "4 O D . As expected, the dose response 
o f the dosimeter is not linear at doses < 1 G y as optica l values defined inside the region o f 
interest w ill not vary w ith  depth as shown in  F igure 6 - 1 3  (the dose response p lotted d id  not 
include the firs t 2 0  pixe ls (~ 5  mm) to exclude the w a ll effects).
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Figure 6-12: (a) R esults o f the linearity  o f  attenuation  coeffic ients in the sam ple at dose p lane  1 ( • ) ,  dose p lane  2 
( 0 ,  and dose p lane 3 (-) versus dose; (b) A  calibration  d istribution  consisting  o f three pencil x-ray beam s w ith 
d ifferent doses producing  a w ell defined dose pattern. E rror bars are sm aller than  the size o f  the p lo t sym bols.
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Figure 6-13: T he percentage depth dose o f  6 M V  x-ray beam , 1 cm x  1 cm  irradiated  w ith estim ated  doses o f  0.5, 
1, 2, 4, 6, 10 and 15 G y w ith the reconstructed  3-D  im age o f  the irradiated sam ple (inset).
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Figure 6-14 shows the calibration curve for the PRESAGE™ sample irradiated with 
the seven vertical 6 MV x-ray beams (Figure 6 -13-Inset) with nominal doses ranging from 0.5 
to 15 Gy specified at Dmax. The gradient of this curve should theoretically match the curve 
measured in Figure 6-12 as the estimated doses were inferred from Figure 6-13 but the 
calculated gradient from the fitted trendline in Figure 6-12 (a) is lower than the one calculated 
in the above figure. This is due to the fact that the calculated gradient in Figure 6-12 includes 
the three dose planes and we know that PRESAGE™ is less sensitive at doses < 1 Gy causing 
an uncertainty in our measurements of the accumulated dose in the first dose plane, e.g. the 
calculated gradient in that plane is 5.25 x 10'4 as opposed to the overall 3.34 x 10‘4 giving rise 
to a relative error of approximately -14 % from the expected dose response in Figure 6-14.
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Figure 6-14: C alibration  curve o f  nom inal doses versus optical-C T  value ±  SEM  o f  figure 6-13. E rro r bars are 
sm aller than the size o f  the p lo t sym bols.
6.5 Conclusion
The excellent quality of 3-D dose measurement that was achieved with the 
PRESAGE™/Optical-CT system after applying correction scans pre-irradiation accounting 
for optical non-uniformity due to imperfections in PRESAGE™ and replacing the old LED 
light source reducing ring artefacts supports its viability as a clinical 3-D dosimetry tool. In 
addition, the calibration protocol proposed by De Jean et al in DOSGEL 2006 establishes a
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practical dose conversion to o l fo r our samples. In  particu lar, th is chapter has shown how both 
a ca lib ra tion  and test irrad ia tion  may be included in  the same sample.
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7 Overall conclusions and outlook
Contem porary rad ia tion therapy techniques (e.g., in tensity modulated rad ia tion therapy 
(IM R T ), image-guided rad ia tion therapy (IG R T), proton and heavy-ion therapy, and 
brachytherapy) are becom ing increasingly com plex and sophisticated requ iring  an accurate 
and practical 3-D  dosimeter. Current dose ve rifica tio n  systems inc lud ing  ion  chambers, film , 
and diode arrays, etc. are insu ffic ien t as a tru ly  comprehensive and convenient dose 
measurement in  three dimensions. ‘Gel dosim etry’ o r more accurately 3-D  rad ia tion 
dosim etry is considered to be a prom ising, e ffic ien t, re liab le, and comprehensive three- 
dim ensional dosim etry system consisting o f tw o essential components: (a) a 3-D  
radiosensitive dosim eter (e.g., polym er gels [161], F ricke gels [145], or PRESAGE™  [109]) 
and (b) a dose-readout m odality (e.g., m agnetic resonance im aging (M R I) [6 ], ultrasound 
[107], x-ray computed tom ography (C T) [106] and optica l-C T  [7 ]) w ith  spatial resolution o f 
order 1 mm fo r teletherapy [1 4 ,1 5 ] and 0.2 mm fo r brachytherapy [16].
A  novel 3-D  dosim eter system com prising a light-absorbing leuco-dye doped p lastic 
3-D  dosim eter (PRESAGE™ ) and an in-house parallel-beam  CCD-based optica l computed 
tom ography (C T) scanner has shown considerable potentia l fo r radiotherapy applications 
[157].
The prim ary objective o f th is PhD study was to irradiate  PRESAGE™  dosimeters 
w ith  heavy charged particles (HCPs) and investigate the im pact o f the high ion iza tion  density 
on the optica l dose response. Furtherm ore, to  have a better understanding o f three- 
dim ensional measurements o f rad ia tion induced changes in  optica l density (O D ) the optica l 
behaviour o f light-absorbing radiochrom ic dosimeters has to  be studied ca re fu lly. This 
enables us to  distinguish optica l artefacts from  genuine effects resulting from  rad ia tion- 
induced dose-dependent polym erization in  the so lid  dosimeter, and any non linearities in  the 
dose versus optica l extinction  response. A  cy lind rica l phantom, containing e ither absorbing or 
scattering m odel systems was designed to fa c ilita te  accurate three-dim ensional optica l readout 
o f un ifo rm  optica l densities and to generate known baseline conditions that could be used to 
v e rify  the performance o f the scanner. The c lin ica l potentia l o f the PRESAG E™ /parallel 
beam optica l-C T  system as a practical, three-dim ensional, dosim etric qua lity  assurance to o l o f 
su ffic ien t accuracy, resolution and precision has been then investigated.
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7.1 E ffects o f  ion isation  density
The resultant reconstructed images o f PRESAGE™  irradiated w ith  protons w ith  an in itia l 
energy o f 62 M eV  show excellent properties fo r 3-D  scanning (Figure 3-9 (b )), but currently 
PRESAGE™  does not fa ith fu lly  reproduce the varia tion  o f absorbed dose at the Bragg peak 
confirm ing  a dependence on LE T  fo r the proton beams. For an unm odulated Bragg peak 
(Figure 3-6), the ra tio  o f the Bragg peak dose to  the entrance dose in  our PRESAGE™  sample 
is approxim ately 2:1 as opposed to 4.5:1, the measured ra tio  at C latterbridge Centre fo r 
O ncology, a 60% under-estim ate. F igure 3-8 shows that, fo r the range-m odulated proton 
beam (SOBP), the absorbed dose close to  the end o f the proton range (i.e. the Bragg peak) is 
underestimated by approxim ately 20% compared to  the corresponding diode measurement 
due to PRESAGE™  dosim eter having a d iffe ren t response at d iffe ren t LE T  values (i.e ., 
although linear, the gradient o f a graph such as Figure 3-5 is progressively reduced at h igh- 
LE T ). Gustavsson et al. [17] reported an under-estim ate o f approxim ately 20% in  the 
absorbed dose at the end o f the Bragg peak o f a 133 M eV  unm odulated beam w ith  TH P 
polym er gel compared to  the diode measurements and Jirasek et al. [19] reported a re la tive  
effectiveness (proton beam gel measurement compared to photon beam measurements) o f 0.3 
at the end o f a 74 M eV  spread out Bragg peak (SOPB).
The ca lib ra tion  curve in  F igure 3-5 demonstrates fo r the PRESAGE™  samples 
irradiated w ith  a 60 M eV  proton beam that the onset o f radiation-induced saturation occurs at 
the Bragg peak before optica l saturation such that the upper lim it on the dynam ic range o f the 
optica l-C T  is set by the saturation o f radiation-induced oxidation, rather than by op tica l 
saturation effects.
In  order to  c la rify  the cause o f th is under-response and to  understand the e ffect o f 
LE T  on PRESAGE™ , a part theoretica l/ part em pirica l m odel known as track structure theory 
(TST) in itia lly  introduced by Katz in  the late 1960s attempts to  understand the pattern o f dose 
deposition that leads to  activation o f the chosen dosim eter by the relevant physico-chem ical 
events (e.g., the development o f co lour in  a PRESAGE™  leuco dye m olecule); however, 
other effects such as kinetics o f rad ica l form ation, rad ica l-radical interactions, and rad ia tion- 
induced destruction o f latent event sites, are not incorporated in to  the m odel. In  spite o f 
several sim p lifica tions made to ease calculations the experim ental and theoretical results o f 
re lative  effectiveness o f PRESAGE™  at the entrance and Bragg peak regions o f an 
unm odulated Bragg peak are in  good agreement using th is m odel showing that TST could 
qua lita tive ly  account fo r a ll the m ain features o f the experim ental proton data.
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Therefore, we conclude that PRESAGE™  in  its  current fo rm  is not a very suitable 
m aterial fo r re la tive  dosim etry o f HCPs i f  one wishes a dose response that in  general is 
independent o f LE T  effects. This illum inates the d iffic u lty  in  extracting a quantita tive dose 
map fo r PRESAGE™  irradiated w ith  HCPs in  general.
V irtu a lly  a ll lite ra ture  concerning proton o r ion  dosim etry has demonstrated an under­
response in  the Bragg peak due to a s ign ifican t increase in  the LE T. This is attributed to  (a) 
decrease in  in itia tio n  o f polym erization as the interaction sites get close together and the ion  
clusters overlap and in ter-rad ica l recom bination o f free radicals is more probable e.g. polym er 
gels or (b) single h it theory i.e . saturation o f the sensitive site w ith  one ion isation, e.g. alanine, 
film , and currently PRESAGE™ , o r (c) Band structure m odel based on the conduction 
band/valence band m odels’ k ine tic  theory o f the transport o f charge carriers e.g. T L D  and 
OSL.
O ther dosimeters that have been investigated w ith  proton beams that d isp lay s im ila r 
LE T  dependence o f dose response w ith  h igh LE T  radiation are: (a) EBT and M D -V 2-55  
G afChrom ic film  s ign ifican tly  towards the end o f the proton range [162], (b) the re lative  
signal o f PTW  diamond detector is  18% low er than the M arkus IC  signal in  the Bragg peak 
region o f 60 M eV  proton beam at the CCO even though results reported by V a tn itsky 
investigating narrow  beams used in  proton stereotactic radiosurgery (PSRS) showed a good 
agreement between the dose d istribu tions along the beam central axis o f 126 M eV  
unm odulated proton beam obtained by the PTW  diamond detector compared the M arkus 
paralle l-p la te ion ization  chamber [163], and (c) crysta lline  alanine dosimeter w hich showed a 
s ign ifican t reduction o f the Bragg peak, both in  an unm odulated and a m odulated beam [164] 
even though the calculated reduction o f the response was larger than the one observed by a 
number o f other investigators who measured the depth dose d istributions w ith  both alanine 
pellets and film s  e.g. O nori et al. [165] who results showed agreement, w ith in  the 
experim ental uncertainties, between the M arkus ion ization  chamber and alanine doses, 
suggesting that alanine is energy independent down to the Bragg peak region and does not 
perturb the dose d is tribu tion  in  a tissue-equivalent phantom. M oreover, the Bragg curve and 
SOBP o f 190 M eV  therapeutic proton beams measured by the M OSFET dosim eter were 
estimated to  be 20-40%  low er than those measured by the IC  [166].
A  detector that has shown prom ise is  the H i-p  S i diode detector where no change in  
its  characteristics w ith  the accumulated absorbed dose was observed even a fte r h igh 
accumulated doses in  a 173 proton beam compared to N AC P plane-parallel ion isation  
chamber [167], however, th is detector does not constitute a three-dim ensional dosimeter.
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7.2 Optical scanning of light absorbing phantoms
The perform ance o f firs t generation optica l-C T  scanning systems, com m ercia lly available or 
otherw ise, is generally prom ising w ith  h igh resolution, h igh sensitiv ity  and low  noise being 
particu la rly  attractive features o f optica l-C T ; however, the m agnitude o f artefacts is not yet 
w e ll understood, and it  remains to  be seen what accuracy can be achieved in  dose resolution 
fo r irregu la r c lin ica l d istribu tions. There is a grow ing need to characterize the perform ance o f 
these systems and com patible 3-D  dosimeters, and more w ork is required to  develop 
techniques addressing and correcting m ost o f these issues.
O ptica l tom ography is com plicated by the re flection  and refraction o f lig h t rays in  the 
phantom m aterials, producing a b lin d  spot in  the transm ission p ro files w hich, results in  a 
s ign ifican t loss in  the reconstructed images. C orrection techniques to  m in im ize re flective  and 
refractive  w a ll artefacts have been proposed by Gore et a l., K e lly  et al. and Doran et a l. [7, 
112, 116]. W e investigated the e ffect o f m atching the refractive  indices o f the phantom ’ s 
container, m atching liq u id  and the medium , and applied a correction scan to  correct fo r a ll 
effects that m od ify the in tensity o f the pro jection, other than the radiation-induced changes. 
F igure 5-11 (c &  d) shows how  the correction scan not on ly corrects fo r the inhom ogeneity o f 
the lig h t fie ld , detector properties and im perfections in  the container but also lowers the w a ll 
artefacts considerably. This, in  addition to  a correct but not necessarily precise m atching o f 
the refractive  indices at the w a ll interface, helps to  s lig h tly  increase the usable fie ld -o f-v ie w  
but is s till lim ite d  in  the amount o f in form ation  that can be retrieved close to  the w alls o f the 
phantom.
W e also examined the “ d ishing”  artefact described by Bosi et al. at the 2006 
DO SG EL meeting [148], whether the e ffect is on ly inherent to  an o p tica lly  scattering 
medium, sim ulating radiation-exposed polym er gels, and whether it  is  relevant on ly to  cone- 
beam scanners. Analysis has shown that the incorrect image p ro file  is not specific to  a 
scattering sample but occurs in  other cases where high absorbance values are inco rrectly  
measured by the scanner. The hypothesis that the cause o f the e ffect is an incorrect 
measurement o f the dark current o r unaccounted fo r ambient lig h t and our attem pt to  correct 
fo r it  by increasing the dynam ic range has proved our hypothesis to  be incorrect (F igure 5-18) 
and the proposed correction method to be im practica l (.Blooming effect (F igure 5-15)). 
Another hypothesis that a scatter component is contam inating our prim ary signal proved 
inconclusive and the o rig in  o f the artefact remains unclear.
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Thus, a series o f experiments w ith  polym erizing PAG -type gels are required fo r a 
comparison o f the calculated extinction  coefficients o f the antiseptic-infused phantom  w ith  
those fo r irradiated PAG -type gels to  look at whether we obtain equivalent optica l 
perform ance between antiseptic concentration in  a phantom and an irradiated PAG -type gel. 
O ptica l M onte Carlo sim ulation o f a scattering m edium  is also very cruc ia l fo r a better 
understanding o f the behaviour o f para lle l beam optica l-C T  apparatus and lig h t scattering 
polym er gels.
7.3 6 MV x-ray calibration curve of PRESAGE™ with parallel 
beam Optical-CT apparatus
A pp ly ing  a correction scan reveals maps o f the changes in  optica l attenuation that were 
induced by the radiation. A lso , adding a few  drops o f green oil-based dye helps optim ize the 
dynam ic range o f measurement o f the scanner.
O ptical-C T  o f PRESAGE™  provides an inexpensive, safe, and convenient method 
fo r measuring three-dim ensional dose d istribu tions. In  addition, the optica l CT scanner 
images dose d istribu tions w ith  much better linea rity , accuracy, and rep roduc ib ility  and can be 
assembled at m in im al cost, avoiding the need fo r access to  a M R I scanner. Based on the dose 
response curve in  F igure 6-13 dose sensitiv ity  can easily be achieved at > 1 Gy.
The ca lib ra tion  protocol proposed by De Jean et a l in  DO SG EL 2006 [21] establishes 
a p ractical dose conversion to o l (F igure 6-12) fo r PRESAGE™ .
7.4 Future work
New form ulations o f PRESAGE™  need to be developed specifica lly  fo r proton beams and 
fu rthe r experiments w ith  proton beams at CCO need to  be undertaken to study w hich  batch 
w ould have the least under-response at the Bragg peak. W e already know  that the activation 
p robab ility  o f a dye m olecule o f PRESAGE™  is dependent on the photon characteristic dose 
D 37. I t  is evident that the so lution is to  create a batch w ith  a h igher D 37 value (> 1000 G y).
E xisting  hadron therapy treatm ent planning implem ents energy-loss tables based on 
M C  sim ulations to model the physical processes o f prim ary and secondary particles to  a great 
deta il or on experim ental measurements. Since Fricke gels, polym er gels and PRESAGE™
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are the on ly available 3-D in tegrating dosimeters suitable fo r treatm ent p lanning in te r­
comparison, the track structure ca lcu lation results could sim ply be included in  any treatm ent 
p lanning system. The extended target dose (Dsite) m ust be calculated fo r each step in  the 
m odulator wheel (passive scanning systems) o r each narrow  p enc il-like  beam (active 
scanning systems) fo r SOBP as dose contributions from  several d iffe ren t incident particle  
energies are present. This w ould enable the planning system to  calculate the optica l-C T  
response d irec tly  and th is could be compared w ith  the results o f experim ent. W h ils t there 
w ould be no d irect re lation  o f response to  absorbed dose, i t  w ould be h ig h ly  u n like ly  that the 
3-D optica l response measured w ould match that calculated by the planning system i f  the 
underlying dose deposited was s ign ifican tly  d iffe ren t from  that predicted. S im ulations and 
studies are needed to establish whether th is is a viab le route forw ard.
A lso , a m odel that takes in ter-rad ica l recom bination in to  consideration needs to be 
devised. This correction facto r could be applied to the experim ental dose response in  
PRESAGE™  to get a better agreement w ith  ion isation chamber measurements.
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I N P U T  P A R A R M E T E R S
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C A L C U L A T IO N  O F  E N E R G Y  C O N S T A N T
P = 1 -
f  2 \ 2m„c
^mpC +  K E j
(  R2 >2  P2m„c X---
i - p ;
X J ,
relative speed of heavy charged 
particle
maximum electron energy
= — x k x w . maximum electron range
C2JCN e
N =
m„cv y
x 10-7
- 2/  '
1 — exp (—125P2 73)
energy constant
effective charge from stopping 
power in emulsion, z<18
[dimensionless]
[168]
[cm]
[J/cm]
N / A
210
References
1. W ilson, R. R ., Radiological use of fast protons. R adiology, 1946. 47(5): p. 487-491.
2. Newhauser, W . D ., Bum s, J., Sm ith, A . R., Dosimetry fo r ocular proton beam 
therapy at the Harvard Cyclotron Laboratory based on the ICRU Report 59. M edica l 
Physics, 2002. 29(9): p. 1953-1961.
3. Tomo Therapy spinoff to delve into proton technology, 2008. 
h ttp://w w w .isonline.com /business/29493444.htm l.
4. Orecchia, R., Fossati, P., Rossi, S., The national center fo r oncological hadron 
therapy: status of the project and future clinical use of the facility. T um ori, 2009. 
95(2): p. 169-176.
5. Day, M . J., Stein, G ., Chemical effects of ionizing radiation in some gels. Nature, 
1950.166(4212): p. 146-147.
6. Gore, J. C., Kang, Y . S., Schulz, R. J., Measurement of radiation-dose distributions 
by Nuclear Magneic-Resonance (NMR) imaging. Physics in  M edicine and B io logy, 
1984. 29(10): p. 1189-1197.
7. Gore, J. C., et al., Radiation dose distributions in three dimensions from tomographic 
optical density scanning of polymer gels .1. Development of an optical scanner. 
Physics in  M edicine and B io logy, 1996.41(12): p. 2695-2704.
8. M aryanski, M . J., Zastavker, Y . Z ., Gore, J. C., Radiation dose distributions in three 
dimensions from tomographic optical density scanning of polymer gels .2. Optical 
properties of the BANG polymer gel. Physics in  M edicine and B io logy, 1996. 41(12): 
p. 2705-2717.
9. K rsta jic , N ., Doran, S. J., Fast laser scanning optical-CT apparatus fo r 3D radiation 
dosimetry. Physics in  M edicine and B io logy, 2007. 52(11): p. N257-N263.
10. K rsta jic , N ., Doran, S. J., Focusing optics of a parallel beam CCD optical 
tomography apparatus fo r 3D radiation gel dosimetry. Physics in  M edicine and 
B io logy, 2006. 51(8): p. 2055-2075.
11. Sakhalkar, H . S., Oldham, M ., Fast, high-resolution 3D dosimetry utilizing a novel 
optical-CT scanner incorporating tertiary telecentric collimation. M edica l Physics, 
2008. 35(1): p. 101-111.
12. W olodzko, J. G., Marsden, C., Appleby, A ., CCD imaging fo r optical tomography of 
gel radiation dosimeters. M edical Physics, 1999.26(11): p. 2508-2513.
13. Bero, M . A ., Jenneson, P., G ilboy, W . B ., G lover, P. M ., Doran, S. J . , . Faster optical 
tomography with parallel-beam white light fo r three-dimensional dosimetry. 1 st 
International Workshop on Radiation Therapy Gel Dosimetry, Kentucky. 1999.
211
14. K irk , R ., The 3D dosimeter Presage and CCD based optical CT scanner as an 
electron beam radiotherapy dosimetry system. 2007, U n ive rs ity  o f Surrey: G u ild fo rd , 
Surrey.
15. Talbot, D ., An Investigation of a Novel Dosimeter fo r Three-Dimensional Dosimetry 
of Radiotherapy Beams. 2007, U n ive rs ity  College London, U n ive rs ity  o f London: 
London.
16. W ai, P., The application of 3-D dosimetry in brachytherapy treatment. 2007, 
U n ive rs ity  o f Surrey: G u ild fo rd , Surrey.
17. Gustavsson, H ., et a l., Linear energy transfer dependence of a normoxic polymer gel 
dosimeter investigated using proton beam absorbed dose measurements. Physics in  
M edicine and B io logy, 2004.49(17): p. 3847-3855.
18. H eufelder, J., et a l., Use of BANG (R) polymer gel fo r dose measurements in a 6 8  
MeV proton beam. M edical Physics, 2003. 30(6): p. 1235-1240.
19. Jirasek, A ., D uzenli, C., Relative effectiveness of polyacrylamide gel dosimeters 
applied to proton beams: Fourier transform Raman observations and track structure 
calculations. M edica l Physics, 2002.29(4): p. 569-577.
20. Ramm, U ., et a l., Three-dimensional BANG (TM) gel dosimetry in conformal carbon 
ion radiotherapy. Physics in  M edicine and B io logy, 2000.45(9): p. N95-N102.
21. DeJean, P., Senden, R ., M cA u ley, K ., Rogers, M ., Schreiner, L . J., Initial experience 
with a commercial cone beam optical CT unit fo r polymer gel dosimetry II: Clinical 
potential. Journal o f Physics: Conference Series, 2006. 56: p. 183-186.
22. H a ll, E ., Radiobiology fo r the Radiobiologist. 1994, Philadelphia: L ip in co tt 
Company.
23. Johns, H ., The Physics of Radiation Therapy. 11 ed. 1953, S p rin fie ld : Charles C 
Thomas.
24. Johns, H ., et a l . 1,000 curie cobalt units fo r radiation therapy. 1. The Saskatchewan 
cobalt 60 unit. B ritish  Journal o f R adiology, 1952.25: p. 296.
25. Karzm ark, C.J., Nunan C. S., Tanabe E ., Medical electron accelerators. 1993, New 
Y ork: M cG raw - H ill.
26. W ebb, S., The Physics of Three- Dimensional Radiation Therapy. M edica l Science 
Series. 1993, B ris to l: Institu te  o f Physics Publishing.
27. Chen, J., et a l., Improving treatment planning accuracy through multimodality 
imaging. In ternational Journal o f Radiation O ncology B io logy Physics, 1996. 35: p. 
117-124.
28. Petti, P., et a l., Integration of multimodality imaging data fo r radiotherapy treatment 
planning. International Journal o f R adiation O ncology B io logy Physics, 1991. 21: p. 
1653-1667.
29. M icha lsk i, J. M ., et a l., The use of on- line imaging verification to estimate the 
variation in radiation therapy dose delivery. In ternationa l Journal o f R adiation 
O ncology B io logy Physics, 1993. 27: p. 707-716.
212
30. Brewster, L ., et a l., Three dimensional conformal treatment planning with multileaf 
collimators. In ternationa l Journal o f Radiation O ncology B io logy Physics, 1995. 33: 
p. 1081-1089.
31. Gaballa, H . E., et a l., Tissue compensation using dynamic collimation on a linear 
accelerator. In ternationa l Journal o f Radiation O ncology B io logy Physics, 1995. 32: 
p. 723-731.
32. Fraass, B . A ., et a l., A computer- controlled conformal radiotherapy system I: 
overview. In ternational Journal o f R adiation O ncology B io logy Physics, 1995. 33: p. 
1139-1157.
33. W ebb, S., Intensity- Modulated Radiation Therapy. M edical Science Series. 2001, 
B ris to l: Institu te  o f Physics Publishing.
34. W ieszxzycka, W ., Scharf, W ., Proton radiotherapy accelerators. 2001: W orld  
S cientific .
35. Orecchia, R., et a l., Particle beam therapy (hadrontherapy): Basis fo r interest and 
clinical experience. European Journal o f Cancer, 1998.34(4): p. 459-468.
36. K n o ll, G. F., Radiation detection and measurement. 3rd ed ition  ed. 2000, 
Philadephia: John W ile y  &  Sons.
37. Khan, F., The Physics of Radiation Therapy. T h ird  ed. 2003, Philadelphia: L ip p in co tt 
W illiam s &  W ilk in s .
38. Turner, J. E., Atoms, Radiation, and Radiation Protection. 3rd ed. 2007: W iley-V C H .
39. IC R U , Linear Energy Transfer. 1970, In ternational com m ission on rad ia tion units 
and measurements: W ashigton, D .C .
40. Bethge, K ., K ra ft, G., K re isle r, P., Medical Applications of Nuclear Physics. 2004, 
B e rlin : Springer.
41. Chen, G. T . Y ., Castro, J. R., Q uivey, J. M ., Heavy Charged-Particle Radiotherapy. 
Annual Review  o f B iophysics and B ioengineering, 1981.10: p. 499-529.
42. Raju, M . R., Heavy particle radiotherapy. 1980, New Y ork: Academ ic Press.
43. Tubiana, M ., D utre ix, J., W ambersie, A ., Introduction to Radiobiology. 1990, 
London: T aylo r &  Francis.
44. Hendry, J. H ., et al, Basic radiobiology. Review  o f R adiation O ncology Physics: A  
Handbook fo r Teachers and Students, ed. E .B . Podgorsak. 2003, V ienna: IA E A .
45. K ron, T . Biological effects. 2003. R adiation protection in  Radiotherapy. Am m an, 
Jordan.
46. N ias, A . H . W ., An introduction to Radiobiology. 2nd E d ition  ed. 1998, Chichester: 
John W ile y  &  Sons.
47. M ichael, B . D ., H eld, K . D , Fractionation in Radiotherapy, in  V SESSAO DE 
SEMINARIOS -  TEMAS DE RADIOBIOLOGIA E BIOLOGIA TUMORAL. 2008: 
UNIFESP.
213
48. K ra ft, G ., Progress in Particle and Nuclear Physics. Vol 45, Supplement 2. 2000, 
E LS E V IE R  SCIENCE B V : Am sterdam, p. S473-S544.
49. K ra ft, G ., Radiobiological effects of highly charged ions. The Physics o f H ig h ly  and 
M u ltip ly  Charged Ions, ed. F.J. C urre ll. 2002: K luw er Academ ic Publisher.
50. A lonso, J. R., Hadron Particle Therapy. IEEE, 1996: p. 58-62.
51. Lennox, A . J., Accelerators fo r cancer therapy. R adiation Physics and Chem istry, 
2001. 61: p. 223-226.
52. M eyroneinc, S., Therapy. CERN A ccelerator School, 2001: p. 1-25.
53. Ferrari, E ., et al, Principles of Particle Accelerators. 1968, New  Y ork: W .A . 
Benjam in.
54. Bryant, P. J. A  brief history and review of accelerators. CAS - CERN Accelerator 
School: 5th General Accelerator Physics Course. 1992. Jyvaskyla, F inland.
55. C ro w le y -M illin g , M . C ., High-energy particle accelerators. Institu te  o f Physics, 
1983.46: p. 51-95.
56. Strijckm ans, K ., The isochronous cyclotron: principles and recent developments. 
Com puterized M edica l Im aging and Graphics, 2001. 25(2): p. 69-78.
57. Craddock, M . K ., Symon, K . R ., Cyclotrons and Fixed-Field Alternating-Gradient 
Accelerators. Reviews o f Accelerator Science and Technology (R A ST), 2008. 1(1): 
p. 65-97.
58. Paganetti, H ., B ortfe ld , T ., Proton beam therapy-State of the Art, in  New 
Technologies in Radiation Oncology, W . Schlegel, A .L . Grosu, and T . B o rtfe ld , 
Editors. 2005, Springer Verlag: H eidelberg, p. 1-36.
59. M a, C. M ., et a l., Development of a laser-driven proton accelerator fo r cancer 
therapy. Laser Physics, 2006.16(4): p. 639-646.
60. Num berg, F., et a l., Radiochromic film  imaging spectroscopy of laser-accelerated 
proton beams. Review  o f S cien tific  Instrum ents, 2009.80(3).
61. Bulanov, S. S., et a l., Accelerating protons to therapeutic energies with ultraintense, 
ultraclean, and ultrashort laser pulses. M edica l Physics, 2008. 35(5): p. 1770-1776.
62. Schwoerer, H ., et a l., Laser-plasma acceleration of quasi-monoenergetic protons 
from microstructured targets. Nature, 2006. 439(7075): p. 445-448.
63. Pedroni, E., et a l., The 200-Mev Proton Therapy Project at the Paul-Scherrer- 
Institute - Conceptual Design and Practical Realization. M edical Physics, 1995. 
22(1): p. 37-53.
64. Paganetti, H ., et a l., Accurate Monte Carlo simulations fo r nozzle design, 
commissioning and quality assurance fo r a proton radiation therapy facility. M edica l 
Physics, 2004. 31(7): p. 2107-2118.
65. Yasuyuki, A. Proton Beam Therapy. 2004. http://www.nmrc.tsukuba.ac.jp.
214
66. K ra ft, G ., Debus, G. Proton and Heavy Ion Beam Therapy, [c ited; A va ilab le  from : 
http://w w w .nupecc.org/iai2001/report/B31 .pdf.
67. K ra ft, G ., Tumor therapy with ion beams. Nuclear Instrum ents &  M ethods in  Physics 
Research Section A - Accelerators Spectrometers Detectors and Associated 
Equipm ent, 2000.454(1): p. 1-10.
68. Gross, K . D ., P avlovic, M . (ed), Proposal fo r a Dedicated Ion Beam Facility fo r 
Cancer Therapy. 1998, GS1: Darmstadt.
69. Petti, P. L ., Lennox, A . J., Hadronic Radiotherapy. Annual Review  o f N uclear and 
P article Science, 1994.44: p. 155-197.
70. K irsch, D . G ., Tarbell, N . J., Conformal radiation therapy fo r childhood CNS tumors. 
O ncologist, 2004. 9(4): p. 442-450.
71. T s u jii, H . Preliminary Results of Phase I / l l  Carbon Ion Therapy at NIRS. 1996. In t. 
Part. Therapy M eeting and X X IV . PTCOG M eeting. D etro it, M ich igan.
72. Debus, J., Haberer, T ., Schulz-Ertner, D ., Jakel, O., W enz, F., Enghardt, W ., 
Schlegel, W ., K ra ft, G., Wannenmacher, M ., Fractionated carbon ion irradiation of 
skull base tumors at GSI. First clinical results and future perspectives. 
Strahlentherapie Und O nkologie, 2000.176(5): p. 211-216.
73. Orecchia, R ., K reng li, M ., Jereczek-Fossa, B . A ., Franzetti, S., Gerard, J. P., Clinical 
and research validity of hadrontherapy with ion beams. C ritica l Reviews in  O ncology 
Hem atology, 2004. 51(2): p. 81-90.
74. Verhey, L . J., M unzenrider, J. E., Proton beam therapy. Annual Review  o f 
B iophysics and Bioengineering, 1982.11: p. 331-357.
75. Suit, H ., U rie , M ., Proton beams in radiation therapy. Journal o f the N ational Cancer 
Institu te , 1992.84(3): p. 155-164.
76. Bonnett, D . E., Current Developments in Proton Therapy - a Review. Physics in  
M edicine and B io logy, 1993. 38(10): p. 1371-1392.
77. Bogardus, C., IMRT: An Overview. O ncology Issues, 2003.18(2): p. 5-7.
78. Lom ax, A . J., et a l., A treatment planning inter-comparison of proton and intensity 
modulated photon radiotherapy. Radiotherapy and O ncology, 1999. 51(3): p. 257- 
271.
79. Yeboah, C., Sandison, G. A ., Optimized treatment planning fo r prostate cancer 
comparing IMPT, VHEET and 15 MVIMXT. Physics in  M edicine and B io logy, 2002. 
47(13): p. 2247-2261.
80. Bussiere, M . R., Adams, J. A ., Treatment planning fo r conformal proton radiation 
therapy. Technology in  Cancer Research &  Treatment, 2003. 2(5): p. 389-399.
81. Landberg, T ., W ambersie, A ., Prescribing, Recording, and Reporting Photon Beam 
Therapy. 1993, In ternational Com m ission on R adiation U nits and Measurements: 
Bethesda.
215
82. Lom ax, A ., Intensity modulation methods fo r proton radiotherapy. Physics in  
M edicine and B io logy, 1999.44(1): p. 185-205.
83. Lom ax, A . J., G oite in, M ., Adams, J., Intensity modulation in radiotherapy: photons 
versus protons in the paranasal sinus. Radiotherapy and Oncology, 2003. 66(1): p. 
11-18.
84. Lom ax, A . J., et a l., Intensity modulated proton therapy: A clinical example. M edica l 
Physics, 2001.28(3): p. 317-324.
85. Pedroni, E. Latest development in proton therapy, in  EPAC. 2000. V ienna, A ustria.
86. Shortt, K . R ., et a l, Dosimetric principles, quantities and units. Review  o f Radiation 
O ncology Physics: A  Handbook fo r Teachers and Students, ed. E .B . Podgorsak. 
2003, V ienna: IA E A .
87. IC R U , Clinical Proton Dosimtery Part I. 1998, In ternational Com m ission on 
R adiation U nits and Measurements: Bethesda.
88. A ttix , F. H ., Roesch, W . C., and T o ch ilin  E., ed. Radiation dosimetry. Second ed. 
Sources, F ields, Measurements, and A pplica tios. V o l. m . 1969, Academ ic Press: 
New Y ork.
89. Cam bria, R., et a l., Proton beam dosimetry: A comparison between the Faraday cup 
and an ionization chamber. Physics in  M edicine and B io logy, 1997. 42(6): p. 1185- 
1196.
90. Paganetti, H ., Nuclear interactions in proton therapy: dose and relative biological 
effect distributions originating from primary and secondary particles. Physics in  
M edicine and B io logy, 2002. 47(5): p. 747-764.
91. A A P M , Protocol fo r heavy-charged particle therapy beam dosimetry. Report No. 16. 
1986, Am erican Institu te  o f Physics: New Y ork.
92. Palmans, H ., et al., A  small-body portable graphite calorimeter fo r dosimetry in low- 
energy clinical proton beams. Physics in  M edicine and B io logy, 2004. 49(16): p. 
3737-3749.
93. Schulz, R. J., et a l., Water Calorimeter Dosimetry fo r 160 MeV Protons. Physics in  
M edicine and B io logy, 1992. 37(4): p. 947-953.
94. Andreo, P., Bum s, D . T ., H oh lfe ld , K ., Huq, M .S ., Kanai, T ., Laitano, F ., Smythe, 
V .G ., V ynckier, S., Absorbed Dose Determination in External Beam Radiotherapy. 
An International Code of Practice fo r Dosimetry Based on Standards of Absorbed 
Dose to Water. Technical Reports Series No. 398. 2000, IN T E R N A T IO N A L  
A T O M IC  ENERG Y A G E N C Y (IA E A ): V ienna.
95. Geiss, O. B ., Kram er, M ., K ra ft, G., Verification of heavy ion dose distributions using 
thermoluminescent detectors. Nuclear Instrum ents &  M ethods in  Physics Research 
Section B - Beam Interactions w ith  M ateria ls and Atom s, 1998.146(1-4): p. 541-544.
96. Rajan, G., Izewska, J., Radiation dosimeters. Review  o f R adiation O ncology Physics: 
A  Handbook fo r Teachers and Students, ed. E .B . Podgorsak. 2003, V ienna: IA E A .
216
97. V ynckie r, S., Bonnett, D . E., Jones, D . T . L ., Code of Practice fo r Clinical Proton
Dosimetry. Radiotherapy and O ncology, 1991.20(1): p. 53-63.
98. V ynckie r, S., Bonnett, D . E., Jones, D . T . L ., Supplement to the Code of Practice fo r
Clinical Proton Dosimetry. Radiotherapy and Oncology, 1994. 32(2): p. 174-179.
99. V a tn itsky, S., et a l., Proton dosimetry intercomparison. Radiotherapy and O ncology,
1996. 41(2): p. 169-177.
100. V atn itsky, S., et a l., Proton dosimetry inter-comparison based on the ICRJJ report 59 
protocol. Radiotherapy and O ncology, 1999. 51(3): p. 273-279.
101. Kanai, T ., et a l., Cross-calibration of ionization chambers in proton and carbon 
beams. Physics in  M edicine and B io logy, 2004. 49(5): p. 771-781.
102. Watanabe, Y ., et al, Evaluation of a new self-developing instant film  fo r imaging and 
dosimetry. R adiation Protection D osim etry, 2006.120(1-4): p. 121-124.
103. O ldham, M ., et a l., An investigation into the dosimetry of a nine-field tomotherapy
irradiation using BANG-gel dosimetry. Physics in  M edicine and B io logy, 1998. 
43(5): p. 1113-1132.
104. Oldham, M ., et a l., High resolution gel-dosimetry by optical-CT and MR scanning. 
M edical Physics, 2001.28(7): p. 1436-1445.
105. Baldock, C., et a l., Fourier transform Raman spectroscopy of polyacrylamide gels 
(PAGs) fo r radiation dosimetry. Physics in  M edicine and B io logy, 1998. 43(12): p. 
3617-3627.
106. H ilts , M ., et a l., Polymer gel dosimetry using x-ray computed tomography: a 
feasibility study. Physics in  M edicine and B io logy, 2000. 45(9): p. 2559-2571.
107. M ather, M . L ., Baldock, C., Ultrasound tomography imaging of radiation dose 
distributions in polymer gel dosimeters: Preliminary study. M edica l Physics, 2003. 
30(8): p. 2140-2148.
108. Schreiner, L . J., Review of Fricke gel dosimeters. Journal o f Physics: Conference 
Series, 2004. 3: p. 9-21.
109. Adam ovics, J., M aryanski, M . J. A new approach to radiochromic three-dimensional 
dosimetry-polyurethane. Third International Conference on Radiotherapy Gel 
Dosimetry. 2004. Ghent, Belgium : Institu te  o f Physics publishing.
110. De Deene, Y . Essential characteristics of polymer gel dosimeters, in  Journal of 
Physics: Conference Series. 2004.
111. Baldock, C., H arris, P. J., P iercy, A . R ., H ealy, B ., Experimental determination of the 
diffusion coefficient in 2D in ferrous sulphate gels using the finite element method. 
Australas. Phys. Eng. Sci. M ed., 2001. 24: p. 19-30.
112. K e lly , R. G., Jordan, K . J., Battista, J. J., Optical CT reconstruction o f 3D dose 
distributions using the ferrous-benzoic-xylenol (FBX) gel dosimeter. M edica l Physics, 
1998. 25(9): p. 1741-1750.
217
113. Fong, P. M ., et al., Polymer gels fo r magnetic resonance imaging of radiation dose 
distributions at normal room atmosphere. Physics in  M edicine and B io logy, 2001. 
46(12): p. 3105-3113.
114. De Deene, Y ., Fundamental characteristics of ‘normoxic’ polymer gel dosimeters. 
IF M B E  Proceedings o f the W orld  Congress on M edica l Physics and B iom edical 
Engineering, 2003.
115. Adam ovics, J., M aryanski, M . J ., Characterisation of PRESAGE ™: A new 3-D 
radiochromic solid polymer dosemeter fo r ionising radiation. R adiation Protection 
D osim etry, 2006.120(1-4): p. 107-112.
116. Doran, S. J., et a l., A CCD-based optical CT scanner fo r high-resolution 3D imaging
of radiation dose distributions: equipment specifications, optical simulations and
preliminary results. Physics in  M edicine and B io logy, 2001. 46(12): p. 3191-3213.
117. O ldham, M . 3 D  dosimetry by Optical-CT scanning. In  DOSGEL-4th International
Conference on Radiotherapy Gel Dosimetry. 2006. Sherbrook (Quebec), Canada.
118. X u , Y ., W uu, C. S., M aryanski, M . J., Performance of a commercial optical CT 
scanner and polymer gel dosimeters fo r 3-D dose verification. M edica l Physics, 
2004.31(11): p. 3024-3033.
119. Heard, M ., Adam ovics, J., and Ibbo tt, G. S., Measurement of a 200 MeV proton beam 
using a polyurethane dosimeter. Journal o f Physics: Conference Series, 2006. 56: p. 
228-230.
120. Adam ovics, J. A ., Personal communication. 2006.
121. Bonnett, D . E., Kacperek, A ., Sheen, M . A ., G oodall, R ., Saxton, T . E., THE 62 MEV 
PROTON-BEAM FOR THE TREATMENT OF OCULAR MELANOMA AT 
CLATTERBRIDGE. B ritish  Journal o f R adiology, 1993. 66(790): p. 907-914.
122. Doran, S. J., et al. True-3D scans using PRESAGE™ and Optical-CT: A case study in 
proton therapy. Fourth International Conference on Radiotherapy Gel Dosimetry. 
2006. Sherbrooke, Quebec, Canada: Institu te  o f Physics.
123. K rsta jic , N ., Doran, S. J., Characterization of a parallel-beam CCD optical-CT 
apparatus fo r 3D radiation dosimetry. Physics in  M edicine and B io logy, 2007. 
52(13): p. 3693-3713.
124. Kacperek, A ., Protontherapy of eye tumours in the UK: A review of treatment at 
Clatterbridge. A pp lied  Radiation and Isotopes, 2009. 67(3): p. 378-386.
125. Kacperek, A ., Personal communication. 2006.
126. Zeig ler, J. F., SRIM-2006. 2006, h ttp ://w w w .S R IM .org .
127. Back, S. J., et a l., Ferrous sulphate gel dosimetry and MRI fo r proton beam dose 
measurements. Physics in  M edicine and B io logy, 1999.44(8): p. 1983-1996.
128. Katz, R., Sharma, S. C., Hom ayoonfar, M ., The structure of particle tracks, in  Topics 
in radiation dosimetry, F.H . A ttix , E d itor. 1972, Academ ic press: New Y ork. p. 317- 
383.
218
129. Lea, D . E., Actions of radiations on living cells. Second ed. 1962, New Y ork: 
Cambridge U n ive rs ity  Press.
130. Janni, J. F., Proton range-energy tables, 1 keV-10 GeV. Energy Loss, Range, Path 
Length, Time-of-Flight, Straggling, Multiple Scattering, and Nuclear Interaction 
Probability. A T O M IC  D A T A  A N D  N U C LE A R  D A T A  TA B LE S , 1982. 27: p. 147- 
339.
131. Bethe, H ., Zur Theorie des Durchgangs schneller Korpuskularstrahlen durch 
Materie.Aim. d. Physik, 1930. 5: p. 325-400.
132. Edmund, J. M ., Andersen, C. E ., G re ilich , S., A  track structure model of optically 
stimulated luminescence from AI2 O3  : C irradiated with 10-60 MeV protons. N uclear 
Instrum ents &  M ethods in  Physics Research Section B-Beam  Interactions w ith  
M ateria ls and Atom s, 2007. 262: p. 261-275.
133. Paretzke, H . G ., Physical events of heavy ion interactions with matter. A dv Space 
Res, 1986. 6(11): p. 67-73.
134. Fain, J., M onnin, M ., M ontret, M ., Spatial energy-distribution around heavy-ion 
path. R adiation Research, 1974. 57(3): p. 379-389.
135. Butts, J. J., Katz, R., Theory of RBE fo r heavy ion bombardment of dry enzymes and 
viruses. R adiation Research, 1967. 30(4).
136. Katz, R ., Track structure theory in radiobiology and in radiation detection. Nuclear 
Track Detection, 1978. 2(1): p. 1-28.
137. Kobetich, E. J., Katz, R., Width of heavy ion tracks in emulsion. Physical review , 
1968.170(2): p. 405-411.
138. W a ligo rski, M . P. R., Hamm, R. N ., Katz, R ., The radial-distribution of dose around 
the path of a heavy-ion in liquid water. N uclear Tracks and Radiation Measurements, 
1986.11(6): p. 309-319.
139. Hansen, J. W ., Olsen, K . J., Experimental and calculated response of a radiochromic 
dye film  dosimeter to high-LET radiations. R adiation Research, 1984. 97(1): p. 1-15.
140. Hansen, J. W ., Experimental investigation of the suitability of the track structure 
theory in describing the relative effectiveness of High-LET irradiation of physical 
radiation detectors. 1984, R iso N ational Laboratory, D K-4000 R oskilde, Denm ark.
141. Zhang, C. X ., Dunn, D . E., Katz, R ., Radial-distribution of dose and cross-sections 
fo r the inactivation of dry enzymes and viruses. Radiation Protection D osim etry, 
1985.13(1-4): p. 215-218.
142. Olsen, K . J., Hansen, J. W ., Experimental and calculated effectiveness of a 
radiochromic dye film  to stopping 21 MeV Li-7 AND 64 MeV 0-16 ions. N uclear 
Instrum ents &  Methods in  Physics Research Section B-Beam  Interactions w ith  
M ateria ls and Atom s, 1984.233(3): p. 497-504.
143. Prelec, K ., Ions and Ion Accelerators fo r Cancer Treatment. F IZ IK A  B , 1997.
144. Z a jic , V ., Energy vs. LET vs. Range calculator, 
h tttp ://tvd g l0 .p h y  .bnl.gov/LE TC alc.htm l.
219
145. Schreiner, J. L ., Review of Fricke gel dosimeters, in  Third International Conference 
on Radiotherapy Gel Dosimetry. 2004, Institu te  o f Physics publish ing: Ghent, 
B elgium , p. 9-21.
146. De Deene, Y . Essential characteristics of polymer gel dosimeters, in  Third 
International Conference on Radiotherapy Gel Dosimetry. 2004. Ghent, Belgium : 
Institu te  o f Physics Publishing.
147. DeJean, P., Senden, R ., M cA u ley, K ., Rogers, M ., Schreiner, L . J., Initial experience 
with a commercial cone beam optical CT unit fo r polymer gel dosimetry I: Optical 
dosimetry issues. Journal o f Physics: Conference Series, 2006. 56: p. 183-186.
148. Bosi, S., Naseri, P., Puran, A ., Davies, J., Baldock, C., Initial investigation of a novel 
light-scattering gel phantom fo r evaluation of optical CT scanners fo r radiotherapy 
gel dosimetry. Physics in  M edicine and B io logy, 2007. 52(10): p. 2893-2903.
149. Jenkins, F. A ., and W hite, H . E., Fundamentals of Optics. 4th ed ition  ed. 
In ternationa l student edition. 1981, Singapore: M cG raw -H ill.
150. Loth ian, G. F ., Absorption spectrophotometry. T h ird  ed. 1969, London: Adam  H ilg e r 
L td .
151. B rian, M . http://www. fdes.chem.vt. edu/chem-ed/spec/beerslaw.html. 2000.
152. Hecht, E ., Optics. Fourth (International ed ition) ed. 2002, San Francisco: Addison 
W esley.
153. W ikiped ia . Rayleigh scattering. h ttp ://en.w ik iped ia .o rg /w iki/R avle igh  scattering.
154. O ldham, M ., et a l., Optical-CT gel-dosimetry I: Basic investigations. M edica l 
Physics, 2003.30(4): p. 623-634.
155. Bosi, S., et a l., Initial investigation of a novel light-scattering gel phantom fo r 
evaluation of optical CT scanners fo r radiotherapy gel dosimetry. Physics in  
M edicine and B io logy, 2007. 52(10): p. 2893-2903.
156. Jordan, K ., and Battista, J., Scatter measurements fo r optical cone-beam computed 
tomography. 2008: 5th In ternational Conference on Radiotherapy G el D osim etry, 
Hersonissos, Crete, Greece, p. 159-163.
157. Doran, S. J., et a l., Optical CT scanning of PRESAGE™ polyurethane samples with a 
CCD-based readout system. Third International Conference on Radiotherapy Gel 
Dosimetry. 2004, Institu te  o f Physics Publishing: Ghent U n ive rsity, Ghent, B e lg ium  
p. 240-243.
158. Oldham, M ., M cJury, M ., Baustert, I. B ., W ebb, S., Leach, M . O., Improving 
calibration accuracy in gel dosimetry. Physics in  M edicine and B io logy, 1998. 
43(10): p. 2709-2720.
159. Brow n, S., et al., Radiological properties of the PRESAGE and PAGAT polymer 
dosimeters. A pp lied  R adiation and Isotopes, 2008. 66(12): p. 1970-1974.
160. Gunderson, L . L ., Tepper, J. E., Clinical radiation oncology. Second ed. 2007: 
E lsevier Health Sciences. 1827 pages.
220
161. M aryanski, M . J., e t a l., NMR relaxation enhancement in gels polymerized and cross- 
linked by ionizing radiation- A new approach to 3D dosimetry by MRI. M agnetic 
Resonance Im aging, 1993.11(2): p. 253-258.
162. K irb y , D ., et a l. Relative Effectiveness of GafChromic EBT and MD-V2-55 film  fo r 
low energy proton dosimetry, with help from FLUKA and MCNPX. M C N E G  -30-31 
M arch.2009.http://bham .academ ia.edu/docum ents/0011/4830/M CNEG 2009 D K  V  
l.p d f.
163. F idanzio, A ., et a l., A correction method fo r diamond detector signal dependence with 
proton energy. M edica l Physics, 2002. 29(5): p. 669-675.
164. Palmans, H ., Effect of Alanine Energy Response and Phantom Material on Depth 
Dose Measurements in Ocular Proton Beams. Technology in  Cancer Research &  
Treatment, 2003.2 (6): p. 579-586.
165. O nori, S., et a l., Alanine dosimetry of proton therapy beams. M edica l Physics, 1997. 
24(3): p. 447-453.
166. Kohno, R ., et a l., Experimental evaluation of a MOSFET dosimeter fo r proton dose 
measurements. Physics in  M edicine and B io logy, 2006. 51(23): p. 6077-6086.
167. G rusell, E., M edin, J., General characteristics of the use of silicon diode detectors fo r 
clinical dosimetry in proton beams. Physics in  M edicine and B io logy, 2000. 45(9): p. 
2573-2582.
